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In this study, we showed that activated human CD8 T-cells could induce DCs to produce 
IL-12p70 in vitro and this interaction also resulted in the production of a cytokine milieu 
that promoted the differentiation of monocytes into TNF/iNOS-producing (Tip) DCs. 
These Tip-DCs expressed high levels of MHC class II and upregulated co-stimulatory 
molecules CD40, CD80, CD86 and the classical DC maturation marker CD83. Tip-DCs 
exhibited T-cell priming ability and were capable of further driving Th1 responses, 
through their expression of TNF-α and iNOS, by priming naive CD4 T-cells for IFN-γ 
production. Finally, we showed that the ability of CD8 T-cells to differentiate monocytes 
into Tip-DCs also occurred in an in vivo mouse model of allergic contact hypersensitivity 
(CHS). This differentiation and activation of Tip-DCs during CHS responses were 
observed to be compromised in β2m
-/-
, IFN-γ-/- and CCR2-/- mice and mice that were 
depleted of CD8, but not CD4, T-cells. In particular, the presence of Tip-DCs was 
significantly increased in mice that have been treated with a Th1-inducing topical 
sensitizer, DNCB, but not in mice that have been treated with a Th2-inducing sensitizer, 
TMA. Collectively, our results identify a role for CD8 T-cells in orchestrating Th1-
mediating signals, not only through the rapid initiation of DC IL-12p70, but also through 
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CHAPTER 1: Introduction 
_____________________________________________________________________ 
 
1.1   Immunity 
 
“The sick and the dying were tended by the pitying care of those who had recovered, 
because they knew the course of the disease and were themselves free from 
apprehensions. For no one was ever attacked a second time, or not with a fatal result” 
--- Thucydides, 430 B.C. A description of the plague which hit Athens. 
 
Immunity was originally described as a condition that permits resistance and protection 
from a disease. However, it is now clear that many of the crucial mechanisms governing 
a body’s immune response to infections are also involved in the individual’s response to 
non-infectious foreign substances. Importantly, the immune system consists of different 
layers of defenses with increasing specificity which can be subdivided into the innate and 
adaptive immune response. 
 
1.1.1   Innate Immunity 
 
Innate immunity is the natural resistance a person is born with which does not 
discriminate between most foreign agents. It provides resistance through several physical, 
chemical, and cellular approaches. The first consists of physical barriers such as skin and 
mucous membranes while the subsequent general defenses include cytokines, 
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complement, fever, and phagocytic activity. Phagocytes such as dendritic cells (DCs) and 
macrophages express pattern recognition receptors (PRR) such as Toll-like receptors 
(TLRs) which bind and respond to common molecular patterns expressed on invading 
microbes. Granulocytes (i.e. neutrophils, basophils and eosinophils) can release a variety 
of toxic substances that kill or inhibit growth of bacteria and fungi while basophils, 
eosinophils and mast cells secrete histamine which is important for parasite eradication. 
Lastly, Natural Killer (NK) cells destroy compromised host cells, such as tumor cells or 
virus-infected cells by recognizing low levels of MHC class I (major histocompatibility 
complex) expressed on cells. Through these approaches, the innate immune system can 
prevent the colonization, entry, and spread of microbes. However, it does not confer 
long-lasting immunity to the host as they operate through receptors encoded in the 
genome; therefore our body has a second line of defense known as the adaptive 
immunity. 
 
1.1.2   Adaptive immunity 
 
Thought to have arisen in the first jawed vertebrates, the adaptive or "specific" immune 
system is initiated by cells of the innate immune system, such as DCs. The adaptive 
immune response caters the ability to recognize and remember specific pathogens so as to 
mount stronger defense each time the pathogen is encountered. The system is highly 
adaptable because of somatic hypermutation, a process of accelerated somatic mutations, 
and V(D)J recombination, which is an irreversible genetic recombination of antigen 
receptor gene segments. This mechanism allows a small number of genes to generate a 
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vast number of different antigen receptors, which are then uniquely expressed on each 
individual lymphocyte. B cells and T cells are the major types of lymphocytes. T cells 
provide important cell mediated immunity by participating in the cytolysis of infected 
cells through the recognition of antigen presented on MHC class I. They do so through 
the T cell receptor (TcR) which is composed of two different polypeptide chains, α and β, 
linked together by disulphide bonds. They can also recognize antigen on MHC class II 
molecules and provide help to other immune cells by secreting cytokines. On the other 
hand, B cells provide humoral immunity by producing antibodies or immunoglobulins 
(Ig) which are used by the immune system to identify and neutralize foreign particles. 
Like T cells, B cells express a unique B cell receptor (BCR), which recognizes and binds 
to only one particular antigen. While T cells recognize their cognate antigen in a 
processed form such as a peptide in the context of a MHC molecule, B cells recognize 
antigens in their native form. Once a B cell encounters its antigen, it receives help from T 
cells which results in isotype class switching from IgM to either IgG, IgA, IgE isotypes. 
In this way, the adaptive immune system allows the formation of memory such that these 
cells can be called upon to respond quickly upon a re-infection; while the host 
experiences few, if any, symptoms. 
 
1.2   CD8 T-cells 
 
The role of CD8 T-cells was first discovered when it was demonstrated in 1960 that 
lymphocytes, as opposed to antibodies made from B-cells in sera, destroyed allogeneic 
targets in vitro (GOVAERTS, 1960). Subsequently, Golstein, Wigzell, and colleagues 
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(Golstein et al., 1971) demonstrated that these lymphocytes were both cytotoxic and 
specific. This killing mechanism was then further explained by Rolf Zinkernagel and 
Peter Doherty (Zinkernagel and Doherty, 1974a; Zinkernagel and Doherty, 1974b), who 
observed that cytotoxic T-cells exert their killing functions by using their TCRs to 
recognize antigenic peptides presented on MHC class I. Finally, depletion of Ly-2 
(CD8α) and Ly-3 (CD8β) bearing lymphocytes by treatment with anti-sera and 
compliment abolished cell mediated cytotoxic function, thereby establishing the cytotoxic 
role of CD8 T-cells (Cantor and Boyse, 1975; Kisielow et al., 1975; Shiku et al., 1975) 
 
1.2.1   Activation of CD8 T-cells 
 
By virtue of a defined set of homing receptors such as CD62L and the chemokine 
receptor CCR7, naive CD8 T-cells circulate between the blood and secondary lymphoid 
organs. Upon encounter with antigen presented on DCs, CD8 T-cells proliferate and 
differentiate into effector T-cells. These activated effector CD8 T cells express killing 
molecules such as Fas Ligand (FasL) and secrete the pore forming molecule perforin and 
granule enzymes granzyme A and B (Berke, 1995). They then induce cytolysis of 
infected cells either by the granule exocytosis pathway through co-ordinated delivery of 
perforin and granzymes into target cells, or by upregulation of FasL which initiates 
programmed cell death by aggregation with Fas (CD95) on target cells. Notably, while all 
nucleated cells express MHC class I, CD8 T-cells only kill infected or tumor cells that 
present the appropriate antigenic peptides on MHC class I. Effector CD8 T-cells also 
elaborate cytokines, including IFN-γ and TNF-α, as well as chemokines, such as 
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RANTES, MIP-1α and MIP-1ß, that function to recruit and activate mononuclear cells 
and granulocytes (Harty and Bevan, 1999).  
 
During an infection, the CD8 T-cell response typically peaks about 7 days after encounter 
with antigen and is followed by a contraction phase, when 90–95% of the effector cells 
die in the ensuing days and weeks and the remaining 5–10% become long-lived memory 
cells (Harty and Badovinac, 2008; Joshi and Kaech, 2008; Prlic et al., 2007). These 
memory cells are able to mobilize their effector mechanisms very rapidly upon re-
encounter with the same antigen which serves as a basis for protective vaccination 
against infectious diseases. Human CD8 T-cells can be distinguished into naive, effector 














 (Sallusto et al., 1999). In addition, 
a population of “memory revertants” has been shown to express CD45RA but are CCR7-. 
In mice, the expression of CD44 is also an indicator of the memory status of CD8 T-cells 
(Gerberick et al., 1997).  
 
1.2.2   CD8 T-cell subsets 
 
Just like the Th1/Th2 classification of CD4 T cells, activated CD8 T cells can also be 
broadly classified into Tc1 or Tc2 cells upon activation by stimuli based on their cytokine 
expression profiles. Tc1 cells secrete IFN-γ and TNF-α while Tc2 cells predominantly 
secrete IL-4 and IL-5 (Croft et al., 1994; Noble et al., 1995; Sad and Mosmann, 1995). 
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Despite the similarities between CD4 and CD8 T-cells, CD4 Th1 cells require the 
presence of IL-12 for IFN-γ production while CD8 Tc1 cells are capable of producing 
IFN-γ independently of IL-12 (Carter and Murphy, 1999; Croft et al., 1994). Since CD8 
T-cells are predominantly IFN-γ producers and rarely make Th2 cytokines, they are 
strongly biased towards the Tc1 phenotype (Fong and Mosmann, 1990). However, under 
the appropriate conditions such as in the presence of IL-2 and IL-4, CD8 T-cells can 
produce significant amounts of IL-4 thereby resembling the Tc2 phenotype (Seder et al., 
1992; Vukmanovic-Stejic et al., 2000). Tc2 cells have also been observed clinically, 
especially in lesions of lepromatous leprosy patients (Salgame et al., 1991), in asthma 
(Ying et al., 1997), in chronic obstructive pulmonary disorder (Barczyk et al., 2006), in 
graft-versus-host disease (Fowler et al., 2006) and in several forms of cancer (Dobrzanski 
et al., 2006; Ito et al., 2005a; Sasaki et al., 2007). Recently, CD8 T cells expressing IL-17 
have also been documented and have been termed Tc17 cells (Burrell et al., 2008; Yen et 
al., 2009). As with cytolytic effector mechanisms, expression of cytokine molecules by 
CD8 T cells is tightly regulated through TCR-dependant signals (Harty et al., 2000). 
 
1.3   Dendritic cells  
 
Dendritic cells (DCs) were discovered in 1973 by Ralph Steinman and Zanvil Cohn when 
they observed an unusual looking population of cells with a distinct stellate morphology. 
They had long cytoplasmic processes containing large spherical mitochondria which, in 
the living state in vitro, are continually elongating, retracting, and reorienting themselves, 
leading to a wide variety of cell shapes (Steinman and Cohn, 1973). Thereafter, the 
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authors found that these DCs had an unprecedented ability to activate naive T cells 
(Steinman and Cohn, 1974). These cells are now known as the primary instigators of the 
adaptive immunity as they are vital for detecting, alerting and priming the adaptive 
immune system to invading pathogens (Banchereau et al., 2000; Banchereau and 
Steinman, 1998)  
 
1.3.1   Activation of DCs 
 
According to the classical paradigm, DCs are located in peripheral tissues in an immature 
state where they act as immune sentinels, exemplified by their ability to sample their 
local environment for pathogens through macropinocytosis and endocytosis 
(Guermonprez et al., 2002; Sallusto et al., 1995). However, immature DCs are poor 
APCs, because they retain most of their MHC molecules intracellularly and are unable to 
form peptide–MHC class II complexes (Cella et al., 1997; Pierre et al., 1997). 
Nevertheless, upon encounter with pathogens, they undergo activation and “maturation” 
and migrate via lymphatic vessels to the draining lymph nodes where they interact with 
T-cells (Randolph et al., 2005). This maturation process also transforms immature DCs 
from efficient antigen capturers into professional antigen presenters through carefully 
orchestrated alterations in membrane traffic. Besides the downregulation of endocytosis 
controlled by Rho family GTPases, such as Cdc42 (Garrett et al., 2000), cathepsin S 
activity is activated upon maturation resulting in the release of MHC class II from Ii 
chain and the subsequent delivery of peptide-αβ dimers to the plasma membrane (Turley 
et al., 2000). Internalized antigens are directed to specialized intracellular compartments 
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where they are degraded and subsequently loaded onto MHC class II molecules. MHC 
class II-peptide complexes are then directed to the surface for presentation to CD4 T 
cells. Mature DCs can also process and cross present antigenic peptides by transporting 
them via the TAP transporter to the endoplasmic reticulum (ER) where they bind to 
nascent MHC class I and are directed to the surface for priming of CD8 T cells 
(Cresswell et al., 1999; Suh et al., 1994). These mature DCs also increase the expression 
of co-stimulatory molecules and secrete cytokines that have an influential impact on the 
outcome of the adaptive immune response (Banchereau and Steinman, 1998). 
 
1.3.2 Heterogeneity of DCs in mice 
 
DCs are heterogeneous and exist in various locations, such as in the peripheral tissues, 
lymphoid organs and the blood. In mice, conventional DCs (cDCs) can be classified as 
migratory where they are mainly located in peripheral tissues or residential where they 
reside in lymphoid organs (Shortman and Liu, 2002). In lymphoid organs such as the 
spleen, there are three distinct populations of lymphoid resident DCs, namely 
CD4
+CD8α-, CD4-CD8α+ and CD4-CD8α- (Vremec et al., 2000). Skin draining lymph 
nodes also contain three extra DC subsets representative of skin DC migrants derived 
from the periphery. These are Langerhans DCs (CD8αloCD11b+ CD205hiLangerin+) and 2 
subsets of dermal DCs distinguished by their expression of CD11b and CD103 (CD4
-
CD8α-CD11b+CD103- and CD4-CD8α-CD11b-CD103+) (Bursch et al., 2007; Ginhoux et 
al., 2007; Poulin et al., 2007). There are also other non-conventional DC subsets 








) (Asselin-Paturel et 
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) (Chan et al., 2006; Taieb et 
al., 2006) which respond rapidly to viruses by the rapid production of type I interferons.  
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Fig 1.1 Known Mouse DC subsets and their characteristics 
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1.3.3   Heterogeneity of DCs in humans 
 





 myeloid DCs and pDCs (Collin et al., 2011; Grage-Griebenow et al., 2001; 
MacDonald et al., 2002). The non-classical CD16
+
 human monocyte may also be 
considered a blood myeloid DC (MacDonald et al., 2002). However, CD8α, the major 
marker used to segregate mouse cDC subsets, is not expressed by human cDCs (Dzionek 
et al., 2000). CD141
+
 myeloid DCs found in human blood are thought to have equivalent 
antigen cross-presenting function to mouse DCs that can be identified by CD103 
expression in most tissues and by CD8 expression in lymphoid organs. In both species, 
C-type lectin 9A (CLEC9A), XC-chemokine receptor 1 (XCR1) and Toll-like receptor 3 
(TLR3) are conserved on these cells (Bachem et al., 2010; Crozat et al., 2010; Jongbloed 
et al., 2010; Poulin et al., 2010). While tissue equivalents of the blood CD141
+
 DC have 
not yet been described in humans, most organs contain a sizeable proportion of migratory 
CD1c
+
 myeloid DCs that are distinct from macrophages (Ochoa et al., 2008; Zaba et al., 
2007) and monocyte-derived DCs that express CD14 and CD209 (also known as DC-
SIGN) (Angel et al., 2007). A recent study has also shown that human DC subsets in the 
spleen were functionally and phenotypically similar to those in human blood (Mittag et 
al., 2011). However due to the small numbers of such DCs in the blood, human studies of 
DCs are often conducted using monocyte-derived DCs generated by culturing monocytes 
with IL-4 and GM-CSF (Sallusto and Lanzavecchia, 1994). Fig 1.2 illustrates a 
comparison of human DCs with known mouse equivalents 
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1.4   T helper responses 
 
A principal component of the adaptive immune response is the CD4 T helper cell which 
differentiates according to distinct stimuli. To date, at least four different T helper subsets 
have been described. These main subsets are known as Th1, Th2, Th17 and Treg cells 
(Harrington et al., 2005; Langrish et al., 2005; Mosmann and Coffman, 1989; Sakaguchi, 
2004). 
 
1.4.1   Th1 and Th2 cells 
 
Before the discovery of Th17 and Treg cells, effector CD4 T-cells were classically 
divided into two distinct lineages: Th1 cells, characterized by their production of IFN-γ, 
are essential for eradicating intracellular pathogens while Th2 cells, distinguished by their 
production of IL-4, IL-5,  IL-10 and IL-13, are potent activators of B-cell IgE production 
and eosinophil recruitment for eradicating parasites (Mosmann and Coffman, 1989). 
Immune pathogenesis that results from dysregulated Th1 responses to self or commensal 
floral antigens can promote tissue destruction and chronic inflammation while 
dysregulated Th2 responses results in allergy and asthma. 
 
1.4.2 Th17 and Treg cells 
 
Recent studies have suggested a greater diversification of the CD4 T-cell effector 
repertoire than that encompassed by the Th1/Th2 paradigm. New studies that link the 
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cytokines IL-23 and IL-17 to immune pathogenesis previously attributed to the Th1 
lineage have delineated a new effector CD4 T-cell arm — referred to as Th17 (Cua et al., 
2003). Th17 cells produce IL-17, IL-21 and IL-22 and are important for immunity against 
extracellular bacteria and fungi species. However, excessive numbers of these cells are 
known to cause tissue injury in autoimmune diseases (Harrington et al., 2005; Stockinger 
et al., 2007). In addition, another subset known as the T regulatory (Treg) cells 
characterized by CD25 and Foxp3 expression were found to produce IL-10 and TGF-ß 
(Fehérvari and Sakaguchi, 2004). These cells are crucial for dampening the immune 
response during infections to prevent excessive inflammation but have also been involved 
in the pathogenesis of leishmaniasis, AIDS, and certain cancers (Cools et al., 2007). 
 
1.4.3   Control of T helper responses 
 
The response to a pathogen at the early stages of an infection or disease is typically 
dominated by one T cell subset, and T cell subsets may be antagonistic to each other. 
This highlights the importance of mounting a proper protective T helper response during 
an infection. Since DCs are the principle cell type that prime T cells, controlling DC 
activity is the key to mounting a proper T cell response. The differentiation of CD4 Th1 
cells by DCs is largely mediated by IL-12p70 (Trinchieri, 2003). Additionally, IL-18 
(Nakanishi et al., 2001; Salagianni et al., 2007) and type I interferons (Brinkmann et al., 
1993; Parronchi et al., 1992) also contribute to Th1 polarization. Th2 polarization is 
mediated by IL-4 (Le Gros and Erard, 1994; Swain et al., 1990), OX40L (Ito et al., 
2005b), IL-25 (Fort et al., 2001) and IL-33 (Schmitz et al., 2005). The notch ligand 
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families, Delta and Jagged, also regulate Th1 and Th2 polarization respectively (Amsen 
et al., 2004). On the other hand, DC production of TGF-ß, IL-6, IL-21 and IL-23 were 
shown to favour differentiation of Th17 cells (Dong, 2008; Stockinger and Veldhoen, 
2007) while the presence of TGF-ß, IL-4 and IL-10 can induce Treg cells (Chatenoud, 
2006).  
 
1.4.4   Transcription factors 
 
T-bet is the central transcription factor involved the development of Th1 cells (Szabo et 
al., 2000). T-bet potently activates the transcription of the IFN-γ gene, and its expression 
is correlated with IFN-γ production by Th1 and NK cells. IL-12 and IFN-γ triggers 
STAT1 and STAT4 which eventually leads to the activation of T-bet (Afkarian et al., 
2002; Grogan et al., 2001; Lighvani et al., 2001). GATA-3 is the critical regulatory 
transcription factor involved in Th2 differentiation controlling IL-4, IL-5, IL-10 and IL-
13 transcription (Ouyang et al., 1998; Zhang et al., 1997; Zheng and Flavell, 1997). 
STAT6 is also a central mediator of IL-4 signaling and Th2 development that acts 
upstream of GATA-3 (Hou et al., 1994). In contrast, STAT3, ROR-α and ROR-γ 
mediates the development of Th17 cells (Dong, 2008). Fig 1.3 illustrates the development 
















Fig 1.3 Development of T helper subsets after interacting with DCs  
 
1.5   Interleukin-12  
 
IL-12 is a pivotal pro-inflammatory cytokine comprising of the p35 and p40 subunits 
whose genes are located on separate chromosomes, namely chromosome 3 and 5 in 
humans, and chromosome 6 and 11 in mice respectively (Trinchieri, 1998). These two 
genes are regulated independently (Trinchieri, 1998) and have to be expressed in a highly 
coordinated fashion in the same cell to produce the biologically active heterodimer, IL-
12p70 (Wolf et al., 1991). IL-12 is mainly produced by APCs (Trinchieri, 2003) and 
differential control of p35 and p40 subunit transcription results in modest IL-12p40, but 
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with LPS together with IFN-γ or CD40 Ligand, but not either alone, results in the 




While the Th1 inducing capacity is only restricted to the IL-12p70 heterodimer (Gubler et 
al., 1991; Kobayashi et al., 1989; Trinchieri, 2003), the p40 subunit is often produced in 
excess over the p70 heterodimer and has also been shown to have important 
immunological functions. For example, IL-12p40 homodimers are known to bind to the 
IL-12 receptor, IL-12Rβ1, which antagonizes the activity of IL-12p70 (Gately et al., 
1996; Gillessen et al., 1995; Mattner et al., 1993). It also activates T-cells, acts as a 
chemokine that attracts macrophages (Ha et al., 1999) and induces DC migration (Khader 
et al., 2006). It can also induce the expression of TNF-α and iNOS in myeloid cells (Jana 
et al., 2003; Pahan et al., 2001).  
 
1.5.2   Importance of IL-12p70 
 
Notably, IL-12p70 is the primary factor produced by DCs that drives the development of 
Th1 responses (Heufler et al., 1996; Macatonia et al., 1995; Trinchieri, 2003). IL-12p70 
binds to the IL-12 receptor which is composed of two chains, the IL-12Rβ1 and IL-
12Rβ2. The IL-12 receptor is expressed by T cells and NK cells (Presky et al., 1996), 
DCs and B cell lines (Airoldi et al., 2000; Grohmann et al., 1998). CD4 Th1 cells, but not 
Th2 cells, express IL-12Rβ2 and respond to IL-12 (Rogge et al., 1997; Szabo et al., 
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1997). Upon activating the IL-12 signalling cascade, IL-12p70 causes NK cells to 
produce IFN-γ, which enhances the bactericidal activity of macrophages during the early 
phases of infection (Gazzinelli et al., 1994). It also plays an important role by activating 
bystander resting T cells and maintaining the antigen specific Th1 response (Kubin et al., 
1994). IL-12p70 also enhances the cytotoxic activity of CTLs through upregulation of 
adhesion molecules and transcription of genes that encode perforin and granzymes 
(Kobayashi et al., 1989; Trinchieri, 1998). 
 
The importance of IL-12 in the development of functional Th1 responses has been 
established in several in vivo studies with IL-12 neutralizing antibodies, IL-12 knockout 
mice or STAT-4-deficient animals (Magram et al., 1996; Stern et al., 1996; Trinchieri 
and Scott, 1994). These examples highlight its function as an immunoregulatory cytokine 
that bridges the innate resistance and adaptive immunity (Trinchieri, 2003). While IL-
12p35
-/-
 mice are deficient in Th1 responses, IL-12p40 deficient mice are also susceptible 
to infections with several intracellular pathogens.  However IL-12p35
-/-
 mice, but not IL-
12p40
-/- 
mice, developed experimental autoimmune encephalomyelitis (Becher et al., 
2002; Gran et al., 2002). These observations are due to the association of the p40 subunit 
with the p19 subunit which forms IL-23 (Oppmann et al., 2000). IL-23 promotes the 
differentiation of Th17 cells (Park et al., 2005) and is involved in the development of 
inflammatory and autoimmune associated diseases (Cua et al., 2003; Langrish et al., 
2005; Murphy et al., 2003; Wiekowski et al., 2001). However IFN-γ, which can be 
induced by IL-12p70, has been shown to inhibit Th17-cell development and this finding 
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may help to explain how IL-23-induced Th17-cell-mediated pathology might be 
negatively regulated by IFN-γ or IL-12p70 (Bettelli et al., 2007; Weaver et al., 2007). 
 
1.6   Modulation of DCs by immune cells 
 
Since DCs form an important bridge between the innate and adaptive immune systems, 
the microenvironment where DCs receive their first signals is important for their 
subsequent T-cell inducing properties. For example, the lung microenvironment, 
mediated by lung resident pDCs, conditions DCs to induce tolerance to harmless inhaled 
antigens, thereby suppressing the potential of lung derived myeloid DCs to generate 
effector T cells (de Heer et al., 2004). During an allergic reaction, however, stimulation 
of lung epithelial cells via pathogen recognition receptors (PRRs) results in the 
production of thymic stromal lymphopoietin (TSLP) that directly activates DCs to 
differentiate CD4 T-cell into Th2 cells in an OX40L dependent manner (Hammad and 
Lambrecht, 2008; Ito et al., 2005b; Wang et al., 2006b).  
 
1.6.1   Modulation of DCs by B-cells 
 
It has been shown that B cells can generate Th2 promoting DCs by producing IL-10 
(Mizoguchi et al., 2002; Moulin et al., 2000; Skok et al., 1999). DCs from B cell deficient 
mice were shown to produce increased levels of IL-12 and exhibit enhanced Th1 
responses (Moulin et al., 2000). Conversely, cell mediated immunity can be enhanced by 
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the binding of antigen IgG complexes on FcγRI and FcγRIII on DCs that promotes cross-
presentation of these antigens (Regnault et al., 1999).  
 
1.6.2   Modulation of DCs by mast cells and fibroblasts 
 
Mast cells are found abundantly in mucosal tissues and are located in close proximity to 
immature DCs where they may have a Th2 directing effect on DCs. Mast cells secrete 
histamine in response to IgE-immune complexes that binds to Fcε receptors. Histamine 
has a profound effect on DCs by suppressing IL-12 and promoting the production of IL-
10 (Caron et al., 2001; Mazzoni et al., 2001; van der Pouw Kraan et al., 1998). Similarly, 
prostaglandin D2, another major product of activated mast cells, strongly suppresses 
DC’s production of IL-12 (Faveeuw et al., 2003). More recently, the presence of 
fibroblasts in the tissue environment can promote DC maturation (Saalbach et al., 2007) 
and migration (Saalbach et al., 2010), and have also been shown to induce DCs to 
produce IL-23 in an inflammatory condition in vitro, thereby promoting Th17 responses 
(Schirmer et al., 2010). 
 
1.6.3   Modulation of DCs by NK cells 
 
NK cells have been shown to promote the activation of DCs for anti-tumor effects 
(Fernandez et al., 1999) and viral immunity (Andrews et al., 2003). Activated NK cells 
produce TNF-α and IFN-γ that promotes DC maturation and Th1 polarization (Gerosa et 
al., 2002; Mailliard et al., 2003; Mocikat et al., 2003). Alternatively, NK cells can 
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negatively regulate DCs by killing them (Piccioli et al., 2002; Wilson et al., 1999). 
Neutrophils have also been shown to activate DCs to trigger Th1 responses and this 
interaction is driven by the binding of the DC-specific, C-type lectin DC-SIGN to the β2-
integrin Mac-1 (van Gisbergen et al., 2005). 
 
1.6.4   Modulation of DCs by CD4 T-cells 
 
Mice deficient in CD4 T-cells are unable to mount effective cytotoxic responses as they 
are important for “licensing” DCs to activate the killing ability of CD8 T-cells (Bennett et 
al., 1998; Ridge et al., 1998; Schoenberger et al., 1998). This licensing process is 
dependent on CD40L as mice lacking CD40 or CD40L did not mount helper-dependent 
cytotoxic responses. In particular, pre-stimulation of DCs with anti-CD40 in vitro, or the 
injection of anti-CD40 antibodies into helper T-cell deficient mice, restored the ability of 
DCs to produce inflammatory cytokines such as IL-12 and thereby stimulating CD8 T 
cell killer responses (Caux et al., 1994; Cella et al., 1996).  
 
1.6.5   Modulation of DCs by CD8 T cells 
 
Besides their role in cytotoxic killing, CD8 T-cells have been shown to be important for 
the promotion of Th1 responses. In particular, CD8 T cells were demonstrated to induce 
protective Th1 responses against microbial infections in vivo. It was observed that low 
dose Lesihmania major infection resulted in Th2 responses and that CD8 T cells were 
required for the eventual down modulation of low dose induced Th2 responses and 
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resistance to L. major (Uzonna et al., 2004). Likewise, depletion of CD8 T cells 
abrogated the protective Th1 response induced by DNA vaccination (Gurunathan et al., 
2000), suggesting that CD8 T cells were vital for the polarization of Th1 cells. This was 
also supported by studies demonstrating the involvement of CD8 T cells in the generation 
of protective CD4 Th1 responses during retroviral infection (Peterson et al., 2002).  
 
Importantly, CD8 T cells have the ability to deviate immune responses away from 
allergic Th2 phenotypes. Previous work from our group have demonstrated that depletion 
of CD8 T-cells in vivo in OVA/alum sensitized and challenged animals caused a drastic 
increase in IgE responses. On the other hand, adoptive transfer of OVA specific CD8 T-
cells resulted in a significant reduction in IgE (MacAry et al., 1998). Subsequently, it was 
shown that CD8 T-cell mediated IgE suppression was abolished in IL-12 and IL-18 
deficient hosts, but could be restored by the transfer of wildtype DCs (Salagianni et al., 
2007; Thomas et al., 2002). These results indicate that CD8 T cells can exert their pro-
Th1 response by stimulating DCs to produce IL-12 and IL-18. Above all, CD8 T cells are 
able to induce DCs to mature (Ruedl et al., 1999) and enhance their Th1 capabilities by 
utilizing IFN-γ, GM-CSF, TNF-α and CD40L, to induce IL-12p70 from DCs (Mailliard 
et al., 2002; Thomas et al., 2002; Wong et al., 2008; Wong et al., 2009). Importantly, 
CD8 T-cells are shown to interact with DCs in lymph nodes (Mempel et al., 2004) and 
peripheral tissue sites (Aldridge et al., 2009; McGill et al., 2008) where they exert their 
pro-Th1 influence. 
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Similarly to NK cells, CD8 T cells can also negatively regulate DC activity by inducing 
their apoptosis in vivo (Guarda et al., 2007). However, DCs are also protected from 
killing by CD8 T-cells by expressing protease inhibitors, such as protease inhibitor-9 and 
serpin serine protease inhbitor-6 (Hirst et al., 2003; Medema et al., 2001). These 
proteases are up-regulated by factors that activate DCs including LPS and TNF-α. 
Interestingly, recent studies have shown that memory CD8 T cells protected DCs from 
killing through cytotoxic granules by releasing TNF-α early during interaction, thereby 
inducing the expression of granzyme B inhibitor PI-9 in these DCs (Nakamura et al., 
2007; Watchmaker et al., 2008). 
 
1.7   Bystander mediated effects 
 
While most immune mechanisms involve specific cell-cell interactions, studies have 
shown that the activation and suppression of other immune cells in the nearby vicinity 
can also occur without physical interaction. Of note, such “bystander mediated effects” 
often occur during inflammation and is mediated by cytokines being produced by 
activated cells which further modulate the immune response.  
 
1.7.1   Bystander mediated effects on uninfected cells 
 
Virus-specific T-cells have been shown to migrate
 
to areas of infection in peripheral sites 
where they encounter viral peptides presented by viral infected cells. CD8 T-cells 
recognizing such cells would then release cytotoxic granules resulting in the killing of 
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these infected cells. Under these circumstances, the dying cells, CD8 T-cells and other 
APCs such as macrophages and DCs within the inflammatory focus would release 
cytokines such as TNF-α, TNF-ß, lymphotoxin (LT), and reactive oxygen species such as 
nitric oxide (NO), which would lead to bystander killing of the uninfected neighboring 
cells. This results in additional immunopathology at sites of infection (Duke, 1989; 
Smyth and Sedgwick, 1998). Such bystander mediated effects also appear to occur for 
CD4 T cells that recognize peptides on MHC class II (Yasukawa et al., 1993). In this 
case, CD4 T-cells can release cytokines that would not only kill uninfected cells but may 
also stimulate nearby macrophages which would kill uninfected cells in a bystander 
manner (Mitrovic et al., 1994). 
 
1.7.2   Bystander activation of T-cells 
 
Bystander activation of T cells, i.e. the stimulation of unrelated, heterologous T-cells by 
cytokines during an antigen-specific T-cell response can also occur for CD8 T-cells and 
to a lesser extent, CD4 T-cells. T cell proliferation in vivo is presumed to reflect a TCR-
mediated polyclonal response. However, the massive proliferation of T cells seen in viral 
infections is suggestive of a cytokine-driven bystander reaction instead of the TCR as 
such proliferation was not associated with up-regulation of CD69 or CD25 (Tough et al., 
1996). In particular, memory CD44
hi
 CD8 T-cells are activated through such bystander 
mediated mechanisms when they are stimulated by IFN-α/β (Tough et al., 1996), IFN-γ, 
IL-12, IL-15, and IL-18 produced by APCs interacting with antigen specific T-cells 
(Tough et al., 1999; Zhang et al., 2001). These CD8 T-cells produce IFN-γ rapidly and 
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while they may be protective in some bacteria models (Lertmemongkolchai et al., 2001; 
Yajima et al., 2002), they are often dispensable and may even contribute to the induction 
of autoimmune diseases due to their cross reactivity (Fujinami et al., 2006; Gilbertson et 
al., 2004; Mueller and Jenkins, 1997).  
 
1.7.3   Bystander activation or suppression of immune responses 
 
Bystander mediated activation or suppression of DCs can also influence the outcome of 
an immune response. Oral infection with Salmonella enterica serovar typhi causes 
typhoid and in particular, Salmonella flagellin, which is recognized by host cells through 
TLR 5 has been identified as a mediator of inflammation (Honko and Mizel, 2005; 
Salazar-Gonzalez and McSorley, 2005). However splenic DCs express little or no TLR5 
and are not responsive to flagellin (Means et al., 2003; Uematsu and Akira, 2006). It was 
subsequently discovered that the activation of such splenic DCs occurred in a bystander 
mediated fashion through activation of bone marrow-derived cells and required MyD88 
expression (Salazar-Gonzalez et al., 2007). Such innate immune responses to flagellin is 
highly deleterious to the growth of Salmonella in vivo, and offers an explanation for 
bacterial modulation of flagellin expression in vivo (Cummings et al., 2006; Eriksson et 
al., 2003). Similar bystander activation of DCs has also been described with LPS (Yadav 
et al., 2006). In contrast, pathogens such as Mycobacterium tuberculosis can evade 
immune responses by inhibiting the differentiation of bystander non-infected monocytes 
into DCs through the release of interleukin-10 (Remoli et al., 2011). Therefore, the 
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presence of different cytokines in the microenvironment can directly affect the outcome 
of bystander mediated immune responses. 
 
1.8   Monocytes 
 
Monocytes are heterogeneous bone marrow-derived cells that circulate in the blood and 
rapidly extravasate into inflamed tissues upon sensing environmental signals.  
 
1.8.1   Monocyte heterogeneity 
 
Two major subsets of blood monocytes have been described in mice and humans 
(Geissmann et al., 2003; Sunderkötter et al., 2004; Ziegler-Heitbrock, 2007). In mice, 









)(Ziegler-Heitbrock et al., 2010). Analogously, human monocytes can also 








(Ingersoll et al., 2010; Ziegler-
Heitbrock, 2007; Ziegler-Heitbrock et al., 2010). Differential gene expression profiles 
between monocyte subsets are well conserved between mice and humans, suggesting that 
mouse models of trafficking may reveal clues to human monocyte behavior in disease 
(Ingersoll et al., 2010). However, despite their similarities, the subset ratio in the blood is 
vastly different between these two species. While the ratio of classical to non-classical 
subsets in mice is about 1:1, classical monocytes account for about 90% of total blood 
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monocytes and the non-classical monocytes account for the remaining 10% in humans 
(Ziegler-Heitbrock et al., 2010). 
 
1.8.2   Developmental relationship of monocyte subsets 
 
A developmental relationship between the two subsets of monocytes has been proposed, 
supported by the discovery of a small subset of monocytes, known as the “intermediate” 




 (Ancuta et al., 2003), and is proposed to be a transitional 
population bridging the classical and non-classical monocyte subsets (Ziegler-Heitbrock 
et al., 2010). 
 
In humans, during the course of an infection or in the presence of 
macrophage colony-stimulating factor (M-CSF) treatment, there is an increase first of the 
intermediate cells followed by an increase of the non-classical subset (Weiner et al., 
1994). Cell-depletion studies in mice have also shown that the non-classical monocytes in 
mouse blood are more mature and are derived from the classical monocytes (Sunderkötter 
et al., 2004). Furthermore, the intermediate subset was shown to express a handful of 
surface markers at levels in between the classical and non-classical subsets (Ancuta et al., 
2009; Ancuta et al., 2003; Cros et al., 2010). Fig 1.4 illustrates the development of 
monocyte subsets. 
 



































Fig 1.4 Development of monocyte subsets 
 
1.8.3   Functional heterogeneity of monocyte subsets 
 
Importantly, monocyte subsets also exhibit functional heterogeneity. Non-classical 
monocytes demonstrate a patrolling behaviour along blood vessel walls (Auffray et al., 
2007) and accumulate in non-inflamed peripheral tissues (Geissmann et al., 2003) where 
they contribute to resident macrophage populations (Jakubzick et al., 2008). In contrast, 
increasing evidence suggest that the recruitment of classical monocytes dominates early 
in inflammatory responses. For example, classical monocytes preferentially infiltrate into 
inflamed tissues, such as in sterile peritonitis models, than their non-classical 
counterparts in mice and rats. In addition, they are specifically increased in the 
Chapter 1: Introduction 
 45 
circulation during systemic and chronic infection (Geissmann et al., 2003; Sunderkötter 
et al., 2004; Tacke et al., 2007; Yrlid et al., 2006). This is further supported by evidence 
showing the migration of only classical monocytes, and not non-classical monocytes, into 
the skin of mice receiving an intra-cutaneous injection of latex microspheres (Qu et al., 
2004) and in a model of skeletal muscle injury (Arnold et al., 2007). However, after 
engulfing dying cells, classical monocytes have also differentiate into cells that resemble 
non-classical monocytes, which mediate tissue repair mechanisms (Arnold et al., 2007).  
 
1.8.4   Trafficking of monocyte subsets 
 
In particular, the two subsets are under the control of distinct trafficking mechanisms, 
with the classical subset being recruited via CCR2 in response to MCP-1 and non-
classical monocytes utilizing a CX3CR1-dependent pathway (Nahrendorf et al., 2007). 
The importance of CCR2 in mediating the trafficking of classical monocytes is apparent 
in disease studies such as Listeria monocytogenes (Serbina et al., 2003), Mycobacterium 
tuberculosis (Peters et al., 2004) and West Nile virus infections (Getts et al., 2008) 
whereby the inability of these cells to migrate into inflamed tissues in CCR2
-/-
 mice is 
detrimental to the host; although it may also be protective in certain circumstances as 
seen in dengue virus infections (Guabiraba et al., 2010).    
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1.9   Monocyte derived cells 
 
Monocytes are known for their plasticity and ability to differentiate into osteoclasts, 
macrophages or DCs upon migrating into tissues (Gordon and Taylor, 2005).  
 
1.9.1   Monocyte derived cells in the steady state 
 
However, monocytes are not the precursors of all DC and macrophage subsets, especially 
those that reside in the steady state. Several studies have shown that steady state DCs 
such as splenic conventional DCs (cDCs) originate from a pre-cDC subset that is distinct 
from monocytes (Naik et al., 2006). In addition, Langerhans cells  (Merad et al., 2002) 
and plasmacytoid DCs (Corcoran et al., 2003) in the steady state do not originate from 
monocytes but develop from a distinct pathway. Moreover, while it is generally believed 
that monocytes are the main precursors of tissue residential macrophages, studies of 
many tissue-resident macrophage populations have shown that local proliferation has a 
considerable role in the renewal and maintenance with the recruitment of circulating 
precursors having little, if any, role under steady-state conditions (Gordon and Taylor, 
2005; van Furth et al., 1985).  
 
1.9.2   Monocyte derived cells during inflammation 
 
Nevertheless, while the general consensus suggests that monocytes are not the main 
precursors of steady state DCs and residential macrophages, they are recruited in large 
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numbers into peripheral sites during inflammation and tissue injury. Their differentiation 
into DCs and macrophages are thus only as a consequence of inflammation (Geissmann 
et al., 2003; Naik et al., 2006; Sunderkötter et al., 2004). Classical monocytes have been 
shown to differentiate into macrophages that resemble classically activated M1 
macrophages which are associated with high microbicidal activity, pro-inflammatory 
cytokine production and cellular immunity (Mosser, 2003; Van Furth et al., 1973). In 
contrast, non-classical monocytes are recruited at late phases of inflammation and 
differentiate into alternatively activated M2 macrophages (Geissmann et al., 2010; 
Martinez et al., 2009; Nahrendorf et al., 2007). These M2 macrophages express vascular-
endothelial growth factor (VEGF), and promote tissue repair, angiogenesis and 
deposition of collagen, as well as humoral immunity. Such macrophages can also be 
cultured in vitro by differentiating human monocytes with M-CSF and stimulating them 
with IFN-γ or LPS to achieve M1 macrophages; or by stimulating them with IL-4, IL-10, 
IL-13 or TGF-ß to attain M2 macrophages (Gordon and Taylor, 2005; Mosser, 2003; 
Taylor et al., 2005).  
 
1.9.3   Monocyte-derived DCs 
 
The clearest example of a distinct DC type that is produced during inflammation are 
those that derived from CCR2-expressing classical monocytes (Gordon and Taylor, 2005; 
Sunderkötter et al., 2004; Sánchez-Torres et al., 2001). These classical monocytes 
produced no detectable DC progeny in lymphoid organs or tissues when transferred 
intravenously into sterile, non-irradiated mice, indicating that they make no contribution 
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to steady-state DCs (Geissmann et al., 2003; Naik et al., 2006; Sunderkötter et al., 2004). 
However, when transferred into mice that have been subjected to a vigorous 
inflammatory response, these monocytes produced DCs in the peritoneum and entered the 
spleen where they differentiated into a distinctive DC type (Geissmann et al., 2003; Naik 
et al., 2006). These monocyte-derived inflammatory DCs can be distinguished from 
steady-state splenic cDCs by their intermediate expression of CD11c, high expression of 
CD11b, MAC3 (a glycoprotein also found on activated macrophages) and the absence of 
CD4 or CD8 expression (Naik et al., 2006; Shortman and Naik, 2007). In particular, an in 
vitro study comparing steady-state DCs with inflammatory DCs by culturing bone 
marrow precursors with fms-like tyrosine kinase 3 ligand (Flt3L) or GM-CSF and IL-4 
(GM/IL-4 DCs) respectively showed phenotypic and functional differences between 
these two subsets (Xu et al., 2007). In contrast to steady state FL-DCs, inflammatory 
GM/IL-4 DCs were larger and more granular and although comparable in T cell 
activation, inflammatory GM/IL-4 DCs produced more inflammatory mediators such as 
TNF-α, IL-10, CCL-2 and nitric oxide (NO) upon TLR ligation. Notably, unlike GM/IL-
4 DCs, FL-DCs cannot be differentiated from classical monocytes, suggesting that the 
differentiation of DCs under inflammatory conditions is indeed from the classical subset. 
In addition, the discovery of a subset of inflammatory DCs known as TNF/iNOS-
producing dendritic cells (Tip-DCs) that appear in mice infected with L. monocytogenes 
highlights the important role of such cells during inflammation and infection (Serbina et 
al., 2003). 
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1.10   TNF/iNOS-producing dendritic cells (Tip-DCs) 
 
The presence of Tip-DCs was first discovered in a model of Listeria monocytogenes 
where classical monocytes were shown to migrate into Listeria-infected spleen using 
CCR2 where they differentiate into Tip-DCs (Serbina et al., 2003). These Tip-DCs were 
the key producers of TNF-α and iNOS; expressed intermediate levels of CD11b and 
CD11c, high expression of Mac-3 and MHC class II and were morphologically similar to 
CD11c
hi
 DCs by displaying pleomorphic nuclei and cytoplasmic extensions. However, 
unlike splenic macrophages that were infected with L. monocytogenes, the majority of 
Tip-DCs were not directly infected, suggesting that they differed functionally from 
residential macrophages and were activated indirectly.  
 
1.10.1 Tip-DCs during infection 
 
Cells resembling Tip-DCs have also been identified in several other bacterial infection 
models such as Brucella melitensis (Copin et al., 2007), Uropathogenic Escherichia coli 
(Engel et al., 2006), and Salmonella (Rydström and Wick, 2007). Development of Tip-
DCs has also been observed in viral infections such as influenza (Aldridge et al., 2009), 
where they are important for supporting the proliferation of influenza-specific CD8 T-
cells in the lung. Studies in parasitic infection models, including Trypanosoma brucei 
(Bosschaerts et al., 2010), Leishmania major (De Trez et al., 2009), and Toxoplasma 
gondii infection (Dunay et al., 2008) have also shown the importance of Tip-DCs in 
Chapter 1: Introduction 
 50 




 mice were shown succumb to infection 
more rapidly. 
 
1.10.2   Tip-DCs in mucosal immunity 
 
Tip-DCs have also been shown to regulate IgA production in mucosal immunity (Tezuka 
et al., 2007) as IgA class-switch recombination (CSR) was showed to be impaired in 
iNOS
-/-
 mice. The authors demonstrated that iNOS was preferentially expressed in DCs 
present in the mucosa-associated lymphoid tissues (MALT) in response to the recognition 
of commensal bacteria by TLR and further analysis revealed that these MALT DCs were 
Tip-DCs resembling those identified in mice infected with Listeria monocytogenes. 
Notably, iNOS regulates the T-cell-dependent IgA CSR through expression of TGF-β 
receptor, as well as the T-cell-independent IgA CSR through production of a 
proliferation-inducing ligand (APRIL, also called Tnfsf13) and a B-cell-activating factor 
of the tumour necrosis factor (TNF) family (BAFF, also called Tnfsf13b). Thus, the 
presence of a naturally occurring TNF-α and iNOS producing DC subset may explain the 
predominance of IgA production that is critical for gut homeostasis in the MALT. 
 
1.10.3   Tip-DCs in skin diseases 
 
Tip-DCs have also been demonstrated to contribute to disease pathogenesis. Studies in 
psoriasis have shown the presence of Tip-DCs in skin lesion samples of psoriasis patients 
(Lowes et al., 2005). These cells expressed HLA-DR, CD40, and CD86, lack Langerin 
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and CD14, and to a significant extent expressed the DC maturation markers DC-LAMP 
and CD83. In particular, treatment of psoriasis with efalizumab (anti-CD11a) strongly 
reduced infiltration of these Tip-DCs, suggesting that Tip-DCs are an important target for 
suppressive therapies. Pathogenicity of these Tip-DCs in psoriasis was further confirmed 
by the rapid downmodulation of Tip-DC products during effective treatment with TNF-
blocking drugs (Zaba et al., 2007).  In mouse models of psoriasis (Stratis et al., 2006; 
Wang et al., 2006a), TNF-α and iNOS expressing cells characterized as activated 
macrophages were also found to be present at the dermal/epidermal border where they 
may contribute to hyperkeratosis and parakeratosis, terming these cells as epithelium-
lining macrophages (van den Oord and de Wolf-Peeters, 1994; Weber-Matthiesen and 
Sterry, 1990). However these cells were also shown to express CD83, which suggests that 
they may resemble Tip-DCs seen in human psoriasis studies (Stratis et al., 2006). 
 
1.11   Factors modulating monocyte differentiation 
 
Since the differentiation of monocytes into DCs or macrophages relies on the 
microenvironment, the presence of different cell types and cytokines is a critical feature 
in determining the outcome of differentiation.  While the reference method for obtaining 
monocyte-derived DCs and macrophages in humans consist of the addition of IL-4/GM-
CSF and M-CSF respectively, increasing studies have demonstrated the use of other 
cytokine cocktails to obtain these cells.  
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1.11.1  Factors that favour macrophage differentiation 
 
Studies have shown that the presence of IL-6 and IL-32 favors the differentiation of 
monocytes into macrophages. IL-6, produced by fibroblasts when in contact with 
monocytes, was demonstrated to up-regulate the expression of functional M-CSF 
receptors on monocytes. This allows monocytes to consume their autocrine M-CSF, 
thereby switching monocyte differentiation into macrophages rather than DCs (Chomarat 
et al., 2000). In contrast, the ability of IL-32 to induce the differentiation of monocytes 
into macrophages is mediated through non-apoptotic, caspase-3-dependent mechanisms 
(Netea et al., 2008). Notably, the presence of ox-LDL (Fuhrman et al., 2008), influenza 
virus induced apoptotic cells (Uchide et al., 2002), cholera toxin (Veglia et al., 2011) and 
CXC-chemokine platelet factor 4 (Scheuerer et al., 2000) were shown to favour the 
differentiation of monocytes into macrophages. These cells showed characteristics of 
macrophages as they downregulated the expression of HLA-DR and exhibited robust 
phagocytic activities. 
 
1.11.2   Factors that favour DC differentiation 
 
The differentiation of monocytes into DCs has also been characterized by many studies. 
In particular, factors such as IL-2 (Sanarico et al., 2006), IL-15 (Mohamadzadeh et al., 
2001), IFN-α (Mohty et al., 2003), TNF-α (Chomarat et al., 2003; Iwamoto et al., 2007), 
CD40 Ligand  (Zhang et al., 2007), CD137 Ligand  (Kwajah M M and Schwarz, 2010) 
and Delta-1 (Ohishi et al., 2001) have all been shown to favour the differentiation of 
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monocytes with DC characteristics. Notably, DCs obtained by differentiating monocytes 
in the presence of IFN-α (IFN-DCs) expressed a large number of Toll-like receptors 
(TLRs), including TLR7, which is classically found on plasmacytoid DCs (Mohty et al., 
2003). Like plasmacytoid DCs, IFN-DCs could also secrete IFN-α following viral 
stimulation or TLR7-specific stimulation. Interestingly, addition of IL-15 during the 
differentiation process results in DCs exhibiting features of LCs. However, unlike gold 
standard LCs obtained by differentiating monocytes with TGF-ß1, IL-4 and GM-CSF 
(Geissmann et al., 1998), LCs obtained by differentiation with IL-15 do not exhibit bona 
fide Birbeck granules. 
 
1.12   Contact Hypersensitivity 
 
Contact hypersensitivity (CHS), also known as allergic contact dermatitis, is one of the 
most frequent skin diseases characterized by erythema, edema, and vesiculation. CHS is a 
T cell-mediated inflammatory reaction that occurs after cutaneous exposure to haptens 
(i.e. chemicals and reactive metal ions) which become immunogenic after binding to 
discrete amino acid residues of proteins or peptides (Lepoittevin, 1999).  
 
1.12.1   Mechanism of CHS 
 
The CHS response is antigen specific and develops in two distinct phases. In the 
sensitization phase, haptens penetrating the skin are captured by resident DCs, such as 
LCs and dermal CD103+ DCs, which migrate to regional lymph nodes and induce the 
Chapter 1: Introduction 
 54 
activation of specific T cells (Bursch et al., 2007). The next phase, known as the 
elicitation phase of CHS, is induced by re-exposure to the same hapten at a remote skin 
site. This leads to the rapid recruitment and activation of T cells within a few hours after 
challenge and to the constitution of a local inflammatory response peaking at 24–48 h 
which progressively decreases via active down-regulating mechanisms. A schematic 
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Fig. 1.5 A schematic illustration of the mechanism behind a CHS response 
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Clinical symptoms associated with CHS only appear in the elicitation phase. Re-exposure 
to the same hapten causes cross-linking of IgM molecules which activates the 
complement pathway and generates C5a (Tsuji et al., 2002). This act on platelets, mast 
cells, and macrophages (Tsuji et al., 2000) which results in TNF-α production and 
microvasculature activation (McHale et al., 1999). This facilitates the infiltration of a first 
wave of leukocytes, mainly CD8 T-cells, within 2 hours (Akiba et al., 2002). These 
hapten-primed CD8 T-cells enter the dermis at the site of hapten exposure in response to 
chemokines such as IP-10 or CXCL10 and become re-stimulated by resident APCs 
(Dufour et al., 2002) or hapten-presenting vascular endothelial cells (Kish et al., 2011). 
CD8 T-cells then release pro-inflammatory mediators triggering endothelial cells to 
produce CXCL1 and CXCL2 which directs neutrophils into the site (Kish et al., 2011). 
At the same time, chemokines such as CXCL2 and MCP-1 would lead to monocyte 
infiltration and a massive second wave of leukocyte infiltration (Wang et al., 2006a). 
Importantly, treatment of allergic contact dermatitis with glucocorticoids showed 
reduction in clinical symptoms and its therapeutic action is directed at macrophages and 
neutrophils (Tuckermann et al., 2007). 
 
1.12.2   CD8 T-cells in CHS 
 
Several studies by independent investigators using different haptens (i.e. such as DNFB, 
DMBA, TNP and oxazolone) have shown that CHS is principally mediated by CD8 T-
cells (Akiba et al., 2002; Anderson et al., 1995; Bouloc et al., 1998; Bour et al., 1995; Xu 
et al., 1996). The use of monoclonal antibodies to deplete CD4 or CD8 T-cells selectively 
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have also established that CHS reactions are mediated by CD8 T-cells and down-
regulated by CD4 T-cells (Gocinski and Tigelaar, 1990). Further evidence to support this 
can be drawn from studies in mice that lacked MHC class I which were unable to support 
CHS responses to dinitrofluorobenzene (DNFB), while mice that were deficient in MHC 
class II developed an exaggerated CHS reaction (Bour et al., 1995). Moreover, MHC 
class I+/II- dendritic cells (DCs) could induce hapten-specific immune responses 
(Kolesaric et al., 1997), whereas MHC class I-/II+ DCs down-regulated CHS response 
(Krasteva et al., 1998). CD8 T-cells are recruited early into the skin where they induce 
inflammation and keratinocyte apoptosis (Akiba et al., 2002; Kehren et al., 1999; Xu et 
al., 1996). Their cytotoxicity is critical as mice lacking the perforin and Fas/Fas ligand 
pathways were unable to mount a CHS response (Kehren et al., 1999). Priming of CD8 
T-cells during CHS does not require CD4 T-cells or CD40/40L interaction as mice 
deficient in CD40L or had CD4 T-cells depleted with monoclonal antibodies did not have 
decreased CHS responses (Gorbachev et al., 2001a; Krasteva et al., 1998; Martin et al., 
2000). These CD8 T-cells produce IFN-γ or IL-17 and form distinct populations with 
important effector functions (He et al., 2006; He et al., 2009; Kish et al., 2009).  
 
1.12.3   CD4 T-cells in CHS 
 
On the other hand, CD4 T-cells are known to be important for regulating the immune 
suppression of CHS. CD4 T-cells were found to express Th2 cytokines such as IL-4, IL-5 




 regulatory T-cells were found to be an important 
down-regulator as mice that had CD4 T-cells depleted in vivo had enhanced 
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inflammatory reactions during CHS (Desvignes et al., 1996; Dubois et al., 2003; 
Gocinski and Tigelaar, 1990; Xu et al., 1996). It is noteworthy that CD4 T-cells are 
recruited into challenged skin hours after recruitment of CD8 T-cells (Akiba et al., 2002), 
suggesting that their entry into the skin is responsible for the inactivation of CD8 T-cell’s 
cytotoxic activity, thereby limiting the development pathogenicity. However, despite 
studies showing the role of CD4 T-cells in down-regulating the CHS response, a small 
subset of CD4 T-cells that are polarized towards the Th1 phenotype may still express 
IFN-γ, albeit at a much lower level than CD8 T-cells (He et al., 2009). In addition, CD4 
T-cells could also act as effector cells in CHS to some haptens when the CD8 T-cell 
population is deficient (Martin et al., 2000). 
 
1.13   Aims of this study 
 
While it has been shown previously that the interaction of CD8 T cells and DCs results in 
a Th1 response through IL-12p70 production in mice and humans (Mailliard et al., 2002; 
Thomas et al., 2002; Watchmaker et al., 2008; Wong et al., 2008), it is unclear if CD8T-
cells can induce the production of IL-12p70 from DCs in the absence of CD4 T-cells or 
CD40L-expressing cells in humans.  It has also been shown that CD8 T cells can secrete 
chemokines such as RANTES, MIP1α and MIP-1ß for HIV suppression (Cocchi et al., 
1995) while DCs can secrete MCP-1 in addition to RANTES, MIP1α and MIP-1ß (Lebre 
et al., 2005). This suggests that the CD8 T-cell-DC interaction can result in the 
recruitment of other immune cells such as monocytes which can be influenced to 
differentiate by environmental cytokine factors. Indeed, studies have shown that CD8 T-
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cells are able to infiltrate quickly into inflamed sites (Akiba et al., 2002) which may 
facilitate their early interaction with DCs.  In human psoriasis studies, administration of 
alefacept, an antibody which reduces infiltration of activated memory CD8 T-cells, 
showed reduced monocyte-derived DC content, inflammation and expression of iNOS 
and IFN-γ in the skin (Chamian et al., 2005). These data suggest that CD8 T-cells, upon 
interacting with DCs, may have an impact on the differentiation and function of 
monocytes which may help support Th1 responses. However, the precise mechanism 
underlying these observations remains unclear.  
 
Specific aims: 
1) To determine if human CD8 T-cells can induce DCs to produce IL-12p70 in the 
absence of CD4 T-cells and determine the conditions that are necessary in vitro. 
2) To determine if CD8 T-cells and DCs can create a cytokine milieu that favors the 
differentiation of monocytes 
3) To determine the outcome of this monocyte differentiation and the functional 
properties of these monocyte derived cells 
4) To determine if these monocyte derived cells can support Th1 responses 
5) To demonstrate in vivo using a contact hypersensitivity model that CD8 T-cells 
are principally involved in the differentiation of these monocyte-derived cells. 
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CHAPTER 2:  Materials and methods 
_____________________________________________________________________ 
 
2.1   Media and buffers 
 
PBS buffer 
PBS buffer was commercially obtained from 1st base as a 10 x stock. The 10 x stock 
consisted of 137mM NaCl, 2.7mM KCl and 10mM phosphate buffer. This stock was 
diluted with 9 parts water to give 1 x PBS. The pH was 7.2 to 7.4 
 
Buffers for human blood processing 
To prevent peripheral blood from coagulating, freshly drawn blood was collected with 
PBS + 4% sodium citrate (10:1 blood: buffer ratio). Subsequent washing steps were 
performed with PBS + 0.4% sodium citrate. All buffers were adjusted to a pH of 7.2 to 
7.4 under sterile conditions. 
 
Culture Medium 
All human cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco, 
Invitrogen, Singapore) supplemented with 10% autologous serum or heat-inactivated 
human AB serum (Biowhittaker, Cambrex, Singapore).  
 
All mice cells were cultured in complete medium. This was prepared from RPMI-1640 
with L-Glutamine (Gibco) with the addition of the following: 
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a) 10 % v/v FCS, heat inactivated for 30min at 55oC. 
b) 1 % v/v Non-essential amino acid (100 x from stock) 
c) 1 mM Sodium pyruvate (100 x from 100 mM stock) 
d) 5 μM β-Mercaptoethanol (2 860 000 x from 14.3 M stock) 
e) 100 IU/ml Penicillin and 0.1mg/ml Streptomycin (100 x from 10 000 IU/ml Penicillin 
10mg/ml Streptomycin stock) 
 
Buffers for isolation of mouse skin cells 
1-Dispase (Gibco) was diluted with RPMI-1600 (Gibco) to a working concentration of 
2.4mg/ml (4 U/ml) for the separation of epidermis and dermis. Collagenase Type IV 




) to a working concentration of 1mg/ml 
(4 U/mg) for further digestion of dermis cells.  
 
MACS/FACS buffer: 
MACS/FACS buffer consisted of 1 x PBS with 2% FCS and 5mM EDTA adjusted to pH 
7.2 to 7.4 at 4°C and was prepared under sterile conditions. 
 
Permeabilization/washing buffer for intracellular staining: 
For intracellular staining, the buffer used consisted of PBS containing 0.5% BSA, 0.1% 
saponin and 0.1% sodium azide (perm/wash buffer), adjusted to a pH of 7.2 to 7.4. This 
was used for the permeabilization and washing steps when cells were prepared for 
intracellular analysis using FACS. Alternatively, a commercial permeabilization/washing 
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buffer purchased from BD biosciences (BD Perm/Wash™ buffer) was used according to 
manufacturer’s instructions. 
 
Annexin-V binding buffer: 
10mM Hepes/NaOH with 140mM NaCl, 2.5mM CaCl2, pH 7.4. 5ml of 1 M 
Hepes/NaOH stock was added to 495ml of sterile deionised water. 4.09g of NaCl and 
0.184g of CaCl2 were added to this buffer. pH was adjusted to 7.4 and stored at 4°C  
 
Buffers for ELISA: 
Wash buffer consisted of PBS with 0.5% v/v Tween-20, pH adjusted to 7.2 to 7.4. The 
block buffer consisted of PBS with 1% v/w BSA, pH adjusted to 7.2 to 7.4. 
Diethanolamine buffer was used to dissolve the pNPP substrate for ELISA. 
 
Buffers for immunostaining: 
Wash buffer consisted of PBS with 10mM of glycine, pH adjusted to 7.2 to 7.4. 
Antibodies were diluted in permabilization buffer. For staining of tissue cryosections, 
blocking buffer consisted of 0.2% BSA in PBS. Buffer used to dilute antibodies was PBS 
with 1% normal mouse serum and 10mM glycine. PBS was used to wash samples in 
between each step. 
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2.2.    Human Studies 
 
2.2.1   Cell isolation  
 
Isolation of Human Peripheral Blood Mononuclear Cells (PBMCs): 
All blood was collected after informed consent in accordance with the Declaration of 
Helsinki and under an approved protocol by the National University of Singapore 
Institutional Review Board (NUS IRB code: 05-024). Briefly, PBMCs were isolated from 
blood samples by Ficoll-Paque
TM
 (GE Healthcare, Singapore) density gradient 
sendimentation.  
 
1. 50ml of peripheral blood was collected from healthy donors by venipuncture into 
5ml of 4% sodium citrate in a 50ml falcon tube. 
2. Blood was diluted with equal volume of PBS + 0.4% sodium citrate. 
3. 35ml of diluted blood was layered carefully onto 15ml of Ficoll-PaqueTM. 
4. Cells were centrifuged at 650 x g for 20 min, with brakes off at room temp.  
5. Cell interface was harvested and volume diluted at least 3 fold with PBS + 0.4% 
sodium citrate and centrifuged at 450 x g for 15 min. 
6. Washes were repeated 2 more times at 300 x g, 10 min with PBS + 0.4% sodium 
citrate until supernatant was clear. 
7. Cells were counted by trypan blue exclusion method for selective isolation 
through MACS column  
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Blood CD8 T-cell isolation 
To isolate CD8 T-cells, contaminating NK cells were first depleted with anti-CD56 
conjugated magnetic beads as NK cells express low levels of the CD8 molecule. CD8 T-
cells were then positively selected from PBMCs by anti-CD8 conjugated magnetic beads 







1. PBMCs were centrifuged at 350 x g for 5 min at 4oC. 
2. MACS buffer was added to the cell pellet and washing was repeated by 
centrifugation at 350 x g for 5 min at 4°C. 
3. Supernatants were discarded and anti-CD56 conjugated microbeads were added to 
the cell pellet at a volume of 10μl per 10 x 106 cells. Clumping was prevented by 
pipetting several times. 
4. The mixture was incubated at 4oC for 20 min. 
5. After incubation, the cells were washed by adding 3ml of MACS buffer. Cells 
were centrifuged at 350 x g for 5 min at 4
o
C. 
6. A LS MACS column was inserted into the magnetic stand. This was pre-wetted 
with 3ml of MACS buffer. 
7. After centrifugation, supernatants were discarded and cells were resuspended with 
1ml of MACS buffer. Cell clumps which will cause column blockage were 
prevented by vigorous pipetting several times. 
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8. Cells were loaded into the column and allowed to flow into the column. An 
additional 3ml of MACS buffer was added to wash the column once the reservoir 
was dry. Washing was repeated thrice. 
9. The effluent was collected and the column was washed 3 times. Each flowthrough 
was collected in the same tube as the effluent.  
10. Cells were washed by centrifugation at 350 x g for 5 min at 4oC and subsequently 
resuspended with appropriate media before cell counting was performed.  
11. Anti-CD8 conjugated microbeads were added to the cell pellet at a volume of 
10μl per 10 x 106 cells. Clumping was prevented by pipetting several times. 
12. The mixture was incubated at 4oC for 20 min. 
13. After incubation, the cells were washed by adding 3ml of MACS buffer. Cells 
were centrifuged at 350 x g for 5 min at 4
o
C. 
14. After discarding the supernatant, cells were resuspended in 1ml of MACS buffer 
and loaded into the pre-wet LS column on the magnetic stand. 
15. Cells bounded in the column were harvested by removing the column from the 
magnetic stand. 3ml of MACS buffer or culture media (depending on 
experimental purpose) was added into the reservoir and cells were forced out of 
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Blood naive CD4 T-cell isolation 
Naive CD4 T-cells were negatively selected from PBMCs using the Naive CD4 T cell 
Isolation Kit II (Miltenyi Biotec, Singapore) according to the manufacturer’s instructions. 







1. Cell number was first determined and cell pellet was resuspended in 40µl of 
MACS buffer per 10 x 10
6
 total cells 
2. 10µl of Biotin-Antibody Cocktail II per 10 x 106 total cells was added. 
3. The cell suspension was mixed well and was incubated for 10 min at 4°C. 
4. Cells were washed by adding 3ml of MACS buffer per 10 x 106 cells and 
centrifuged at 350 x g for 5 min. Supernatant was aspirated completely. 
5. Cell pellet was resuspended in 80µl of MACS buffer per 10 x 106 total cells. 
6. 20µl of Anti-Biotin MicroBeads per 10 x 106 total cells was added. 
7. The cell suspension was mixed well and incubated for 15 min at 4°C. 
8. Cells were washed by adding 3ml of MACS buffer per 10 x 106 cells and 
centrifuged at 350 x g for 5 min. Supernatant was aspirated completely. 
9. Cells were resuspended in 1ml of MACS buffer. Cell clumps which will cause 
column blockage were prevented by vigorous pipetting several times. 
10. Cell suspension was loaded onto a LS column that was pre-wet with 3ml of 
MACS buffer on a magnetic stand. 
11. The column was washed with 3ml of MACS buffer and the effluent was collected 
together with the flowthrough for cell counting. This contained the enriched naive 
CD4 T-cell fraction. 
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Blood monocyte isolation 
Monocytes were negatively selected from PBMCs using the Monocyte Isolation Kit II 
(Miltenyi Biotec, Singapore) according to the manufacturer’s instructions. This routinely 
gave a purity of 97 ± 0.5% CD14
+
cells. 
1. Cell number was first determined and cell pellet was resuspended in 30µl of 
MACS buffer per 10 x 10
6
 total cells. 
2. 10µl of FcR Blocking Reagent per 10 x 106 total cells was then added. 
3. Next, 10µl of Biotin-Antibody Cocktail per 10 x 106 total cells was further added 
to the mixture. 
4. The cell suspension was mixed well by pipetting several times to prevent cell 
clumping. Cells were incubated for 10 min at 4°C. 
5.  After incubation, 30µl of MACS buffer per 10 x 106 total cells was added, 
followed by 20µl of Anti-Biotin MicroBeads per 10 x 10
6
 total cells into the cell 
mixture. 
6. The cell suspension was mixed well by pipetting several times to prevent cell 
clumping and incubated for an additional 15 min at 4°C. 
7. Cells were washed by adding 3 ml of MACS buffer and centrifuged at 350 x g for 
5 min. Supernatant was discarded completely. 
8. The cell pellet was then resuspended in 1 ml of MACS buffer and cell clumps 
which will cause column blockage were prevented by vigorous pipetting several 
times. 
9. Cell suspension was loaded into a LS column that had been pre-wet with 3 ml of 
MACS buffer on a magnetic stand 
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10. Cells were allowed to pass through and the column was washed 2 times with 3 ml 
of MACS buffer before the entire effluent was collected. This fraction represented 
the enriched population of monocyte cells. 
 
2.2.2   Preparation of cells for flow cytometry 
 
Surface staining of cells for flow cytometry analysis: 
1. Cells were transferred into FACS tubes. Typically 1 x 105 to 1 x 106 cells would 
be used per tube. 
2. Cells were centrifuged at 350 x g, 4oC for 5 min. 
3. Supernatants were discarded by inversion of the tubes.  
4. Cells were washed by adding 1.5 ml of FACS buffer into each tube, and 
centrifuged at 350 x g, 4
o
C for 5 min. 
5. Supernatants were discarded by inversion of the tubes.  
6. 0.5 μg per million cells of FcBlock (1μl of 0.5 mg/ml stock per million cells) was 
added and incubated for 5 min at 4
o
C. This prevents non-specific binding of 
antibodies to Fc receptors. 
7. Antibodies directly conjugated to fluorophores or appropriate isotype controls 
were added directly to cell pellet (typically 0.1μg of antibody per million cells), 
and mixed by raking gently on tube racks. 
8. Cells were incubated in the dark at 4oC for 30 min. 
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9. After incubation, cells were washed by adding 3 ml of FACS buffer and 
centrifuged at 350 x g, 4
o
C for 5 min. Supernatants were discarded and washing 
was repeated. 
10. After the final wash, cells were raked and cells resuspended in 0.5 ml of FACS 
buffer for immediate analysis, or fixed with 1% PFA in PBS if analysis was 
performed after several hours. For some experiments, 1μl of 1 mg/ml of 7-AAD 




 cells are dead cells that 
were gated out of analysis. 
11. Cells were filtered through a 61 μm gauze into a new FACS tube prior to analysis. 
 
Intracellular staining of cells for flow cytometry analysis: 
1. Cells for intracellular staining were first restimulated with 10 ng/ml PMA and 400 
ng/ml ionomycin for T-cells or 100 ng/ml of LPS for monocytes. Protein 
secretion was blocked with Golgi stop (BD PharMingen) containing monensin. 
Golgi stop was used at 1 μl per 1 ml of culture. 
2. After 6 h, cells were harvested, transferred into FACS tubes and washed by 
adding FACS buffer and centrifugation at 350 x g, 5 min at 4
o
C. Washing was 
repeated once more. 
3. Cells were stained for surface markers using the “Surface staining of cells for 
FACS analysis” protocol. 
4. Cells were fixed using 500 μl of 1 % PFA in PBS per tube. Tubes were vortexed 
immediately after addition to prevent cell clumping. Tubes were incubated in the 
dark for 15 min. 
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5. Fixed cells were permeabilized by the addition of 2 ml of permeabilization/wash 
buffer. Cells were then centrifuged at 350 x g for 5 min. Washing was repeated. 
6. The appropriate antibodies specific for intracellular targets or isotype controls 
were added to the tubes. These were incubated for 30 min at r.t in the dark. 
7. After incubation, cells were washed twice with 3 ml of perm/wash buffer. 
8. Cells were subsequently resuspended in FACS buffer for immediate analysis or 
1% PFA in PBS for future analysis. 
 
Preparation of cells for sorting: 
1. Cells for sorting where prepared and placed into sterile FACS tubes. 
2. 0.5 μg per million cells of FcBlock (1μl of 0.5 mg/ml stock per million cells) were 
added and incubated for 5 min at 4
o
C. This prevents non-specific binding of 
antibodies to Fc receptors. 
3. Antibodies directly conjugated to fluorophores were added directly to cell pellet 
and mixed by raking gently on tube racks. 
4. Cells were incubated in the dark at 4oC for 30 min. 
5. After incubation, cells were washed by adding 3 ml MACS buffer and 
centrifugation at 350 x g, 4
o
C for 5 min. Supernatants were discarded and 
washing was repeated. 
6. Cells were raked and resuspended to 10 x 106/ml, filtered through a 61 μm guaze 
and sorted using a MOFLO cell sorter (Dako). 
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2.2.3   Generation of monocyte-derived DCs and macrophages 
 
Monocytes were cultured with appropriate cytokines to induce their differentiation into 
DCs or macrophages. Monocyte-derived DCs were used in co-cultures with CD8 T-cells 
to study their interaction and induction of IL-12. These DCs, together with monocyte-
derived macrophages, were also used as controls to compare the morphology and 
phenotype of Tip-DCs in later studies. 
 
1. Isolated blood monocytes were seeded in 6-well plates (Nunc) at 2 x 106 cells per 
ml, resulting in 6 x 10
6
 monocytes in 3 ml of culture medium per well. For 
generation of cells with smaller monocyte numbers, monocytes were seeded in 
24-well plates (Nunc) at 5 x 10
5
/well in 1 ml of culture medium. 
2. To generate immature DCs, 1000 U/ml of rhGM-CSF and 1000 U/ml of rhIL-4 
(Peprotech, Gene-Ethics, Singapore) was added to the culture medium. To 
generate macrophages, 1000 U/ml of rhM-CSF (Peprotech) was added to the 
culture medium. All cells were incubated for 6 days at 37°C/5% CO2. 
3. To induce their maturation, LPS (100ng/ml) was added for a further 24 h where 
indicated. 
 
2.2.4   Generation of influenza specific CD8 T-cells 
 
CD8 T cells specific for the influenza peptide (Flu M1; 58-66; GILGFVFTL) in the 
context of HLA-A2.01, were obtained by tetramer isolation and kept in culture through 
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re-stimulation with peptide-loaded DCs and with growth cytokines every week. The 
percentage of tetramer-binding cells was >80%.  
 
1. To synthesize the tetramers, 50ng of biotinylated monomeric recombinant HLA-
A2.01 (containing the influenza A matrix 1 protein encoded peptide, 
GILGFVFTL) were incubated with extravidin-PE (Sigma-Aldrich, Singapore). 
20μl were added every 10 min for a total of 150 min to form 200ng/ml of each 
tetramer. 
2. CD8 T-cells were isolated from fresh blood of healthy donors that have been 
tested to be HLA-A2.01 positive.  
3. The CD8 T cell fraction was subsequently stained with the PE-labeled tetramer 
and sorted using a MoFlo cell-sorter (Beckman Coulter, Singapore). 
4. To prepare peptide-loaded DCs for re-stimulation, autologous immature 
monocyte-derived DCs (from the same donor as the CD8 T-cells) was pulsed 
with 5µM of influenza peptide in 1ml of DMEM without serum at 37°C for 1 h. 
DCs were subsequently γ-irradiated at 3000 rad (gamma irradiation chamber 
4000a) and washed three times with DMEM to remove excess peptide. 
5. Sorted CD8 T-cells that stained positive for the influenza peptide were cultured 
for 14 days in the presence of IL-2 (50 U/ml) and IL-7 (5 ng/ml) and re-
stimulated with peptide-loaded autologous DCs every week.  
6. The cells were then harvested and used for co-culture studies 
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2.2.5    CD8 T-cell and DC co-cultures 
 
Allogeneic co-cultures 
1. Freshly isolated CD8 T-cells were activated with 10ng/ml of PMA and 400ng/ml 
of ionomycin, seeded at 1 x 10
6
 cells/well in 24-well plates (Nunc) and incubated 
at 37°C/5% CO2 for 48 hours. Alternatively, CD8 T-cells were used unactivated 
in some studies. 
2. Activated CD8 T-cells were washed extensively with pre-warmed DMEM three 
times to remove excess PMA and ionomycin. Cells were resuspended with culture 
medium to a final concentration of 1.33 x 10
6
 cells/ml. 
3. Allogeneic immature monocyte-derived DCs were harvested and washed with 
pre-warmed DMEM three times to remove excess IL-4 and GM-CSF. Cells were 
resuspended with culture medium to a final concentration of 0.67 x 10
6
 cells/ml. 
4. 100 µl of activated or freshly isolated CD8 T-cells (1.33 x 105 cells) were then 
added to 100 µl of allogeneic DCs (0.67 x 10
5
 cells) such that CD8 T-cells and 
DCs were cultured in a ratio of 2:1 to a total of 2 x 10
5
 cells in 200μl of culture 
medium per well in triplicates in U-bottom 96-well plates (Costar). Cells were 
then incubated at 37°C/ 5% CO2 for 18 h. 
5. Where indicated, LPS (100ng/ml) was added into the co-cultures simultaneously.  
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Autologous co-cultures 
1. Immature HLA-A2.01 restricted DCs were pulsed with 5µM influenza peptide 
(Flu M1; 58-66; GILGFVFTL) for 1 h in 1ml of DMEM without any serum. 
Alternatively, the irrelevant peptide (EV 71 protein-encoded peptide, 
KLTDPPAQV) was used as a control. 
2. DCs were washed with 5ml of DMEM three times to remove excess peptide. 
3. Influenza specific CD8 T-cells were subsequently added with peptide-pulsed DCs 
in a ratio of 2:1 to a total of 2 x 10
5
 cells in 200ul of culture medium per well in 
triplicates in U-bottom 96-well plates (Costar) and incubated at 37°C/ 5% CO2 for 
18 h. 
4. Where indicated, LPS (100ng/ml) was added to co-cultures simultaneously. 
 
2.2.6   Detection of cytokines in supernatants 
 
ELISA: 
IL-12p40 and IL-12p70 levels were detected using sandwich ELISA with DuoSet ELISA 
development kit from R&D systems (Singapore) according to the manufacturer’s 
protocol. The substrate, 1 mg/ml of pNPP was dissolved in 0.05 M diethanolamine 
buffer. 
 
1. The appropriate capture antibody was diluted in PBS to the concentration 
recommended by the manufacturer (typically 180 x dilutions) 
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2. The diluted capture antibodies were dispensed into 96 well Maxisorb plates at 50 
μl per well and incubated O/N at r.t. 
3. Capture antibody coated wells were then washed thrice with wash buffer 
4. Coated wells were blocked with 300μl block buffer for 1 h at r.t. 
5. Wells were washed thrice with wash buffer 
6. Pre-diluted standards and supernatants diluted with block buffer to 50μl were 
added to the appropriate wells and incubated for 2 h at r.t. 
7. Wells were washed thrice with wash buffer 
8. The appropriate detection antibody pair was diluted in block buffer to the 
recommended concentration (typically 180 x). 
9. Diluted detection antibodies were dispensed into wells at 50 μl per well and 
incubated for 2 h at r.t. 
10. Wells were washed thrice with wash buffer 
11. Avidin conjugated AP was diluted 1000 x with block buffer and dispensed into 
wells at 50 μl per well and incubated for 1 h at r.t 
12. Wells were washed 4 x with wash buffer 
13. 50μl of 1 mg/ml of PNPP dissolved in 0.05 M diethanolamine per well were 
dispensed. 
14. Color intensity at 405 nm was determined using a microplate reader (Biorad, 
model 680). Levels of cytokines present were determined by reference to standard 
curves. 
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Multiplex bead array: 
Multiplex bead arrays were performed for cytokines IL-1α, IL-1β, IL-4, IL-6, IL-10, GM-
CSF, IFN-γ, TNF-α and chemokines IP-10, RANTES, MCP-1, MIP-1α, MIP-1β using 
Bio-rad multiplex assay kit according to the manufacturer’s instruction. However, we 
used 2 x less of the stock reagents (for example, 50 x dilution of beads becomes 100 x 
dilution of beads). This gave the same results as the dilution factor recommended by the 
manufacturer. 
 
1. The master standard stock was reconstituted with 500 ul of complete RPMI-1640 
with 10 % FCS, and vortexed for 1-3 seconds. This was incubated on ice for 30 
min prior to use. 
2. 4 fold serial dilutions of the standard were made with complete media. 
3. Antibody conjugated beads were vortexed for 30 s before being diluted with 
Bioplex assay buffer according to the recommended dilution factor. Diluted beads 
were kept in the dark on ice. 
4. 96 well sterile filter plates (Millipore, Multiscreen HTS, BV, 1.2 μm hydrophil 
low protein binding, durapore membrane) were pre-wet with 100 μl Bioplex assay 
buffer. 
5. Buffer was removed using a vacuum manifold (Millipore, MultiscreenTM HTS), 
with pressures not exceeding 2.5 Hg or 85 mBar  
6. Diluted beads were vortexed for 20 s and 50 μl of beads were added to each well. 
7. Buffer was removed using a vacuum manifold 
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8. 100 μl per well of Bioplex wash buffer was added to each well. Buffer was 
removed using vacuum manifold. 
9. 50 ul of pre-diluted standards and samples diluted in complete media were added 
into the appropriate wells. The filter plates were sealed with the sealing tape 
provided and placed onto a plate shaker. Plates were shaken at 1100 rpm for the 
first 30 s and then 300 rpm for 1 h. Plates were covered with aluminum foil to 
prevent photobleaching. 
10. After incubation, supernatants and standards were removed using vacuum 
manifold. 100 μl of Bioplex wash buffer was added to each well and removed 
using the vacuum manifold. Washing was repeated 2 more times. 
11. Detection antibodies were diluted in detection antibody diluent according to the 
recommended dilution factor given by the manufacturer. 
12. 25 μl of diluted detection antibody was added to each well and sealed using 
sealing tape. Plates were shaken at 1100 rpm for the first 30 s and then 300 rpm 
for 1 h. Plates were covered with aluminum foil to prevent photobleaching. 
13. After incubation, detection antibody solution was removed using vacuum 
manifold. 100 μl of Bioplex wash buffer was added and removed using vacuum 
manifold. Washing was repeated twice more. 
14. 50 µl of streptavidin-PE was diluted with assay buffer at the manufacturer’s 
recommended dilution and added to each well. Plates were shaken at 1100 rpm 
for the first 30 s and then 300 rpm for 20 min. Plates were then covered with 
aluminum foil to prevent photobleaching. 
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15. After incubation, streptavidin-PE solution was removed using vacuum manifold, 
and wells were washed thrice with 100 μl Bioplex wash buffer. 
16. Wells were resuspended with 125 µl of Bioplex assay buffer, sealed and shaken at 
1100 rpm for 30 s. Analysis were performed with the Luminex 100 (Qiagen). At 
least 60 events were collected for each cytokine bead. 
 
2.2.7   Viability Assays 
 
Annexin-V and 7-AAD viability assay 
This assay was used to measure the viability of DCs in co-cultures with CD8 T-cells. As 
such, it also functions as a measure of CTL killing in these co-cultures. 
 
1. Cells were transferred to FACS tubes and washed with PBS. 
2. Cells were resuspended with 100 μl of Annexin-V binding buffer at a 
concentration of 1 x 10
6
 cells/ml. 
3. 5 μl of Annexin-V FITC and 1 μl of 7-AAD were added to each tube. Cells were 
incubated for 15 min at r.t in the dark. 
4. After incubation, 400 μl of Annexin-V binding buffer were added to each tube. 
Cells were analyzed by flow cytometry immediately. 
 
LIVE/DEAD fixable violet dead cell stain kit viability assay 
This assay was used to measure the viability of monocytes after activation with LPS and 
IFNγ. The LIVE/DEAD fixable violet dead cell stain kit (Invitrogen, Singapore) is based 
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on the reaction of a fluorescent reactive dye with cellular amines from necrotic cells 
which results in intense fluorescent staining. The difference in intensity between the live 
and dead cell populations is typically greater than 50-fold and is completely preserved 
following fixation of the sample. 
  
1. One vial of the fluorescent reactive dye and one vial of the anhydrous DMSO 
from the kit were allowed to sit at room temperature before the caps were 
removed. 
2. 50 µl of DMSO was added to the vial of reactive dye. The solution was mixed 
well and visually confirmed that all of the dye had been dissolved. The solution of 
reactive dye was used as soon as possible, ideally within a few hours of 
reconstitution. 
3. Cells that were to be used for analysis were first counted to determine the cell 
number and centrifuged at 350 x g for 5 min before supernatant was discarded. 
4. Cells were washed once with 1 ml of PBS, centrifuged at 350 x g for 5 min and 
supernatant was aspirated completely. 
5. 400 µl of PBS was added to the cell suspension. 
6. Next, 0.4 µl of the reconstituted fluorescent reactive dye (from step 2) was added 
to the cell suspension and pipetted several times to ensure that the solution was 
mixed well. Ideally, the reconstituted fluorescent reactive dye should be used at a 
1000 x dilution. 
7. Cells were incubated at 4ºC for 20 min, protected from light. 
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8. If other surface markers were to be stained, cells were washed twice with 1 ml of 
FACS buffer before proceeding to the “surface staining of cells for FACS 
analysis” protocol. Otherwise, cells were washed once with 1 ml of PBS and fixed 
with 1% PFA. 
9. The fixed cell suspension was analyzed by FACS using the channel which 
corresponds to 405 nm excitation and ~450 nm emission (450/50 nm) 
 




Cr release assay was used as a measure to determine the ability of CTLs to lyse 
target cells. These CTLs were specific for the Flu M1 peptide in the context of HLA-
A2.01 and were generated according to the protocol “Generation of Influenza-specific 
CD8 T-cells”. 
 
1. The assay was performed under sterile conditions and with culture medium 
(DMEM + 10% human AB serum) 
2. Target cells (e.g. T2 cells) were prepared in a 15 ml Falcon tube. 4 x 103 T2 cells 
per well were used. 
3. Cells were spun down at 300 x g for 5 min, r.t. Supernatants were discarded and 
50 µCi of 
51
Cr were added. Cells were placed into a 37°C/5% CO2 incubator for 1 
h. 
4. Labeled cells were washed with 5 ml of pre-warmed media. Cells were split into 
two 15 ml Falcon tubes (e.g. 2 x 450 µl). Antigenic peptide Flu M1 (up to 5 µM) 
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was added to one of the tubes. Both tubes were incubated for 30 min in a 5% CO2 
incubator at 37°C. 
5. Effector cells were plated out at the desired ratios onto a 96 U bottom plate. E.g. 
10:1, 5:1, 1:1. For wells without effectors, 100 µl pre-warmed media were added. 
For total lysis controls, 80 µl of pre-warmed media with 20 µl of 10% Triton-X 
were added. 
6. Peptide-pulsed target cells were washed with 5 ml of pre-warmed media at 300 x 
g, r.t. for 5 mins. Supernatants were discarded. 
7. Target cells were counted and resuspended to 4 x 104 cells/ml. 
8. 100 µl of target cells (4x 103 per well) were added to each well in a 96 U-bottom 
plate. 
9. Plates were incubated for 4 to 6 h at 37°C/5% CO2 incubator. 
10. Supernatants were harvested from the assay plate using the cell harvester and 
transferred into appropriate wells of 96 well Luma plate. The Luma plate was 
dried in oven at 50°C for 2 h or O/N at r.t. Radioactive counts were made with the 
Beckman Top Count. 
11. Cytotoxic activity is defined as %: (sample lysis – spontaneous lysis)/(total lysis-
spontaneous lysis) x 100 
 
2.2.9    Quantitative RT-PCR 
 
To detect the presence of CD40 ligand mRNA in T-cells, quantitative RT-PCR was 
performed on T-cells that have undergone activation in co-cultures. 
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1. Cells were harvested and total RNA isolated using the QiaShredder and RNeasy 
kits (Qiagen), followed by cDNA conversion using reverse transcription with the 
Quantitect Reverse Transcription kit (Qiagen), according to manufacturer’s 
instructions.   
2. 100ng of cDNA per sample was used for Real Time PCR, which was done in 96-
well format using the ABS Power SYBR kit (Applied Biosystems, Singapore) in 
the ABS 7500 Real time PCR machine.  
3. Cycling conditions were 95ºC for 10mins in the first cycle followed by 40 cycles 
of 95ºC for 30s; 60 ºC for 1min; 68 ºC for 1 min.  
4. Results were analyzed using the ddCt method for relative quantification of 
mRNA, with the appropriate endogenous and calibrator controls. The primer 
sequences used are as follows: CD40L Forward 5’-
AGTGGGCTGAAAAAGGATACTACACC-3’ and CD40L Reverse 5’-
TCTCGAATCTACCGGGGGACTTTAG-3’; GAPDH Forward 5’- 
TGCCCCCATGTTCGTCA  -3’ and  Reverse 5’- CTTGGCCAGGGGTGCTAA  
-3’; and 18S RNA Forward 5’- CCGGCGGCTTTGGTGACTCT -3’ and Reverse 
5’- TTCCTTGGATGTGGTAGCCGTTTCT -3’. 
 
2.2.10   Preparation of cytokine milieus for monocyte differentiation studies 
 
To study the effect of cytokines produced during the CD8 T-cell-DC interaction on the 
differentiation of monocytes, supernatants of CD8 T-cell-DC co-cultures were harvested 
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and used as cytokine milieus which would be added to freshly isolated monocytes for 48 
h. The preparation of CD8 T-cell-DC co-cultures in this protocol was slightly modified 
from the previous protocol on co-cultures to reduce the presence of LPS in the 
supernatants. Supernatants and culture medium (in a ratio of 3:1) were then added to 
freshly isolated monocytes seeded at a density of 1.3 x 10
6
 cells/ml and incubated for 48 
h at 37°C/ 5% CO2. 
 
1. Immature monocyte-derived DCs that were previously grown in 6-well plates 
were used.  
2. About three quarters of the culture medium in half of the total number of wells 
(e.g. 2 out of 4 wells of DCs) was carefully aspirated by placing the tip of the 
pipette at the corner edge of each well. Care was taken not to aspirate too quickly 
to prevent cells from being aspirated. 
3. A fresh amount of culture media (typically about 2 ml) containing 100ng/ml of 
LPS was added into each well. Leave the other half of the number of wells 
untouched. 
4. Cells were incubated at 37°C/ 5% CO2 for about 2-3 h. 
5. The DCs that have had their culture medium changed were checked for 
maturation under the microscope for long spindle dendrites and adherence  
6. These DCs were carefully harvested using a cell scraper into a 15 ml falcon tube 
and labeled as “activated DCs” while wells that did not have their culture medium 
changed were also harvested at the same time into a different falcon tube and 
labeled as “non-activated DCs”. 
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7. Both tubes of cells were centrifuged at 350 x g at r.t. for 5 min. 
8. Cells were washed 3 x by adding 5 ml of pre-warmed DMEM and centrifuged at 
350 x g at r.t. for 5 min each time. 
9. Activated and non-activated DCs were resuspended in culture medium to a final 
concentration of 0.67 x 10
6
 cells/ml. 
10. Allogeneic CD8 T-cells that have been pre-activated previously (see Chapter 
2.2.5) were harvested and washed 3 x with DMEM.  




12. 100 µl of activated CD8 T-cells (1.33 x 105 cells) were then added to 100 µl of 
allogeneic DCs (0.67 x 10
5
 cells) such that CD8 T-cells and DCs were cultured in 
a ratio of 2:1 to a total of 2 x 10
5
 cells in 200ul of culture medium per well in 
triplicates in U-bottom 96-well plates (Costar). Cells were then incubated at 37°C/ 
5% CO2. 
13. After 18 h, 96-well plates were centrifuged at 350 x g at r.t. for 5 min. 
Supernatants were harvested and can be stored at -80°C in 1.5 ml eppendorf tubes 
for future use. 
14. To use the supernatants for monocyte studies, supernatants were used either right 
after harvesting from co-cultures or thawed out from -80°C at r.t.  
15. Supernatants and fresh culture medium was added in a ratio of 3:1 to freshly 
isolated monocytes and incubated for 48 h at 37°C/ 5% CO2 for differentiation 
studies. Freshly isolated monocytes were cultured at a density of 1.3 x 10
6
 
cells/ml in 24-well plates.  
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2.2.11   Nitric Oxide Assay 
 
For the detection of intracellular nitric oxide (NO) produced by differentiated monocytes, 
a pH insensitive fluorescent dye DAF-FM diacetate (Calbiochem, Merck, Singapore) was 
used. This compound is essentially nonfluorescent until it reacts with NO to form a 
fluorescent benzotriazole.  DAF-FM diacetate is cell-permeant and passively diffuses 
across cellular membranes.  Once inside cells, it is deacetylated by intracellular esterases 
to become DAF-FM. DAF-FM fluorescence emission, which is related to the intracellular 
NO content, was then analyzed by flow cytometry. 
 
1. Monocytes that have been previously differentiated for 48 h with cytokine milieus 
(see Chapter 2.2.10) were used. 
2. The media from each well was aspirated gently by placing the tip of a pipette at 
the corner edge of each well.  
3.  Cells were washed once by adding 1.5 ml of PBS to each well and gently 
aspirating by placing the tip of the pipette at the corner edge of each well. 
Although differentiated monocytes were generally adherent to the plate, care must 
still be taken not to aspirate too quickly. 
4. 2 ml of phenol-red free DMEM (Gibco, Invitrogen) containing 10% human AB 
serum and 100ng/ml of LPS was added to each well. 
5. Cells were incubated for 6 h at 37°C/ 5% CO2. 
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6. 5µM of the the pH insensitive fluorescent dye DAF-FM diacetate (Calbiochem, 
Merck, Singapore) was added directly to the cells and placed back into the 
incubator for another 30min at 37°C/5% CO2. 
7. The media in each well was gently aspirated and cells were washed once by 
adding 2 ml of PBS into each well. The PBS was then aspirated completely. 
8. 2 ml of phenol-red free DMEM (Gibco, Invitrogen) containing 10% human AB 
serum was added to the cells and incubated for another 15-30 min at 37°C/5% 
CO2 to allow complete de-esterification of the intracellular diacetates. 
9. Cells were then gently harvested from the plates by using a cell scrapper, 
transferred to FACS tubes and centrifuged at 350 x g for 5 min. 
10. Supernatants were discarded and cells resuspended in about 250 µl of FACS 
buffer for FACS analysis. The fluorescence excitation and emission maxima are 
495 and 515 nm, respectively, which was detected in the FITC channel. 
 
2.2.12   Phagocytosis  
 
Phagocytosis of differentiated monocytes was determined by incubation with Escherichia 
coli Alexa Fluor
 
488 conjugate bioparticles at 100 µg/ml (Molecular Probes, Invitrogen, 
Singapore) in culture medium. Stained cells were washed thrice with cold PBS, 
resuspended in PBS plus trypan blue 0.4% as a quencher, and
 
analyzed by flow 
cytometry (Cyan-ADP, Beckman Coulter, Singapore). Phagocytosis was expressed as a 
percentage of mononuclear cells that were fluorescent.  
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1. 2 plates of monocytes that have been previously differentiated for 48 h with 
cytokine milieus (see Chapter 2.2.10) were used. 
2. The media from each well was aspirated gently by placing the tip of a pipette at 
the corner edge of each well.  
11. 100 µg/ml of Escherichia coli Alexa Fluor 488 conjugate bioparticles was added 
into each well in fresh culture medium. 1 plate of cells was incubated for 1 h at 
37°C/5% CO2 while the other plate of cells was incubated at 4°C or on ice as a 
negative control. 
3. After incubation, both plates of cells were placed on ice and harvested by gently 
scraping using a cell scraper. Cells were transferred into FACS tubes and 
centrifuged at 350 x g for 5 min at 4°C. Supernatants were then discarded. 
4. Cells were subsequently washed with cold FACS buffer 3 times. 
5. Next, cells were resuspended in 250 µl of PBS + 0.4% trypan blue to quench the 
fluorescence of BioParticles® conjugates that were bound to the surface but not 
internalized. Cells were then analyzed by flow cytometry.  
 
2.2.13   Endocytosis 
 
For measurement of endocytosis, differentiated monocytes were incubated with FITC-
labeled dextran (40,000 molecular weight; Molecular
 
Probes) in culture medium. After 
washing 4 times,
 
cells were analyzed by flow cytometry (Cyan-ADP).  
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1. 2 plates of monocytes that have been previously differentiated for 48 h with 
cytokine milieus (see Chapter 2.2.10) were used. 
2. The media from each well was aspirated gently by placing the tip of a pipette at 
the corner edge of each well.  
3.  1 mg/ml of FITC-labeled dextran was added into each well in fresh culture 
medium. 1 plate of cells was incubated for 30 min at 37°C/5% CO2 while the 
other plate of cells was incubated at 4°C or on ice as a negative control. 
4. After incubation, both plates of cells were placed on ice and harvested by gently 
scraping using a cell scraper. Cells were transferred into FACS tubes and 
centrifuged at 350 x g for 5 min at 4°C. Supernatants were then discarded. 
6. Cells were washed 4 times with cold FACS buffer, subsequently resuspended in 
250 µl of FACS buffer and analyzed by flow cytometry.  
 
2.2.14   Proliferation Assay 
 
Naïve CD4 T cells (1x 10
5
/well) were co-cultured with decreasing numbers of 
differentiated monocytes in U-bottom 96-well plates  and the T cell proliferative response 
was measured 6 days after co-culture by an 18 h pulse with [
3
H]thymidine (1 μCi/well; 
Amersham Pharmacia Incorporation). 
 
1. Naive CD4 T-cells were resuspended in culture medium at a concentration of 1 x 106 
cells/ml. 100 µl of the CD4 T-cell suspension (1x 10
5
 cells) was pipetted into each 
well of a U-bottom 96 well plate. 
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2. Differentiated monocytes were resuspended in culture medium at a concentration of 1 
x 10
5
 cells/ml and added at appropriate ratios. 100ng/ml of LPS was added where 
indicated. 
3. Cells were incubated for 6 days at 37°C/5% CO2. 
4. 1mCi/ml [methyl-3H]-thymidine (Amersham Biosciences) was diluted in culture 
medium to obtain a working concentration of 50µCi/ml. 
5. Each well was pulsed with 20µl of [methyl-3H]-thymidine (1µCi/well) 18 h before 
harvesting. They were collected onto a harvesting plate (Unifilter-96, GF/C from 
Perkin Elmer) using Filtermate Harvester (Perkin Elmer).  
6.  The plate was then placed in a 50°C oven for 2h to dry.  The bottom of the plate was 
then sealed with Backing Tape (Perkin Elmer) and 20μl of Microscint 20 (Perkin 
Elmer) was added to each well containing the harvested cells.  
7. The plate was covered with TopSealTM (Perkin Elmer) and transferred to TopCount 
NXT (Perkin Elmer) for counting. Results were expressed as counts per minute 
(cpm). 
 
2.2.15   Microscopy 
 
Haematoxylin and eosin staining 
Monocytes were differentiated on glass coverslips and fixed with acetone/methanol. 
Haematoxylin and eosin staining was performed to study the morphology of these cells.  
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1. Round-shaped 10mm glass coverslips were first dipped in 70% ethanol and 
allowed to dry on a C-fold towel. They were then placed at the bottom of plastic 
24-well culture plates using forceps. 
2. Freshly isolated monocytes in 1 ml of cytokine milieu (see Chapter 2.2.10) were 
added to these wells and incubated for 48 h at 37°C/5% CO2. Classical monocyte-
derived DCs and macrophages were grown (see Chapter 2.2.3) with coverslips at 
the bottom of each well for 6 days. LPS was added to cells if necessary for an 
additional 24 h. 
3. A hooked needle was used to gently lift the coverslips (which contain the cells) 
out of the wells. The coverslips were then transferred to a clean 24-well plate 
using a pair of forceps and placed sample side facing up.   
4. 2 ml of fixation buffer containing methanol/acetone (1:1) was added to the 
coverslips in the wells and stored at -20 ºC overnight. For longer storage, top up 
of fixation buffer is needed. 
5. For immature DCs that do not adhere to coverslips, 200 μl of cells which have 
been resuspended at 0.5 x 10
6
 cells/ml were loaded onto a microscope slide 
through a cuvette which had been attached with the paper pad in a metal holder. 
Cells underwent a cytospin by centrifugation at 800 rpm for 3 min. They were 
then subsequently fixed with fixation buffer. 
6. To proceed with H&E staining, microscope slides or coverslips that were handled 
with forceps were dipped into the following solutions as follows:  
a. Mayer’s Hematoxylin- 5 min 
b. Washed in a jar of tap water until clear 
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c. 2% NH4OH- 1 to 2 dips 
d. Washed in a jar of tap water 
e. Alcoholic Y Eosin- 1 min 
f. Washed in a jar of tap water until clear 
g. 70% Ethanol-3 dips 
h. 95% Ethanol (1)- 5 dips 
i. 95% Ethanol (2)- 7 dips 
j. 100% Ethanol (1)- 10 dips 
k. 100% Ethanol (2) – 10 dips 
l. Xylene (1)- 10 dips 
m. Xylene (2)- 10 dips 
n. Xylene (3)- 10 dips 
o. Xylene (4)- 10 dips 
 
7. Coverslips and slides were finally mounted with DPX mountant and left to dry 




Monocytes were differentiated on glass coverslips and immunostaining was performed to 
detect intracellular TNF-α and iNOS. The coverslips were then mounted onto slides and 
viewed under a fluorescence microscope. This protocol describes the steps taken for 
immunostaining specific for the detection of intracellular TNF-α and iNOS in monocytes.  
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1. Round-shaped 10mm glass coverslips were first dipped in 70% ethanol and 
allowed to dry on a C-fold towel. They were then placed at the bottom of plastic 
24-well culture plates using forceps. 
2. Freshly isolated monocytes in 1 ml of cytokine milieu (see Chapter 2.2.10) were 
added to these wells and incubated for 48 h at 37°C/5% CO2. 
3. Next, LPS (100ng/ml) and 1 μl/ml of Golgi stop were added to the cells and 
incubated for a further 6 h at 37°C/5% CO2.  
4. A hooked needle was used to gently lift the coverslips (which contain the cells) 
out of the wells. The coverslips were then transferred to a clean 24-well plate 
using a pair of forceps and placed sample side facing up.   
5. 2 ml of fixation buffer containing methanol/acetone (1:1) was added to the 
coverslips in the wells and stored at -20 ºC overnight. For longer storage, top up 
of fixation buffer is needed. 
6. Following fixation, cells were washed 3 times by adding 1ml of PBS/10mM 
glycine into each well. Care was taken to add and aspirate buffers gently from the 
side of each well. 
7. 200 µl of Permeabilization/washing buffer was added into each well containing 
the coverslips and incubate at r.t. for 30 min. 
8. 5 µg/ml of purified mouse anti-human iNOS/NOS Type II (clone 6/iNOS/NOS 
Type II; BD Pharmingen) was added to the buffer in each well. Plates were sealed 
with parafilm and incubated for 30-45 min at r.t. 
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9. The buffer in each well was gently aspirated and 1ml of PBS/glycine was added. 
Washing was carried out 3 times. 
10. Next, secondary antibody goat-anti-mouse Alexa Fluor 647 IgG (Molecular 
Probes, Invitrogen, Singapore) and PE-conjugated mouse-anti-human TNF-α 
(clone 6401.1111; BD Pharmingen) were diluted to a concentration of 5 μg/ml in 
Permeabilization/washing buffer and added to each well. Plates were sealed with 
parafilm and incubated for 20-30 min at r.t. 
11. After incubation, the buffer in each well was gently aspirated and 1ml of 
PBS/glycine was added. Washing was carried out 3 times. 
12. 2 µl of DAPI (100 µg/ml) in 2ml of PBS/glycine was added to each well and left 
for 20 s. Coverslips were then washed with PBS/glycine 3 times. 
13. Coverslips were then dipped in milliQ water and excess water droplets dried off 
by gently tapping it on a C-fold towel.  
14. 3-4 µl of ProLong Gold anti-fading mounting medium (Invitrogen) was pipetted 
onto a glass slide and coverslips were mounted onto the slides with sample side 
facing downwards.  
15. Slides were stored at 4°C overnight in the dark for the mounting medium to set. 
Secure coverslips by placing nail polish at the coverslip edges. Slides were 
viewed under a fluorescence microscope (Axio imager.Z1, Axiocam HRM 
camera; Carl Zeiss Micro Imaging, Inc., Singapore) using AxioVision LE 
software (Version 4.6). 
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 mice on C57BL/6 background were from 
the Jackson Laboratory (Bar Harbor, ME). All mice used were 6-10 weeks of age and of 
the female gender.  Mice were maintained under specific pathogen free conditions within 
National University of Singapore’s satellite animal housing unit and used according to 
institutional guidelines. 
 
2.3.2 Elicitation of Contact Hypersensitivity(CHS) 
 
Chemicals 
1-chloro-2,4-di-nitrobenzene (DNCB), trimellitic anhydride (TMA), acetone and olive oil 
were all purchased from Sigma-Aldrich (Singapore). Chemicals were diluted w/v in 
vehicle (4:1; acetone; olive oil) 
 
Hapten sensitization and challenge to elicit CHS 
Mice were shaved on the flanks one day prior to sensitization with either 1% DNCB or 
10% TMA and challenged 5 days later with the same chemical on the ears.  CHS 
responses were measured by the swelling of the ears measured using a micrometer 
(Mitutoyo, Japan).  
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1. Flanks of mice were shaved 24 h prior to topical application of 50 µl of chemical 
allergen on day 0  
2. Mice were challenged by giving a topical application of 25 µl of chemical 
allergen on the ventral and dorsum of both ears on day 5.  
3. Mice were culled 18 h after challenge unless specified otherwise. 
 
Depletion of CD4 or CD8 T-cells during CHS 
To study the role of CD4 or CD8 T-cells in the elicitation phase of CHS, mice were given 
250μg of anti-CD8α (clone: 53-6.7) or anti-CD4 (clone: GK1.5) via the intra-peritoneal 
route two days before the last challenge.  
 
2.3.3   Isolation of mouse dermal skin cells for flow cytometry  
 
This protocol illustrates the steps taken to remove the epidermis from the dermis of mice 
ears using a solution of dispase before further digesting the dermis in Collagenase type 
IV to liberate the dermal cells. Cells were then washed and prepared for analysis by flow 
cytometry. 
1. Ears were carefully excised from euthanized mice. The dorsal and ventral side of 
each ear was separated by gently pulling them apart with forceps.   
2. The dorsal and ventral side of each ear was made to float on 2 ml of Dispase 
(Gibco) in a 24-well plate with the inner side facing down. The plates were then 
incubated at 37°C/5% CO2 for 90 min. 
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3. After incubation, the dorsal and ventral side of each ear was transferred from the 
Dispase solution and made to float on a drop of 100 µl of PBS in a petri dish. The 
epidermis was carefully removed from the dermis using forceps. 
4. The dermal layers were pulled into a 24 –well plate (4 pieces per well) and 
minced into smaller pieces using a pair of scissors. 2 ml of Collagenase type IV 
containing 1 µl/ml of Golgi-Stop was added to each well and plates were 
incubated at 37°C/5% CO2 for 2.5 h. 
5. After incubation, the suspension in each well was homogenized by gently 
aspirating and dispensing with a 3ml syringe attached with a 19G needle to obtain 
a single cell suspension. 
6. The single cell suspension was then filtered through a 61 μm gauze into a 15 ml 
falcon tube, centrifuged at 1200 rpm for 5 min at 4°C before FACS analysis. 
 
2.3.4   Microscopy 
 
Mice ears were carefully excised and embedded immediately in Tissue-Tek O.C.T 
compound (Sakura, Qiagen, Singapore) for cryosectioning.  
 
Haematoxylin and eosin staining 
Microscope slides with embedded cryosection samples were first fixed in acetone for 5 
min before undergoing the same steps as indicated in Chapter 2.2.15. Coverslips and 
slides were finally mounted with DPX mountant and left to dry under the fumehood 
before capture using a Leica DM2000 microscope (Leica Microsystems, Singapore). 




1. Microscope slides with embedded cryosection samples were allowed to thaw by 
placing them under the fume hood for a minimum of 1 h 
2. A Dako pen was used to outline an area around each sample on the slide 
3. Slides were fixed in acetone for 5 min and washed twice with PBS in washing jars 
4. Slides were then placed in a staining jar containing the blocking buffer for 10 min 
before washing twice with PBS 
5. Excess liquid around each sample was aspirated gently and primary antibodies 
that have been diluted in staining buffer were added onto each sample. Typically 
25-50 ul of antibody solution was added to each sample. 
6. Slides were placed in a humid chamber and incubated overnight at 4°C 
7. After incubation, slides were dipped into a staining jar containing PBS for 5 min 
before transferring slides to another jar containing PBS. Washing steps were 
conducted 3 times. 
8.  Excess liquid around each sample was aspirated gently and secondary antibodies 
that have been diluted in staining buffer were added onto each sample. Typically 
25-50 ul of antibody solution was added to each sample. 
9. Slides were placed in a humid chamber and incubated for 45 min at r.t. 
10. After incubation, slides were dipped into a staining jar containing PBS for 5 min 
before transferring slides to another jar containing PBS. Washing steps were 
conducted 3 times and in the dark. 
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11. Slides were placed in a staining jar containing DAPI diluted in PBS for 5 min at 
r.t. 
12.  Slides were washed once with PBS. 
13. Slides were then mounted with Dako mounting medium and stored at 4°C until 
ready for viewing under a fluorescence microscope (Axio imager.Z1, Axiocam 
HRM camera; Carl Zeiss Micro Imaging, Inc., Singapore) and analyzed using 
AxioVision LE software (Version 4.6). 
 
2.3.5   Isolation of draining lymph nodes for cell culture 
 
 
This protocol illustrates the procedure for testing cytokines produced from lymph node 
cells of sensitized mice. 
 
1. Auricular draining lymph nodes from euthanized mice were carefully excised 
using a pair of forceps 
2. Lymph nodes were physically disrupted and passed through a 70μm cell strainer 
to obtain a single cell suspension 
3. Cells were washed twice with MACS buffer, counted using a hemocytometer and 
resuspended to 4 x 10
6
/ml in complete RPMI-1640 medium. 
4. Cells (2 x 106 cells per well) were placed in 48-well plates that have been pre-
coated with 1μg/ml of anti-CD3 antibodies. 1μg/ml of anti-CD28 antibodies was 
also added into the cell culture. 
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5. Cells were cultured overnight at 37°C 5 % CO2 in an incubator and supernatants 
were harvested the next day for cytokine analysis. 
 
2.3.6   Homogenization of ear tissues 
 
This protocol illustrates the procedure of homogenizing ear tissues for the measurement 
of cytokine protein concentrations. 
 
1. Ear tissues were excised from euthanized mice and cut into small pieces before 
placing each pair of ears into a 2ml RNAse/DNAse free tube pre-filled with 
1.4mm ceramic beads (Omni International, Singapore) 
2. 275μl of RIPA buffer (Sigma-Aldrich) containing protease inhibitor (25 X 
dilution) (Roche, Singapore) was added into the tube. 
3. The tubes containing the ear tissues were homogenized using the Omni Bead 
Rupter 24 Homogenizer (Omni International, Singapore) at a rotation speed of 4.5 
m/s for 45 sec. 
4. The tubes were cooled to remove excess heat by placing in ice for 1 min and 
homogenized again at 4.5 m/s for another 45 sec 
5. The supernatant was removed from each tube and cytokines were analyzed using 
ELISA.  
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2.3.7   Detection of cytokines 
 
GM-CSF, IFN-γ, IL-4, IL-5, IL-10, IL-13 and IL-17a levels were detected using 
sandwich ELISA with DuoSet ELISA development kit from R&D systems (Singapore) 
according to the manufacturer’s protocol.  
 
2.4   Statistical Analysis 
 
Results shown were mean ± SD or mean ± SE as indicated. Comparisons between two 
groups were performed by Student’s t-test. Comparisons between three or more groups 
were performed by one-way ANOVA followed by Tukey’s post test. Data were analyzed 
using Prism 5 (GraphPad).  
TABLE 2.1 Primary antibodies used in human studies 
Target mAB clone Isotype Conjugation Purpose Source 
CCR1 TG4/CCR1 Mouse IgG2b AF647 Surface staining BioLegend 
CCR2 TG5/CCR2 Mouse IgG2b AF647 Surface staining BioLegend 
CCR5 HEK/1/85a Rat IgG2a AF647 Surface staining BioLegend 
CCR7 3D12 Rat IgG2a PE Surface staining eBioscience 
CD3 UCHT1 Mouse IgG1 PB Surface staining BD Pharmingen 
CD4 RPA-T4 Mouse IgG1 FITC Surface staining BD Pharmingen 
CD8 RPA-T8 Mouse IgG1 APC Surface staining BD Pharmingen 
CD14 MΦP9 Mouse IgG2a APC Surface staining BD Pharmingen 
CD40 5C3 Mouse IgG1 FITC Surface staining BD Pharmingen 
CD40L TRAP1 Mouse IgG1 FITC Surface staining BD Pharmingen 
CD80 L307.4 Mouse IgG1 PE Surface staining BD Pharmingen 
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CD83 HB15e Mouse IgG1 APC Surface staining BD Pharmingen 
CD86 2331 Mouse IgG1 PE Surface staining BD Pharmingen 
CX3CR1 2A9-1 Rat IgG2b AF647 Surface staining BioLegend 
DC-SIGN 9E9A8 Mouse IgG2a PE Surface staining BD Pharmingen 
GM-CSF BVD2-21C11 Rat IgG2a AF647 Intracellular staining eBioscience 
HLA-A, B, C W6/32 Mouse IgG2a PB Surface staining BioLegend 
HLA-DR G46-6 Mouse IgG2a FITC Surface staining BD Pharmingen 
IFN-γ 25723.11 Mouse IgG1 PE Intracellular staining BD Pharmingen 
IL-4 MP4-25D2 Rat IgG1 APC Intracellular staining BioLegend 
iNOS/NOS 
Type II 




Perforin dG9 Mouse IgG2b AF647 Intracellular staining BioLegend 
TLR2 TL2.1 Mouse IgG2a PE Surface staining eBioscience 
TLR3 TLR3.7 Mouse IgG1 PE Surface staining eBioscience 
TLR4 HTA125 Mouse IgG2a PE Surface staining BioLegend 
TLR8 44C143 Mouse IgG1 PE Surface staining Abcam 






TABLE 2.2 Primary antibodies used in mice studies 
Target clone Isotype Conjugation Purpose Source 
CD3 145-2C11 Hamster IgG1 Purified Microscopy eBioscience 
CD4 GK1.5 Rat IgG2b Purified Depletion in vivo eBioscience 
CD8α 53-6.7 Rat IgG2a Purified Depletion in vivo eBioscience 
CD11b M1/70 Rat IgG2b PE-Cy7 Surface staining eBioscience 
CD11c HL3 Hamster IgG1 PE Surface staining BD Pharmingen 
CD31 2H8 Hamster IgG1 Purified Microscopy Millipore 
CD45 30-F11 Rat IgG2b APC-Cy7 Surface staining BD Pharmingen 
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CD68 FA-11 Rat IgG2a FITC Surface staining Serotec 
IA/IE M5/ 114.15.2 Rat IgG2b PerCP-Cy5.5 Surface staining eBioscience 
IA/IE M5/114.15.2 Rat IgG2b Purified Surface staining eBioscience 
iNOS/NOS 
Type II 
polyclonal Rabbit IgG1 Purified Microscopy Calbiochem 
iNOS/NOS 
Type II 
polyclonal Rabbit IgG1 Purified Intracellular staining BD Pharmigen 
Ly6C HK1.4 Rat IgG2c PB Surface staining BioLegend 
Ly6G 1A8 Rat IgG2a PE Surface staining BD Pharmingen 
TCRαβ H57-597 Hamster IgG1 APC Surface staining eBioscience 
TNF-α MP6-XT22 Rat IgG1 AF488 Intracellular staining BioLegend 
 
TABLE 2.3 Secondary antibodies  
Target Host Conjugation Source 
Anti-Rabbit Goat AF647 Invitrogen 
Anti-Rabbit Donkey Cy3 Jackson laboratories 
Anti-Rat Donkey Cy2 Jackson laboratories 
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3.1   Introduction 
 
CD4 T-cells were first shown to demonstrate their helper role by utilizing CD40L to 
prime DCs for the production of IL-12 (Cella et al., 1996; Koch et al., 1996) However, in 
contrast to this well established role of CD4 Th1 cells, little was known if CD8 T-cells, 
which normally relied on signals from DCs to induce their cytotoxicity (Bennett et al., 
1998; Jung et al., 2002), could also function as helper cells. Mailliard et al. (2002) then 
showed that naive human CD8 T-cells could co-operate with naive CD4 T-cells to induce 
IL-12p70 from DCs and this was dependent on the expression of IFN-γ and CD40L by 
CD8 T-cells and CD4 T-cells respectively. Recent reports using mouse models from our 
lab have also revealed that activated or memory CD8 T-cells could prime splenic DCs for 
IL-12p70 in the absence of CD4 T-cells and this was heavily dependent on CD8 T-cells’ 
ability to express CD40L (Wong et al., 2008; Wong et al., 2009).  Since CD8 T-cells 
have been shown to acquire their effector functions and infiltrate into inflamed sites at a 
much earlier time than CD4 T-cells (Akiba et al., 2002; Battistini et al., 2003), we 
wondered if human CD8 T-cells were also able to prime DCs for IL-12 in the absence of 
CD4 T-cells. 
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In this chapter, we devised an in vitro system that allowed us to study the effect of human 
blood CD8 T-cells on monocyte-derived DCs during a mixed lymphocyte reaction 
(MLR) and antigen-specific manner using the Flu M1 peptide in the context of HLA-
A2.01. We also utilized blocking antibodies against soluble factors and CD40L to 
determine if these factors were necessary for CD8 T-cells to induce DCs for the 
production of IL-12.  Finally, we also determined if CD8 T-cells could prime DCs for the 
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3.2   Results 
 
3.2.1   Purity of MACS isolated blood CD8 T-cells and Monocytes 
Since we would be studying the effect of CD8 T-cells on DCs in an in vitro co-culture 
system, it is important that the purity of isolated CD8 T-cells and monocytes (which 
would be differentiated into DCs before co-culture) had to be relatively high in order to 
rule out any confounding factors due to contaminating cells. To examine the purity of 
these cells, FACS analysis was performed on isolated cells after MACS separation.  
 
CD8 T-cells were first isolated by positively selecting PBMCs using anti-CD8 
conjugated microbeads. All viable cells were included to give a more stringent picture of 
cell purity (Fig.3.1.A). We found that cells which have been positively selected with only 
anti-CD8 microbeads gave a purity of only 92.3% CD8 T-cells (Fig. 3.1C). As NK cells 
and NKT cells have been shown to express low levels of CD8, we depleted the cell 
fraction of these cells by negative selection with anti-CD56 magnetic beads and 
collecting the fraction of cells which were not bound to the magnetic column. We found 
that this additional step gave an enriched population of CD8 T-cells with a higher purity 
of 98.9% (Fig. 3.1D).  
 
Monocytes were isolated from peripheral blood by negatively selecting PBMCs using the 
Monocyte Isolation Kit II. Non-monocytes were indirectly magnetically labeled using a 
cocktail of biotin-conjugated antibodies provided in the kit against CD3, CD7, CD16, 
CD19, CD56, CD123 and Glycophorin A. Isolation of unlabeled monocytes was 
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achieved by depletion of the magnetically labeled cells. We found that this procedure 
gave a percentage of 97.2% of CD14+HLA-DR+ monocytes (Fig. 3.1G). 
 
The purity of CD8 T-cells and monocytes obtained were periodically checked throughout 
the whole course of the study, and were found to fall within 95-99% for CD8 T-cells and 



















































Fig. 3.1 Purity of blood CD8 T-cells and Monocytes isolated by MACS.  
 
PBMCs were selected for CD8 T-cells and monocytes using MACS and analyzed using 
flow cytometry. (A) Forward and side scatter plot of isolated CD8 T-cells (B) Isolated 
CD8 T-cells stained with isotype antibodies (C) Isolated CD8 T-cells selected using anti-
CD8 positive selection only. Cells were stained with anti-CD3 PB and anti-CD8 APC. 
(D) Enriched population of CD8 T-cells after depletion of contaminating NK cells with 
anti-CD56 MACS beads. (E) Forward and side scatter plot of isolated monocytes. (F) 
Isolated monocytes negatively selected using Monocyte Isolation Kit II and stained with 
isotype antibodies. (G) Isolated monocytes negatively selected and stained with anti-
CD14 APC and anti-HLA-DR FITC antibodies. Results are representative of five 
experiments. 
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3.2.2   CD8 T-cells upregulate the surface expression of co-stimulatory molecules on 
DCs 
To investigate the modulating effects of CD8 T-cells on monocyte-derived DCs, we first 
determined if CD8 T-cells could activate DCs during an allogeneic co-culture. CD8 T-
cells isolated from the blood of healthy donors were used either freshly isolated or 
activated for 48 h using PMA/ionomycin as a stimulus as previously described (Wong et 
al., 2008).  We first determined the activation status of CD8 T-cells after stimulation. We 
found that activated CD8 T-cells downregulated their expression of CD45RA and CCR7 
compared to freshly isolated CD8 T-cells (Fig.3.2A), suggesting that these cells have 
adopted an effector phenotype (Sallusto et al., 1999). Next, freshly isolated and activated 
CD8 T-cells were incubated with anti-CD3/CD28 for 6 h in the presence of Golgi-stop
TM
, 
fixed and stained intracellularly by flow cytometry. We found that CD8 T-cells that were 
freshly isolated did not express much intracellular IFN-γ, however upon activation, 
activated CD8 T-cells expressed a significant higher percentage of intracellular IFN-γ 











































Fig. 3.2 Phenotypic comparison of freshly isolated and activated CD8 T-cells. 
 
CD8 T-cells were analyzed either freshly isolated after MACS selection or after 
activation with PMA/ionomycin for 48 h. (A) CD8 T-cells were stained with anti-
CD45RA APC and anti-CCR7 PE. CD8 T-cells were cultured with anti-CD3/anti-CD28 
antibodies for 6 h in the presence of Golgi-Stop
TM
. Cells were harvested, fixed, 





 cells. Results are representative of three experiments. 
 
 
We then co-cultured CD8 T-cells with allogeneic DCs for 18 h and DCs were evaluated 
by analyzing the expression and/or upregulation of co-stimulatory molecules CD40, 
CD80 and CD86, as well as the maturation marker CD83. Immature DCs that were 
unstimulated did not express CD80 and CD83 but expressed intermediate levels of CD86 
(Fig. 3.3B) compared to the isotype control (Fig. 3.3A). DCs that were activated with 
LPS served as a positive control and showed upregulation of CD40, CD80, CD86, as well 
as the maturation marker, CD83 (Fig. 3.3C). When DCs were co-cultured with CD8 T-
cells, we found that freshly isolated CD8 T cells could only upregulate CD40 and CD80 
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expression (Fig. 3.3D) and this was to a much lesser extent than the positive control of 
LPS. In contrast, activated CD8 T cells induced the up-regulation of all the molecules 
tested (Fig. 3.3E) and was expressed at a higher percentage and MFI than those induced 
by freshly isolated CD8 T-cells. In addition, the increase in MFI expression of CD80 and 
CD86 was higher than those induced by the positive control, LPS. Hence, CD8 T-cells 
are able to activate DCs by inducing the upregulation of these co-stimulatory molecules 
and this activation was best achieved with the co-culture of activated CD8 T-cells. 
 















































































Fig. 3.3 Activated CD8 T-cells induce the up-regulation of co-stimulatory molecules 
and maturation of DCs.   
Cells were first selected for singlets by gating on cells with low pulse width and DCs 
discriminated by gating on the high side scatter plot. (A) Day 6 immature DCs were 
stained with isotype control antibodies. (B) Day 6 immature DCs (C) DCs activated with 
LPS (C) DCs co-cultured with freshly isolated or  (D) activated allogeneic CD8 T cells 
for 18 h were washed and stained for surface expression of DC markers anti-CD40, anti-
CD80, anti-CD83 and anti-CD86 using flow cytometry. Bold numbers indicate mean 
fluorescence index (MFI) and numbers on right indicate the percentage of cells. Results 
are representative of three experiments. 
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3.2.3   Pre-activation of CD8 T-cells and LPS were required for DC IL-12p70 
 
We next examined if CD8 T-cells could induce DCs to produce IL-12. We first used DCs 
that were stimulated with LPS as a readout. DCs that were cultured with LPS for 18 h 
produced IL-12p40 (Fig. 3.4A) but failed to produce IL-12p70 (Fig. 3.4B). Since 
previous reports have suggested that the production of IL-12p70 requires at least 2 
activating signals (Snijders et al., 1998), we added rhIFN-γ together with LPS. DCs 
stimulated with both LPS and IFN-γ produced increased amounts of IL-12p40 compared 
to DCs stimulated with LPS alone (Fig. 3.4A). In addition, they produced robust amounts 
of IL-12p70 (Fig. 3.4B), hence making it a useful positive control. We then analyzed the 
supernatants that were harvested from CD8 T-cell-DC co-cultures. Both freshly isolated 
and activated CD8 T-cells failed to induce the production of both IL-12p40 and p70 from 
DCs alone (Fig. 3.4A and B). We then added LPS to the CD8 T-cell-DC co-cultures to 
determine if a second signal was needed for the production of IL-12. We found that IL-
12p40 was present in supernatants from freshly isolated CD8 T-cells cultured with DCs 
in the presence of LPS, however this condition was still not enough for the production of 
IL-12p70 (Fig. 3.4A and B) even at longer co-culture time points of up to 7 days (data 
not shown). In contrast to the weak modulating activity of freshly isolated CD8 T-cells, 
activated CD8 T-cells induced a significant increase in the amount of IL-12p40 from DCs 
in the presence of LPS (Fig. 3.4A). Strikingly, a significant amount of IL-12p70 was also 
detected from activated CD8 T-cells cultured with DCs and LPS (Fig. 3.4B). Hence, pre-
activation of CD8 T-cells was required not only to induce DC maturation, but also to co-
operate with LPS as the second signal to prime DCs for IL-12p70 production.  


















































































































Fig. 3.4 Pre-activation of CD8 T-cells and LPS were required for induction of DC 
IL-12p70  
Freshly isolated or activated CD8 T cells were cultured with allogeneic Day 6 immature 
DCs for 18 h in the presence or absence of LPS. Supernatants were harvested and 
analyzed for the presence of (A) IL-12p40 and (B) IL-12p70 using ELISA. **p<0.001 
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3.2.4   Priming of DC for IL-12p70 production is antigen specific 
To demonstrate the capacity of CD8 T-cells to induce IL-12p70 production by DCs in an 
antigen-specific manner, we generated CD8 T-cells lines (CTLs) specific for the 
influenza M1 peptide in the context of HLA.A2.1. These flu-specific CTLs were first 
isolated from blood through cell-sorting by specific tetramer isolation and kept in culture 
with addition of IL-2, IL-7 and re-stimulated with peptide-loaded DCs weekly to 
maintain their activation status. The frequency of tetramer-binding cells was found to be 
about 85.7% (Fig. 3.5A inset). When these CTLs were cultured with autologous DCs in 
the presence of an irrelevant peptide EV71, IL-12p70 production was undetectable even 
when LPS was added to the co-cultures (Fig. 3.5A). Consistent with our findings from 
the allogeneic co-cultures (Fig. 3.4B), CTLs cultured with the relevant peptide-loaded 
DCs and LPS produced IL-12p70 while those in the absence of LPS did not (Fig. 3.5A).  
 
We next determined if the production of IL-12p70 was dependent on the amount of 
peptide used. Autologous DCs were pulsed with increasing doses of Flu M1 peptide for 1 
h, washed and co-cultured with CTLs. We found that IL-12p70 production increased in a 
dose-dependent manner with the concentration of Flu M1 peptide used (Fig. 3.5B). 
Hence, these results indicate that CD8 T cell induction of IL-12p70 from DCs occurs in 
an antigen specific system. 
 
 
































































































Fig. 3.5 Production of IL-12p70 is peptide specific.  
(A) Activated CD8 T cells specific for Flu M1 peptide (percentage of cells specific for 
Flu M1 tetramer in inset) were co-cultured with autologous Day 6 immature DCs in the 
presence of 5uM of irrelevant peptide (EV71) or relevant peptide (M1) with or without 
LPS where indicated. Results are pooled from 3 independent donors. (B) Flu M1 specific 
CD8 T-cells were co-cultured with autologous Day 6 immature DCs in increasing dose of 
M1 peptide and LPS for 18 h. Supernatants were harvested and analyzed for IL-12p70 
using ELISA. **p<0.001 using student’s t-test. Results are representative of three 
experiments. 
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3.2.5   DCs were not killed by CD8 T-cells during co-cultures 
We wanted to determine if activated CD8 T-cells may kill DCs during co-cultures, 
thereby affecting their ability to produce IL-12p70. To investigate this, we co-cultured 
allogeneic activated CD8 T-cells and DCs with or without LPS for 18 h before staining 
cells with Annexin-V and 7-AAD. We could not measure DC killing with the 
51
Cr assay 
as DCs were unable to hold the 
51
Cr well and the spontaneous release was very high (data 
not shown). DCs cultured without CD8 T-cells served as controls. DCs were 
discriminated from CD8 T-cells in co-cultures using the forward and side scatter and 
expression of MHC class II. Annexin-V and 7-AAD staining revealed that the proportion 
of live DCs, which were negative for both Annexin-V and 7-AAD, was not significantly 
different among all the co-culture groups, with or without CD8 T-cells (Fig. 3.6A). 
Annexin-V and 7-AAD could accurately pick up dead DCs as we found in a separate 
experiment that these non-viable DCs cultured in media without AB serum were double 
positive for Annexin-V and 7-AAD and stained positive for trypan blue as observed by 
microscopy (data not shown). 
 
We next studied if CD8 T-cells were able to kill non-DC cell types, specifically the T2 
cell line. The T2 cell line only expresses HLA-A2, does not express HLA-DR and is 
MHC class II negative (Cerundolo et al., 1990). T2 cells were pulsed with 
51
Cr before 
pulsing with the Flu M1 peptide. They were then cultured with activated CD8 T-cells that 
were generated from the Flu specific CD8 T-cell line (CTLs) Results from the 
51
Cr assay 
revealed that these CTLs were able to kill T2 cells pulsed with the Flu M1 peptide (Fig. 
3.6B), hence indicating the antigen specificity of the killing activity. Therefore, we 
Chapter 3: Requirements for human CD8 T-cell mediated DC Il-12p70 production 
 115 
conclude that these activated CD8 T-cells retained their cytotoxic ability but did not kill 
































Annexin-V & 7-AAD staining
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Fig. 3.6 Activated CD8 T-cells did not cause significant killing of DCs during co-
culture.  
(A) Co-cultures were harvested after 18 h and DCs were gated using MHC class II. 
Viability of DCs were assessed using flow cytometry for Annexin-V and 7-AAD negative 
cells (B) T1 cells were used as target cells and were used either without peptide or pulsed 
with 5µm of Flu M1 peptide. Flu-specific CD8 T-cells were added to target cells in the 
indicated effector to target ratios for 5 h. Supernatants were harvested and the amount of 
51
Cr released was detected using a gamma counter. Specific lysis was calculated using the 
formula (test cpm – spontaneous cpm) / (maximum release cpm - spontaneous cpm) x 
100 %. Results are mean ± SD and representative of 3 experiments. 
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3.2.6   IFN-γ, and not CD40L, is essential for CD8 T-cell mediated IL-12p70 
production 
Previous studies have indicated that CD40L, IFN-γ and TNF-α are important factors 
involved in CD8 T-cell stimulation of DC IL-12p70 production (Hochrein et al., 2000; 
Mailliard et al., 2002; Nakamura et al., 2007; Wong et al., 2008). Hence, we added 
blocking antibodies to these factors during the co-cultures. We found that IL-12p70 
production was completely abrogated when IFN-γ was blocked with a combination of 
anti-IFN-γ and anti-IFN-γR, while its production was reduced when TNF-α was similarly 
inhibited (Fig. 3.7A). Surprisingly, we noted that blocking CD40L did not affect the 
production of IL-12p70 (Fig. 3.7A). This similar trend was also seen with the influenza 
specific CD8 T cells in our antigen specific model (Fig. 3.7B). As CD40L expressed on 
mouse CD8 T cells was shown to be an important factor for the production of IL-12p70 
(Wong et al., 2008), we further investigated whether CD40L was involved in our model 
of IL-12p70 production. Using CD4 T cells as a positive control, activated and co-
cultured CD8 T cells were shown to express minimal CD40L mRNA in contrast to CD4 
T cells (Fig. 3.8A). In addition, surface expression of CD40L was not detected on 
activated CD8 T cells (Fig. 3.8B). These data indicate that activated human CD8 T cells 











































































Fig. 3.7 Production of IL-12p70 from DCs is dependent on co-operation of TLR 
signal and IFN-γ secretion, but not CD40L, from activated CD8 T-cells.  
(A) Allogeneic activated CD8 T cells or (B) Flu M1 autologous CD8 T cells were 
incubated with immature DCs in the presence of LPS with indicated blocking antibodies 
for 18h. Supernatants were harvested and analyzed for IL-12p70 using ELISA. *p<0.05, 













































Fig. 3.8 CD40L expression was minimally detected on CD8 T-cells, as compared to 
CD4 T-cells.   
Freshly isolated or activated CD4 and CD8 T cells were co-cultured with allogeneic DCs, 
in the presence or absence of LPS for 3 and 6 hours. (A) CD40L mRNA levels were 
determined by quantitative real-time PCR, using 18S levels as endogenous control with 
DC only as a calibrator. (B) Surface expression of CD40L on activated T cell populations 
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3.2.7   Analysis of other cytokines and chemokines produced during co-culture 
We next investigated whether the interaction of activated CD8 T-cells and DCs results in 
the production of other immunomodulatory cytokines and chemokines. DCs stimulated 
with LPS alone produced inflammatory cytokines IL-6 and TNF-α, with small amounts 
of GM-CSF and IL-10 (Table 3.1A) while activated CD8 T-cells stimulated with anti-
CD3 and CD28 produced GM-CSF, IFN-γ and TNF-α (Table 3.1B). When activated CD8 
T cells were cultured with DCs, the levels of IFN-γ and TNF-α were enhanced in the 
presence of LPS. Notably, IL-1 production by DCs required the presence of both CD8 T-
cells and LPS (Table 3.1B). IL-10 was only produced by DCs stimulated by LPS (Table 
3.1A) and was absent in the presence of CD8 T-cells (Table 3.1B). The cytokine profile 
was similar for influenza specific CTLs, with CTLs co-cultured with peptide loaded DCs 
in the presence of LPS secreting the largest amount of pro-inflammatory cytokines (Table 
3.1C). No IL-4, IL-18 and IL-23 were detected in any of the cultures.  
 
We next determined which cell type in the co-cultures was producing these cytokines. 
Using intracellular staining of co-cultured cells, we first ruled out doublets (Fig. 3.9A), 
followed by distinguishing CD8 T-cells from DCs using the forward and side scatter (Fig. 
3.9B and C)  and this was further confirmed by showing that the larger side scatter which 
contains the DCs expressed a much higher level of MHC class II (Fig. 3.9F). We found 
that IFN-γ, GM-CSF and TNF-α were expressed by both CD8 T-cells and DCs (Fig.3.9E 
and F), although IFN-γ was mainly expressed by CD8 T-cells (Fig. 3.9E) while GM-CSF 
and TNF-α were mainly expressed by DCs (Fig. 3.9F). We had difficulty detecting IL-1α 
and β through intracellular staining as the quantity expressed was too small.  
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We also analyzed the production of chemokines by CD8 T-cells and DCs. Activated CD8 
T-cells stimulated with anti-CD3/CD28 secreted RANTES, MIP-1α and ß but failed to 
produce IP-10 or MCP-1 (Table 3.2B) while DCs stimulated with LPS produced large 
amounts of MCP-1, MIP-1α and ß and low levels of RANTES and IP-10 (Table 3.2A). 
Strikingly, when CD8 T-cells were co-cultured with DCs, a sharp increase in MCP-1, 
MIP-1α and ß, IP-10 and RANTES was observed (Table 3.2B). The pattern of 
chemokines was comparable in influenza specific CTL-DC co-cultures (Table 3.2C). 
These data suggest that CD8 T-cell-DC interactions result in the production of 
inflammatory cytokines and chemokines which can potentiate the recruitment and 
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                 TABLE 3.1 Cytokine production from co-cultures 
 
Cytokine levels (ng/ml) in supernatant co-cultures
a
 
(A) (B) Allogeneic co-cultures (C) Peptide-specific co-cultures  
 DC only  DC+LPS  CD8 +anti 
CD3/CD28b 
CD8+DC  CD8+DC 
+LPS  
CTL onlyc CTL+DC  CTL+DC 
+peptide  
CTL+DC 
+peptide +LPS  
IL-1 ND ND ND ND 0.5 ± 0.05  ND  ND  ND  0.4 ± 0.02  
ND ND ND ND 0.4 ± 0.03 ND ND ND 0.2 ± 0.05 
ND ND ND ND 0.1 ± 0.2 ND ND ND 0.1 ± 0.003 
IL-1ß  ND ND ND ND 0.4 ± 0.05  ND  ND  ND  0.2 ± 0.009  
ND ND ND ND 0.2 ± 0.08 ND ND ND 0.1 ± 0.008 
ND ND ND ND 0.2 ± 0.001 ND ND ND 0.1 ± 0.03 
IL-6  ND 13.5 ± 1.8  ND 0.2 ± 0.07  13.6 ± 1.4  ND  0.3 ± 0.05  0.4 ± 0.05  15.0 ± 1.2  
ND 3.2 ± 0.05 ND 0.2 ± 0.05 4.5 ± 0.2 ND 0.1 ± 0.005 1.3 ± 0.3 30.5 ± 10.3 
ND 10.2 ± 1.4 ND 0.3 ± 0.02 11.4 ± 1.7 ND 0.3 ± 0.002 0.8 ± 0.01 22.4 ± 1.2 
IL-10  ND 0.3 ± 0.02  ND ND ND ND  ND  ND  ND  
ND 0.1 ± 0.009 ND ND ND ND ND ND ND 
ND 0.2 ± 0.01 ND ND ND ND ND ND ND 
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Cytokine levels (ng/ml) in supernatant co-cultures
a
 
(A) (B) Allogeneic co-cultures (C) Peptide-specific co-cultures  
 DC only  DC+LPS  CD8 +anti 
CD3/CD28b 
CD8+DC  CD8+DC 
+LPS  
CTL onlyc CTL+DC  CTL+DC 
+peptide  
CTL+DC 
+peptide +LPS  
GM-CSF  ND 0.2 ± 0.02  0.5 ± 0.08  0.5 ± 0.03  0.6 ± 0.08  0.1 ± 0.01  0.05 ± 0.02  0.2 ± 0.01  0.7 ± 0.05  
ND 0.1 ± 0.01 0.4 ± 0.1 0.6 ± 0.02 0.7 ± 0.04 0.05 ± 0.02 0.8 ± 0.06 0.5 ± 0.09 1.2 ± 0.04 
ND 0.3 ± 0.05 0.4 ± 0.006 0.5 ± 0.02 0.7 ± 0.01 0.2 ± 0.01 0.2 ± 0.03 0.4 ± 0.04 1.7 ± 0.06 
IFN- ND 0.1 ± 0.02  5.26 ± 0.7  9.02 ± 2.7  21.7 ± 2.9  5.2 ± 0.09  0.1 ± 0.02  6.5 ± 1.1  10.4 ± 1.1  
ND 0.03 ± 0.004 20.8 ± 0.2 2.1 ± 1.2 18.4 ± 2.8 1.1 ± 0.05 28.6 ± 1.5 0.5 ± 0.06 31.1 ± 0.9 
ND ND 7.6 ± 0.6 4.4 ± 0.5 19.3 ± 2.7 3.8 ± 0.3 10.4 ± 1.3 4.2 ±  1.6 15.4 ± 0.6 
TNF-  ND 2.9 ± 0.3  6.0 ± 0.9  7.0 ± 0.09  16.4 ± 2.8  1.1 ± 0.04  0.4 ± 0.07  1.1 ± 0.2  28.3 ± 4.0  
ND 2.8 ± 0.7 0.3 ± 0.03 0.4 ± 0.1 3.7 ± 0.4 2.1 ± 0.05 5.9 ± 0.03 17.0 ± 1.7 84.1 ± 16.8 
ND ND 4.5 ± 0.04 4.2 ± 0.05 10.4 ± 0.02 0.9 ± 0.01 8.7 ± 0.1 4.6 ± 0.4 32.4 ± 1.8 
aAmount of secreted protein in 18 hour co-cultures of 2 X 10
5
 cells per well with a ratio of 2:1 allogeneic activated CD8 T cells to DCs or 
Autologous Flu M1 specific CTLs to DCs measured by multiplex bead arrays.  Results are mean ± SD of triplicates and listed as 3 independent 
donors. 
b
Activated CD8 T cells were re-stimulated with anti-CD3 (10ng/ml) and anti-CD28 (400ng/ml)  
c
Autologous Flu specific CTLs were re-stimulated with peptide loaded autologous DCs one week before harvesting for culture  
ND indicates not detected
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 TABLE 3.2 Chemokine production from co-cultures 
 
Chemokine levels (ng/ml) in supernatant co-culturesa
  
(A)  (B) Allogeneic co-cultures (C) Peptide-specific co-cultures  













IP-10 (CXCL10)  ND 1.1 ± 0.3  ND 124 ± 8.0  246 ± 2.5  0.4 ± 0.002  10.3 ± 3.5  15.0 ± 0.4  46.4 ± 6.8  
ND 4.8 ± 0.5 ND 114 ± 25 118.4 ± 11.9 0.2  ± 0.001 15.2 ± 1.4 12.3 ± 0.1 50.2 ± 7.1 
ND 2.2 ± 0.1 ND 133 ± 4.8 184 ± 10.3 0.4 ± 0.01 8.4 ± 2.0 19.7 ± 0.09 65.1 ± 9.7 
RANTES (CCL5) ND 0.3 ± 0.02  11.2 ± 4.0  8.4 ± 0.2  13.9 ± 2.8  1.4 ± 0.4  1.7 ± 0.3  5.7 ± 0.6  8.7 ± 2.3  
ND 1.0 ± 0.05 16.5 ± 1.7 9.3 ± 0.1 19.4 ± 2.3 2.8 ± 1.9 2.2  ± 1.8 7.9 ± 0.9 12.7 ± 1.8 
ND 0.2 ± 0.07 14.3  ± 5.5 12.2 ± 0.9 20.2 ± 1.9 3.7 ± 2.7 3.9 ± 4.2 3.4 ± 0.4 18.2 ± 2.4 
MCP-1 (CCL2) 4.8 ± 1.2  12.9 ± 2.2  ND 42.9 ± 5.4  21.3 ± 3.5  ND  28.2 ± 2.1  48.3 ± 1.0  9.5 ± 1.8  
6.2 ± 2.0 23.1 ± 0.5 ND 50.3 ± 7.2 47.6 ± 15.2 ND 11.7 ± 1.2 40.4 ± 2.6 4.4 ± 0.7 
7.3 ± 1.4 45.4 ± 3.2 ND 105.8 ± 2.3 78.2 ± 23.5 ND 19.5 ± 5.1 55.6 ± 3.6 7.7 ± 1.2 
MIP-1α (CCL3) 1.4 ± 0.5  2.0 ± 1.0  2.6 ± 0.3  8.0 ± 1.9  13.1 ± 2.1  1.3 ± 0.5  3.5 ± 0.9  12.7 ± 1.3  90.6 ± 21.7  
ND 4.2 ± 0.3 5.9 ± 0.7 5.6 ± 0.7 19.2 ± 3.8 1.2  ± 0.4 7.3 ± 0.2 11.5  ±  1.1 23.0 ± 0.5 
0.4  ± 0.002 3.7 ± 0.2 2.2  ± 0.009 9.4 ± 0.4 21.4 ± 2.2 0.9 ± 0.03 2.4 ± 0.1 10.9 ± 3.4 44.3 ± 0.8 
Chapter 3: Requirements for human CD8 T-cell mediated DC Il-12p70 production 
 124 
Chemokine levels (ng/ml) in supernatant co-culturesa 
(A)  (B) Allogeneic co-cultures (C) Peptide-specific co-cultures  













MIP-1ß (CCL4) 19.4 ± 7.8  48.5 ± 8.7  20.7 ± 2.7  53.4 ± 10.9  84.1 ± 6.4  15.1 ± 1.2  7.7 ± 0.6  11.2 ± 1.0  78.9 ± 5.0  
0.9 ± 0.07 22.8 ± 2.3 24.3 ± 5.7 32.8 ± 2.1 70.3 ± 12.5 20.2 ± 1.4 4.5 ± 0.8 12.7 ± 2.8 85.2 ± 6.7 
9.4 ± 0.5 33.4 ± 5.3 17.2 ± 0.08 21.7 ± 1.2 89.2 ± 9.3 12.3 ± 1.0 9.0 ± 1.2 19.9 ± 3.4 90.5 ± 10.4 
aAmount of secreted protein in 18 hour co-cultures of 2 X 10
5
 cells per well with a ratio of 2:1 allogeneic activated CD8 T cells to DCs or 
Autologous Flu M1 specific CTLs to DCs measured by multiplex bead arrays. Results are mean ± SD of triplicates and listed as 3 independent 
donors. 
b
Activated CD8 T cells were re-stimulated with anti-CD3 (10ng/ml) and anti-CD28 (400ng/ml)  
c
Autologous Flu specific CTLs were re-stimulated with peptide loaded autologous DCs one week before harvesting for culture  
ND indicates not detected
































































Fig. 3.9. Activated CD8 T-cells expressed high levels of IFN-γ while DCs expressed 
higher levels of TNF-α and GM-CSF.  
 
Activated CD8 T-cells were co-cultured with immature DCs in the presence of 100ng/ml 
of LPS and 1μl/ml of Golgi-StopTM for 6h and cells harvested, washed and stained for 
HLA-DR and permeabilized before staining for intracellular cytokines.  Cells were first 
selected for singlets by gating for cells with (A) low pulse width.(B) CD8 T-cells and (C) 
DCs were then discriminated by gating on the low and high side scatter plots 
respectively. Expression of HLA-DR and production of intracellular cytokines IFN-γ, 
GM-CSF and TNF-α with (D) isotype controls by (E) CD8 T-cells and (F) DCs are 
shown. Numbers represent percentages of positive cells. Data shown are representative of 
four experiments.  
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3.3   Discussion 
 
To understand how human CD8 T-cells could prime DCs for IL-12p70 production, we 
first established an in vitro system using both allogeneic and antigen-specific models. We 
found that, in contrast to freshly isolated CD8 T-cells that had weak DC-modulating 
activities, activated human peripheral blood CD8 T-cells were able to induce DC 
activation by up-regulating co-stimulatory molecules and priming DCs for IL-12p70. In 
addition, we noted that the ability of activated CD8 T-cells to modulate DCs, in 
comparison to freshly isolated CD8 T-cells, was due to their propensity to secrete IFN-γ 
and TNF-α rapidly. We also found that LPS was essential to co-operate with activated 
CD8 T-cells for efficient priming of IL-12p70 from DCs.  
 
The inability of freshly isolated CD8 T-cells to prime DCs for IL-12p70 in our model is 
in line with Kalinski’s studies demonstrating that naive CD8 T cells require the presence 
of CD40L-expressing CD4 T cells and pre-activated DCs for concomitant production of 
IL-12p70 (Mailliard et al., 2002). In this study, DCs were pre-activated with TNF-α for 
24 h before exposing them to naive CD8 T-cells and CD4 T-cells. In contrast, our study 
did not utilize pre-activated DCs but adopted immature DCs co-cultured concurrently 
with freshly isolated CD8 T-cells and LPS for 18 h. These results may also explain why 
activated CD8 T-cells were superior to freshly isolated CD8 T-cells because they could 
secrete IFN-γ and TNF-α rapidly during interaction which may facilitate the maturation 
of the DCs. However, while our studies suggested that CD8 T-cell’s production of IFN-γ 
was the principal factor involved, Kalinski’s studies demonstrated CD8 T-cell’s 
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production of TNF-α to play a more significant role instead (Mailliard et al., 2002; 
Watchmaker et al., 2008). This disparity could be due to the usage of different models as 
we adopted LPS while they chose CD40L as the second signal instead for IL-12p70 
production. In addition, the time course of the co-cultures was also markedly different. 
While Kalinski’s group used a total co-culture period of 72 hours by priming DCs with 
CD8 T cells for 48 hours before re-stimulating them with CD40L-expressing cells for 
another 24 hours, we show that CD8 T cell- induction of DC IL-12p70 in the presence of 
LPS could occur within 18 hours of their interaction. A detailed study of the kinetics of 
CD8 induced IL-12p70 production from DCs will resolve this issue. 
 
Notably, we found that LPS was also necessary to prime DCs for IL-12p70 during co-
cultures with activated CD8 T-cells. This notion is consistent with several previous 
studies that demonstrate the two-signal requirement for efficient production of IL-12p70 
(Schulz et al., 2000; Snijders et al., 1998; Trinchieri, 2003). In these studies, they 
demonstrate that the first signal, usually IFN-γ or CD40L, is provided by T-cells while 
the second signal can be provided by microbial compounds such as LPS. In addition, the 
two-signal requirement proved unique for the production of IL-12, since either CD40 
engagement or LPS was sufficient for the efficient production of other pro-inflammatory 
cytokines such as TNF-α, IL-8 and the p40 subunit of IL-12, and may be considered as a 
safety mechanism for optimal control of potentially harmful Th1 responses (Snijders et 
al., 1998).  
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Our human CD8-DC co-culture studies are also supportive of our previous findings in 
mice (Wong et al., 2008; Wong et al., 2009). However, while CD40L was expressed on 
mouse CD8 T cells and was important for IL-12p70 priming, CD40L was not detected on 
peripheral blood human CD8 T cells. The absence of CD40L on human CD8 T cells can 
be explained by a previous study whereby CD8 T cells were shown to have a strong bias 
towards Th1 immunity with 80-90% of human CD8 T cells differentiating into IFN-γ-
secreting Tc1 cells upon activation and 10-13% expressing CD40L only in the presence 
of Th2 cytokines (Vukmanovic-Stejic et al., 2000).  It is possible that these CD40L-
expressing Tc2 CD8 cells exist in significant numbers only in certain disease states or are 
confined to particular immune compartments (Birkhofer et al., 1996; Maggi et al., 1994; 
Salgame et al., 1991; Till et al., 1995). In addition, while studies in mice showed that 
both CD40L and IFN-γ, together with LPS, were necessary for CD8 T-cell induction of 
DC IL-12p70, our study showed that IFN-γ alone was enough to prime DCs for IL-12p70 
in the presence of LPS. This discrepancy could be due to differences in mice and human 
studies, and also due to the fact that different DC subsets were adopted for both studies. 
Studies in mice used steady state resident lymphoid splenic DCs while ours adopted IL-4 
and GM-CSF generated DCs which were thought to represent inflammatory DCs instead 
(Naik et al., 2006; Shortman and Naik, 2007).  
 
Interestingly, we noticed that activated CD8 T-cells did not seem to kill DCs during their 
interaction, although they were able to kill peptide-pulsed T2 cells. Studies have shown 
that DCs could be protected from CTL killing by upregulating the expression of the 
granzyme B inhibitor serine protease inhibitor (SPI-6) when stimulated with LPS or 
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CD40L expressed on Th1 cells (Medema et al., 2001). In addition, memory CD8 T cells 
that release the DC-activating factor TNF-α before the release of cytotoxic granules were 
showed to induce DC expression of an endogenous granzyme B inhibitor PI-9 that 
protected DCs from CTL killing with similar efficacy as CD4 T cells (Watchmaker et al., 
2008). Hence, DCs could be protected by CD8 T-cells from killing by a similar 
mechanism during their interactions in our study.  
 
Finally, we determined if other soluble factors were produced during CD8 T-cell-DC co-
cultures. We found increased production of cytokines GM-CSF, IFN-γ, TNF-α and 
chemokines MCP-1, MIP-1α and ß, RANTES and IP-10. These results suggest that the 
interaction of CD8 T-cells and DCs might have important implications in the creation of 
a pro-inflammatory environment that could play an essential role in protective immunity. 
Given that many different immune cell types such as T-cells, NK cells, monocytes, DCs, 
eosinophils and neutrophils are also responsive to these chemokines, it is possible that 
CD8 T-cell-DC interactions could initiate the recruitment of other immune effector cell 
types to the site of CD8 T-cell-DC interactions, for example at peripheral inflammatory 
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CHAPTER 4: Phenotypic characterization of human monocyte-derived cells 
(TNF/iNOS-producing dendritic cells) differentiated in the presence of CD8 T-cell-
DC cytokine milieu 
 
 
4.1   Introduction 
 
In the previous chapter, we showed that CD8 T-cells could prime DCs for IL-12, an 
important cytokine for Th1 responses. However in addition to IL-12, we noticed that this 
CD8 T-cell-DC interaction also resulted in an array of inflammatory cytokines and 
chemokines being produced. We were curious if these inflammatory mediators could play 
a role in amplifying the Th1 response by influencing the differentiation of other immune 
cells. In particular, monocytes are known for their plasticity (Geissmann et al., 2003) and 
ability to differentiate into antigen-presenting cells according to the microenvironment 
they encounter (Auffray et al., 2009). This confers the ability to either magnify or 
dampen the immune signals they encounter. Indeed, a previous study showed that NK 
cells can induce the differentiation of monocytes into cells representing DCs that prime 
CD4 T-cells for Th1 responses (Zhang et al., 2007). These monocyte-derived cells were 
characterized by elongated cell bodies and a stellate-like morphology. They also 
displayed DC functional properties and have increased surface expression of CD40, 
CD80, CD86 and DC-SIGN while down-regulating their surface expression of CD14. In 
addition, another study noted that monocytes cultured with activated CD8 T-cells 
upregulated DC associated markers such as HLA-DR, CD1a, CD80, CD83, CD86 
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(Wirths et al., 2002) . However, further analysis of these cells with regards to 
morphological and functional properties were not conducted. Thereafter, similar 
morphological and phenotypic observations of monocytes differentiating into cells 
representing DCs by CD4 T-cells (Mariotti et al., 2008) and γδ T-cells (Eberl et al., 2009) 
were also reported. However, it remains unknown if the differentiation of monocytes into 
APCs can occur without direct contact with other immune cells, and whether soluble 
factors produced by CD8 T-cell-DC interactions can directly influence monocyte 
differentiation in a bystander manner to sustain the immune response. 
 
To determine how CD8 T-cells may sustain the immune response during their interaction 
with DCs, we investigated how the cytokine milieu engendered by CD8 T-cell-DC 
interactions would affect the outcome of monocyte differentiation. In this chapter, we 
first studied the morphology and phenotype of these monocytes after differentiation with 
supernatants harvested from CD8 T-cell-DC co-cultures and compared these 
differentiated cells to classically generated monocyte-derived DCs and macrophages 
generated with IL-4-/GM-CSF and M-CSF respectively. In particular, we investigated 
changes in morphology through H&E staining and studying phenotypic changes by 
characterizing their expression of MHC class I, HLA-DR, co-stimulatory molecules 
CD14, CD40, CD80, CD86, DC-SIGN and the DC maturation marker, CD83. We would 
also further characterize these cells by studying their chemokine and toll-like receptor 
repertoire. 
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4.2   Results 
 
4.2.1   CD8 T-cell-DC cytokine milieu differentiates monocytes into cells with 
distinct morphologies 
We first investigated how the cytokine milieu engendered by CD8 T-cell-DC interactions 
modifies the morphology of monocytes. Supernatants were harvested from CD8 T-cell-
DC co-cultures after 18 h. These supernatants were then added to freshly isolated 
monocytes and incubated for 48 h (see Chapter 2.2.10 for methods and Table 4.1 for 
explanation). Incubation of monocytes with supernatants for longer time periods (up to 5 
days) did not yield any significant changes in cell morphology (data not shown). The 
presence of LPS in supernatants was minimized by washing DCs after 3 hours of LPS 
pulsing thoroughly before addition of CD8 T cells. Residual LPS in the supernatants were 
tested using an endotoxin test kit (CL-1000® Chromogenic LAL Endpoint Assay kit 
(Cambrex)) and 6 EU/ml was found to be present in these supernatants while those that 
had no DCs pulsed with LPS had no endotoxin detected. Hence, the minimization of LPS 
in these supernatants was to ensure that any effect seen in the differentiated monocytes 
was caused as much as possible by immune cell-derived cytokines.  
 
TABLE 4.1 Brief explanation of co-culture supernatants 
Name of supernatant Cells in co-culture Abbreviation 
DC DCs only SupernatantDC 
DCLPS DCs stimulated with LPS SupernatantDCLPS 
CD8DC Activated CD8T-cells with allogeneic 
DCs 
SupernatantCD8DC 
CD8DCLPS Activated CD8T-cells with DCs that 
have been stimulated with LPS 
SupernatantCD8DCLPS 
CD8 Activated CD8 T-cells re-stimulated 
with anti-CD3/CD28  
SupernatantCD8 
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We found that monocytes cultured with DC or DCLPS supernatants (SupernatantDC or 
DCLPS) were round and adherent (Fig. 4.1 B and C) and exhibited similar morphology to 
monocytes cultured with medium alone (Fig. 4.1A). In contrast, monocytes exposed to 
CD8DC or CD8DCLPS supernatants (SupernatantCD8DC or CD8DCLPS) were also adherent 
but developed distinct long, spindle dendrites (Fig. 4.1D and E). We also noted that 
monocytes cultured with supernatants that were harvested from activated CD8 T-cells 
alone (SupernatantCD8) had some cells that displayed long, spindle dendrites (Fig. 4.1F), 
although this was much lesser than those induced by SupernatantCD8DC or CD8DCLPS 
(Fig.4.1D and E). In addition, we also noted that cells differentiated with SupernatantCD8 
were not very viable as about 40-50% of these cells stained positive for trypan blue when 
viewed under the microscope. 
 
We next compared the morphology of these cells with classically generated monocyte 
derived DCs and macrophages. We found that monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS (Fig. 4.1D and E) displayed a closer morphology to mature 
classical IL-4/GM-CSF derived DCs (Fig. 4.1H) with the presence of adherent long 
spindle dendrites rather than immature classical IL-4/GM-CSF derived DCs that were 
non-adherent (Fig. 4.1G) Monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 
4.1D and E) were also clearly distinct from immature M-CSF derived macrophages (Fig. 
4.1I) which were round and mature M-CSF derived macrophages which exhibited 
vacuoles instead (Fig 4.1J). Hence, these results suggest that monocytes differentiated 
with CD8 T-cell-DC cytokine milieus (SupernatantCD8DC or CD8DCLPS) developed distinct 
morphologies that could resemble mature DCs. 
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Fig. 4.1 Monocytes exposed to CD8 T-cell-DC cytokine milieu differentiate into cells 
with distinct morphologies.  
Monocytes were cultured with (A) culture medium alone (no cytokines) or supernatants 
harvested from cultures of (B) DC alone, (C) DCLPS, (D) CD8DC or (E) CD8DCLPS 
for 48 h. (G) Classical DCs and (I) macrophages were generated from monocytes in the 
presence of IL-4/GM-CSF and M-CSF respectively for 6 days. (H, J) LPS was added for 
a further 24h to induce their maturation. Cells were stained with hematoxylin-and-eosin 
(H&E) and captured using a Leica DM2000 microscope (Leica Microsystems, 
Singapore). Original magnification was x 630 for all panels (scale bar: 15 mm). Data 
shown are representatives of six experiments. 
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4.2.2   Expression of MHC class I and HLA-DR by monocytes differentiated with 
CD8 T-cell-DC cytokine milieu 
We further investigated the phenotype of these differentiated monocytes by flow 
cytometry. Monocytes differentiated with the respective supernatants were analyzed for 
their surface expression of MHC class I and II (HLA-DR). We also compared the 
expression of these molecules to classically generated activated IL-4/GM-CSF DCs and 
M-CSF macrophages. Monocytes differentiated in the presence of SupernatantDC or DCLPS 
(Fig. 4.2B and C) had similar MHC class I and HLA-DR levels compared to untreated 
monocytes (Fig. 4.2A). In contrast, monocytes differentiated with SupernatantCD8DC or 
CD8DCLPS (Fig. 4.2D and E) expressed higher levels of both MHC class I and HLA-DR 
compared to monocytes differentiated in the presence of SupernatantDC or DCLPS (Fig. 4.2B 
and C). While monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 4.2D and 
E) expressed lower levels of MHC class I than IL-4/GM-CSF DCs (Fig. 4.2F), they 
exhibited a higher expression of HLA-DR compared to these cells. Notably, monocytes 
differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 4.2D and E) also expressed much 
higher levels of both MHC class I and HLA-DR compared to M-CSF derived 
macrophages (Fig. 4.2G). Thus, these data suggest that monocytes differentiated with 





































Fig. 4.2 Monocytes exposed to CD8 T-cell-DC cytokine milieu upregulate MHC class 
I and HLA-DR.  
 










or (F) mature IL-4/GM-CSF DCs and (G) 
mature M-CSF macrophages were analyzed by flow cytometry for the expression of 
MHC class I and HLA-DR. Numbers indicate relative difference in MFI between surface 
antigen expression and isotype control. Open histograms represent cells stained with 
isotype control and closed histograms represent cells stained with indicated antibody. 
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4.2.3   Monocytes differentiated with CD8 T-cell-DC cytokine milieu upregulate co-
stimulatory molecules 
We next determined if monocytes differentiated with CD8 T-cell DC cytokine milieus 
could upregulate co-stimulatory molecules. We found that compared to untreated 
monocytes (Fig. 4.3A), CD14 expression was increased on monocytes cultured with 
SupernatantDC or DCLPS (Fig. 4.3B and C) but not on monocytes cultured with 
SupernatantCD8DC or CD8DCLPS (Fig. 4.3D and E). Remarkably, monocytes cultured with 
SupernatantCD8DC or CD8DCLPS (Fig. 4.3D and E) showed substantial increase in co-
stimulatory molecules CD40, CD80 andCD86, which was minimally detected on 
monocytes cultured with SupernatantDC or DCLPS (Fig. 4.3B and C). In addition, monocytes 
cultured with SupernatantCD8DC or CD8DCLPS (Fig 4.3Dand E) also expressed CD209 (DC-
SIGN). 
 
Next, we compared the expression of these molecules on monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS to IL-4/GM-CSF DCs and M-CSF macrophages. IL-4/GM-
CSF DCs expressed high levels of CD40, CD80, CD86 and DC-SIGN and downregulated 
CD14 expression (Fig. 4.3F). On the other hand, M-CSF macrophages upregulated CD14 
expression but expressed low levels of CD40, CD80, CD86 and DC-SIGN (Fig. 4.3G). 
We found that with the exception of CD14, monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS (Fig. 4.3D and E) had a much higher expression of CD40, 
CD80, CD86 and DC-SIGN compared to M-CSF macrophages (Fig. 4.3G). In addition, 
monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 4.3D and E) also 
expressed similar levels of CD40 to IL-4/GM-CSF DCs (Fig. 4.3F), although 
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CD80,CD86 and DC-SIGN was expressed lower than that of IL-4/GM-CSF DCs.  
However, the overall data suggest that CD8 T-cell-DC cytokine milieus differentiate 



















































Fig. 4.3 Monocytes exposed to CD8 T-cell-DC cytokine milieu upregulate distinct 
surface markers.  
 










or (F) mature IL-4/GM-CSF DCs and (G) 
mature M-CSF macrophages were analyzed by flow cytometry for the expression of 
CD14, CD40, CD80, CD86 and DC-SIGN. Open histograms represent cells stained with 
isotype control and closed histograms represent cells stained with indicated antibody. 
Numbers indicate relative difference in MFI between surface antigen expression and 
isotype control. Results are representatives of four independent experiments with 
comparable results. 
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4.2.4   Upregulation of chemokine receptors by monocytes differentiated with CD8 
T-cell-DC cytokine milieu 
We further investigated the expression of chemokine receptors on these differentiated 
monocytes. We found that monocytes differentiated with SupernatantDC or DCLPS (Fig. 
4.4B and C) downregulated the expression of CCR1, CCR2 and CCR5 but had similar 
expression levels of CCR7 and CX3CR1 compared to untreated monocytes (Fig. 4.4A). 
In contrast, monocytes that were differentiated with SupernatantCD8DC or CD8DCLPS (Fig 
4.4Dand E) had a significant increase in the expression of CCR1 and CX3CR1, but had 
lower expression levels of CCR2 and CCR5 as compared to monocytes that were 
differentiated with SupernatantDC or DCLPS (Fig. 4.4B and C). In contrast to monocytes 
differentiated with SupernatantDC or DCLPS (Fig. 4.4B and C), monocytes differentiated 
with SupernatantCD8DC or CD8DCLPS (Fig 4.4Dand E) also expressed a slight upregulation of 
CCR7.  
 
In addition, we found that IL-4/GM-CSF DCs (Fig. 4.4F) and M-CSF macrophages (Fig. 
4.4G) expressed low levels of CCR1, CCR2 and intermediate levels of CX3CR1.  In 
comparison to untreated monocytes (Fig. 4.4A), IL-4/GM-CSF DCs up-regulated CCR7 
while M-CSF macrophages maintained its expression of CCR5 (Fig. 4.4F and G). 
Strikingly, we found that monocytes exposed to SupernatantCD8DC or CD8DCLPS (Fig 
4.4Dand E) had higher levels of CCR1, CCR2, CX3CR1 and similar levels of CCR5 as 
IL-4/GM-CSF DCs (Fig. 4.4F). In contrast, monocytes exposed to SupernatantDC or DCLPS 
(Fig. 4.4B and C) resembled M-CSF macrophages through higher expression of CCR5 
and had no upregulation of CCR7 (Fig. 4.4G). These data suggest that CD8 T-cell-DC 
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cytokine milieus differentiate monocytes into cells which differ from the other 
differentiated monocytes through a distinct chemokine repertoire that may influence their 























































Fig. 4.4 Monocytes exposed to CD8 T-cell-DC cytokine milieu upregulate distinct 
chemokine receptors.  
 










or (F) mature IL-4/GM-CSF DCs and (G) 
mature M-CSF macrophages were analyzed by flow cytometry for the expression of 
CCR1, CCR2, CCR5. CCR7 and CX
3
CR1. Open histograms represent cells stained with 
isotype control and closed histograms represent cells stained with indicated antibody. 
Numbers indicate relative difference in MFI between surface antigen expression and 
isotype control. Results are representatives of four independent experiments with 
comparable results. 
 
Chapter 4: Phenotypic characterization of TNF/iNOS-producing dendritic cells 
 141 
4.2.5   Upregulation of toll-like receptors on monocytes differentiated with CD8 T-
cell-DC cytokine milieu 
We also examined the expression of toll-like receptors (TLRs) on differentiated 
monocytes. We found that monocytes differentiated with SupernatantDC or DCLPS (Fig. 4.5B 
and C) upregulated only TLR2 and TLR8 when compared to untreated monocytes (Fig. 
4.5A). In contrast, monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 4.5D 
and E) upregulated all TLRs tested (namely TLR2, TLR3, TLR4 and TLR8) compared to 
monocytes differentiated with SupernatantDC or DCLPS (Fig. 4.5B and C) as well as 
untreated monocytes (Fig.4.5A). 
 
We next compared the expression of TLRs on IL-4/GM-CSF DCs and M-CSF 
macrophages to these differentiated monocytes. Both IL-4/GM-CSF DCs (Fig. 4.5F) and 
M-CSF macrophages (Fig. 4.5G) showed upregulated expression of TLR2, TLR4 and 
TLR8 compared to untreated monocytes (Fig. 4.5A) and were of similar levels to those 
expressed by monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig. 4.5D and 
E). Importantly, we found that TLR3 was only upregulated by IL-4/GM-CSF DCs 
(Fig.4.5F) and monocytes differentiated with SupernatantCD8DC or CD8DCLPS (Fig.4.5D and 
E) and this upregulation was not detected on M-CSF macrophages (Fig.4.5G) nor 
monocytes differentiated with SupernatantDC or DCLPS (Fig. 4.5B and C). Hence, these data 
suggest that monocytes differentiated with CD8 T-cell-DC cytokine milieus upregulate 
important TLRs which may be useful during inflammation and may resemble DCs more 
closely through their expression of TLR3.  
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Fig. 4.5 Monocytes exposed to CD8 T-cell-DC cytokine milieu upregulate distinct 
Toll-Like receptors.  
 










or (F) mature IL-4/GM-CSF DCs and (G) 
mature M-CSF macrophages were analyzed by flow cytometry for the expression of 
TLR2, TLR3, TLR4 and TLR8. Open histograms represent cells stained with isotype 
control and closed histograms represent cells stained with indicated antibody. Numbers 
indicate relative difference in MFI between surface antigen expression and isotype 
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4.2.6   Monocytes differentiated with CD8 T-cell-DC cytokine milieu expressed 
CD83 
We next determined if these differentiated monocytes expressed CD83, a classical 
maturation marker expressed on human DCs (Cao et al., 2005). We found that CD83 was 
expressed on mature IL-4/GM-CSF DCs and neither on untreated monocytes nor mature 
M-CSF macrophages (Fig. 4.6). Strikingly, monocytes that were differentiated with 
SupernatantCD8DC or CD8DCLPS showed a slight upregulation of CD83 and this expression 
was further enhanced upon stimulation with LPS for an additional 24 h (Fig. 4.6) 
Notably, monocytes  differentiated with SupernatantDC or DCLPS did not express CD83 even 
after subsequent stimulation with LPS. Overall, these results suggest that monocytes that 
have been differentiated in the presence of CD8-T-cell DC cytokine milieus closely 







Fig. 4.6 Monocytes exposed to CD8 T-cell-DC cytokine milieu upregulate CD83.  
 
Monocytes differentiated with various supernatants and activated overnight with LPS or 
mature IL-4/GM-CSF DCs or M-CSF macrophages were analyzed by flow cytometry for 
the expression of CD83. Open histograms represent cells stained with isotype control and 
closed histograms represent cells stained with anti-CD83. Numbers indicate relative 
difference in MFI between surface antigen expression and isotype control. Results are 
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4.2.7  Differentiation efficiency of monocytes exposed to cytokine milieus 
To determine the percentage of DCs that have differentiated from monocytes in cytokine 
milieus, we calculated the percentages of viable cells that express HLA-DR and CD86. 
We found that we could obtain a differentiation efficiency of about 60-75% for 
monocytes that differentiate into DCs with SupernatantCD8DCLPS while we only had a 
differentiation efficiency of 15-26% with SupernatantDCLPS. Fig. 4.7 shows a 
representative result of the gating strategy and calculations used for assessing the 
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Fig. 4.7 Differentiation efficiency of monocytes exposed to supernatants  
 
Monocytes differentiated with SupernatantDCLPS or SupernatantCD8DCLPS were stained and 
analyzed via flow cytometry. The differentiation efficiency of monocytes were calculated 
by first gating on live cells, followed by viable cells (gated as cells that stain negative for 
the LIVE/DEAD
®
 fixable violet dead cell stain) and finally on CD86 and HLA-DR 
positive cells.  Results are representative of four experiments. 
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TABLE 4.2  Differentiation efficiency of monocytes exposed to supernatants 
 
Experiment SupernatantDCLPS SupernatantCD8DCLPS 
1 0.224 x 0.961 x 90.2 = 19.4% 0.903 x 0.94 x 80.3 = 68.2% 
2 0.197 x 0.95 x 89.2 =16.7% 0.885 x 0.91 x 82.5 = 66.4% 
3 0.258 x 0.92 x 92.5 = 21.9% 0.952 x 0.92 x 85.7 = 75.1% 
4 0.32 x 0.895 x 91.3 = 26.1 % 0.85 x 0.89 x 79.9 = 60.4% 
5 0.21 x 0.942 x 89.9 = 17.8% 0.91 x 0.93 x 84.2 = 71.3% 
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4.3   Discussion 
 
In this chapter, we show that supernatants derived from CD8 T-cell-DC co-cultures were 
able to induce the differentiation of human monocytes into cells with morphological and 
phenotypic characteristics of DCs. These monocyte-derived cells were adherent and 
exhibited long spindle dendrites, resembling classically activated IL-4/GM-CSF DCs 
rather than macrophages which displayed distinct vacuoles instead. In addition, these 
cells upregulated MHC class I and HLA-DR, as well as co-stimulatory molecules CD40, 
CD80, CD86 and DC-SIGN. They also downregulated CD14, a macrophage associated 
marker, and expressed CD83, an important marker associated with human mature DCs. 
Notably, these monocyte derived cells also upregulated chemokine receptors CCR1 and 
CX3CR1 as well as TLR2, TLR3, TLR4 and TLR8. These results indicate that CD8 T-
cells have the potential to modulate the immune response during their interaction with 
DCs, by producing cytokines that differentiate monocytes into cells with distinct DC 
features. 
 
We found that monocytes differentiated in the absence of cytokines acquired a 
macrophage phenotype, suggesting that the differentiation of monocytes into 
macrophages seem to represent a default differentiation program of monocytes on 
extravasations (Lewis et al., 1999). Moreover, the addition of supernatants derived from 
DC co-cultures did not interfere with this process. Conversely, the addition of 
supernatants derived from CD8 T-cell-DC co-cultures to monocytes resulted in distinct 
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changes associated with DCs such as the elongation of cell bodies and presence of 
characteristic fine cytoplasmic processes instead of the broader pseudopodia of 
macrophages. This is in line with previous studies suggesting the need for a well-defined 
cytokine cocktail for monocytes to differentiate into DCs (Comes et al., 2002; 
Mohamadzadeh et al., 2001; Santini et al., 2000; Zou and Tam, 2002) . In addition, 
several cell types such as CD4 T-cells (Mariotti et al., 2008), CD8 T-cells (Wirths et al., 
2002), NK cells (Zhang et al., 2007) and γδ T-cells (Eberl et al., 2009) have been 
indicated as possible sources of these cytokines. Notably, these cells were shown to 
differentiate monocytes into cells with similar DC phenotypic characteristics such as high 
expression of MHC class I, HLA-DR, upregulation of CD40, CD80, CD86 and DC-SIGN 
as well as the expression of CD83. 
 
Although we noticed that monocytes differentiated with CD8 T-cell-DC derived 
supernatants expressed most markers associated with DCs, we were unable to detect the 
expression of CD1 molecules, such as CD1a, which belong to a family of glycoproteins 
involved in the presentation of lipid antigens to T cells (Porcelli, 1995). However, 
previous studies have suggested that the usage of FCS versus human serum in the culture 
media affects the expression of CD1 molecules on DCs but not their antigen-presenting 
capacity (Duperrier et al., 2000; Smed-Sörensen et al., 2008; Triozzi and Aldrich, 1997) 
Since our cells were all cultured with 10% human serum, this could account for the lack 
of expression of CD1 molecules as we also did not detect CD1a expression on classical 
monocyte-derived DCs in our cultures. 
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Chemokines are significantly involved in inflammatory and immunological responses via 
their ability to recruit selective leukocyte subsets (Rollins, 1997). Studies have also 
shown that expression of chemokine receptors are heavily implicated in DC trafficking to 
tissues and lymph nodes (Dieu et al., 1998; Sozzani et al., 1999). We found that 
monocytes differentiated with CD8 T-cell-DC supernatants expressed substantial levels 
of CCR1, CCR2 and CCR5 which is in line with previous studies documenting the 
expression of these chemokine receptors on monocyte-derived DCs (Sato et al., 1999; 
Sozzani et al., 1999). Interestingly, monocytes differentiated with CD8 T-cell-DC 
supernatants expressed increased levels of CX3CR1 which was shown to be expressed by 
non-lymphoid tissue resident DCs (Geissmann et al., 2010) and implicated in diseases 
(Liu et al., 2008; Niess and Reinecker, 2005). Altogether, the expression of these 
chemokine receptors by monocytes differentiated with CD8 T-cell-DC supernatants 
suggest that these monocyte-derived cells may reside in inflamed tissues. However, 
although these cells do not express high levels of CCR7, we cannot exclude the fact that 
they may still be found in lymph nodes where they prime T-cells as monocytes can 
migrate directly into lymph nodes through CCR2 to differentiate into DCs (Nakano et al., 
2009). 
 
The expression of TLRs on monocyte-derived cells is important for the recognition of 
molecular patterns specific to microbial pathogens (Aderem and Ulevitch, 2000; 
Medzhitov and Janeway, 2000; Medzhitov et al., 1997). This is critical as signaling 
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through TLRs strongly activates DCs to upregulate co-stimulatory molecules and to 
produce pro-inflammatory cytokines (Akira et al., 2001; Hertz et al., 2001). We found 
that monocytes differentiated with CD8 T-cell-DC supernatants upregulated TLR2, 
TLR3, TLR4 and TLR8. The upregulation of TLR2 and TLR4 suggests that 
differentiated monocytes become more sensitive to bacterial products such as LPS while 
the upregulation of TLR8 indicate increased responsiveness to single stranded RNA 
present on viruses during inflammation. Interestingly, studies have shown that the 
expression of TLR3 is restricted only to DCs among monocyte-derived cells (Muzio et 
al., 2000). Upon recognition of double stranded RNA, TLR3 induces the activation of 
NF-κB to increase production of type I interferons (Alexopoulou et al., 2001). Its 
presence have also been shown to be involved in DC cross-presentation, CTL responses, 
and antiviral protection (Jelinek et al., 2011). Thus, the presence of TLR3 on monocytes 
differentiated with CD8 T-cell-DC supernatants indicates that these monocyte-derived 
cells may acquire DC characteristics associated with the functions of TLR3. 
 
While, the current morphological and phenotypic characterization of these monocyte-
derived cells suggest that monocytes differentiated with CD8 T-cell-DC supernatants 
may represent DCs, DCs are a heterogeneous population with no single surface marker 
that unequivocally identifies them (Shortman and Liu, 2002). Hence, further 
characterization of these cells would rely on the functional abilities which would be 
addressed in the next few chapters.  
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CHAPTER 5: Functional characterization of human monocyte-derived cells 
(TNF/iNOS-producing dendritic cells) differentiated in the presence of CD8 T-cell-
DC cytokine milieu 
 
 
5.1    Introduction 
 
Despite the availability of different markers to classify monocyte-derived cells as DC and 
macrophages, it still remains a challenge to separate these two cell populations. This is 
largely attributed to the many phenotypic similarities showed by these cells, including 
similar surface marker expression such as CD11c and F4/80 and the requirement for 
analogous growth factors such as M-CSF in mice (Hume, 2008; MacDonald et al., 2002). 
In human studies, the phenotypic properties of monocyte-derived cells are often 
compared to the gold standard DCs generated by culturing monocytes with IL-4 and GM-
CSF (Sallusto and Lanzavecchia, 1994; Schuler et al., 2003). In turn, macrophages are 
believed to exhibit properties that mimic monocytes that have been differentiated with M-
CSF  (Brugger et al., 1991). However, others have also shown that various other stimuli 
(Chomarat et al., 2000; Mohamadzadeh et al., 2001; Santini et al., 2000; Zou and Tam, 
2002) can induce the differentiation of monocytes into DCs or macrophages which may 
exhibit different phenotypic properties from these gold standard protocols. Therefore, 
although results in our previous chapter have suggested that monocytes differentiated 
with CD8-T-cell-DC cytokine milieus exhibit phenotypic characteristics of DCs, it is still 
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important to investigate their functional properties as the defining characteristic of a DC 
is unarguably, its ability to activate naive T-cells (Banchereau and Steinman, 1998) 
 
To further understand these monocyte-derived cells, recent studies have focused on the 
role of these cells during inflammation. Notably, Serbina et al. (2003) discovered that a 
subset of inflammatory DCs, known as TNF/iNOS-producing DCs (Tip-DCs) were 
crucial for the clearance of Listeria monocytogenes bacteria in mice. These Tip-DCs 
expressed high levels of TNF-α and iNOS and unlike macrophages present in the spleen, 
these cells were not infected with Listeria monocytoges. In addition, these cells were also 
capable of priming naive T-cells for proliferation. Subsequently, Tip-DCs in other 
disease models such as influenza (Aldridge et al., 2009), psoriasis (Lowes et al., 2005) 
and parasitic infections (Bosschaerts et al., 2010) were documented. Therefore, the ability 
of monocyte-derived cells to express high levels of TNF-α and iNOS, in addition to their 
ability to prime naive T-cells, served as an important functional characteristic in 
classifying monocyte-derived cells as Tip-DCs. 
 
In this chapter, we investigated the functional properties of cells that were differentiated 
from monocytes with CD8 T-cell-DC cytokine milieus. We first studied their ability to 
express TNF-α, iNOS as well as other pro-inflammatory cytokines before determining 
their ability to exhibit phagocytosis, endocytosis and naive T-cell priming. Finally we 
analyzed their ability to polarize T-cells through intracellular cytokine analysis. 
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5.2   Results 
 
5.2.1  Monocytes differentiated with CD8 T-cell-DC cytokine milieu expressed 
increased amounts of TNF-α and iNOS 
We first investigated the ability of differentiated monocytes to expressed pro-
inflammatory mediators such as TNF-α and iNOS. Monocytes were cultured with the 
respective supernatants for 48 h and stimulated for an additional 6 h in the presence of 
LPS and Golgistop
TM
. We found that more monocytes differentiated with 
SupernatantDCLPS (Fig. 5.1B) expressed intracellular TNF-α and iNOS than monocytes 
differentiated with SupernatantDC (Fig. 5.1A). However, monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS (Fig, 5.1C and D) expressed not only the highest percentage 
of cells with TNF-α and iNOS, but also expressed these inflammatory mediators at a 
much higher level, as indicated by the  larger MFI, than monocytes differentiated with 
SupernatantDC or DCLPS (Fig. 5.1A and B). We next compared the intracellular levels of 
TNF-α and iNOS of these differentiated monocytes to IL-4/GM-CSF DCs and M-CSF 
macrophages. In contrast to IL-4/GM-CSF DCs that expressed moderate levels of TNF-α 
and low levels of iNOS (Fig. 5.1E), M-CSF macrophages expressed low levels of TNF-α 
and high levels of iNOS instead (Fig. 5.1F). Notably, monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS (Fig. 5.1C and D) expressed similar levels of iNOS as M-
CSF macrophages but expressed higher levels of TNF-α than both IL-4/GM-CSF DCs 
and M-CSF macrophages (Fig. 5.1E and F). 
 

























































Fig. 5.1 Monocytes exposed to CD8 T-cell-DC cytokine milieu expressed increased 
amounts of TNF-α and iNOS.  









(E) IL-4 and GM-CSF (F) M-CSF. 
Differentiated monocytes were washed and unstimulated (left) or stimulated with 100 
ng/ml of LPS (right) together with 1ul/ml of Golgi-stop
TM
 in fresh medium for 6 h to 
detect intracellular TNF-αand 12 h to detect iNOS. All cells were subsequently analyzed 
by flow cytometry. Top left numbers represent percentages of positive cells and bottom 
numbers indicate the mean fluorescence index (MFI). Results are representative of four 
independent experiments with comparable results. 
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We further confirmed the expression levels of TNF-α and iNOS expressed by these 
differentiated monocytes. We found that the increased levels of TNF-α and iNOS 
expressed by monocytes differentiated with SupernatantCD8DC or CD8DCLPS compared to 
monocytes differentiated with SupernatantDC or DCLPS were statistically significant (Fig. 
5.2). In addition, the number of nitric oxide (NO) producing monocytes differentiated 
with SupernatantCD8DC or CD8DCLPS were significantly higher than monocytes differentiated 
with SupernatantDC or DCLPS (Fig. 5.3). Finally, immunostaining further confirmed the 
expression of both intracellular TNF-α and iNOS by monocytes differentiated with 
































Fig. 5.2 TNF-α and iNOS expression by monocytes exposed to CD8 T-cell-DC 
cytokine milieu was significant.  
Monocytes were differentiated with indicated supernatants or conditions, washed and re-
cultured with 100 ng/ml of LPS together with 1ul/ml of Golgi-stop in fresh medium for 6 
h to detect intracellular TNF- and 12 h to detect iNOS. All cells were subsequently 
analyzed by flow cytometry. Graph represents average expression (mean ± SD) of TNF-a 
(white bars) and iNOS (black bars) produced from differentiated monocytes from five 
donors. *p<0.05; **p<0.005 using one-way ANOVA.  


























Fig. 5.3 Monocytes exposed to CD8 T-cell-DC cytokine milieu expressed significant 
amounts of NO.  
Monocytes were differentiated with indicated supernatants or conditions, washed and re-
cultured with or without 100 ng/ml of LPS together with 1ul/ml of Golgi-stop in fresh 
medium for 6 h to detect intracellular NO. Graph represents Nitric Oxide (NO) 
production (mean ± SD) from 3 donors detected using DAF-FM diacetate and analyzed 
by flow cytometry. *p<0.05; **p<0.005 using one-way ANOVA.  
 
 












Fig. 5.4 Monocytes exposed to CD8 T-cell-DC cytokine milieu expressed increased 
amounts of TNF-α and iNOS.   
(A) Monocytes were differentiated on glass coverslips with indicated supernatants, 
stimulated with LPS for 6h in the presence of Golgi Stop
TM
 before staining with DAPI, 
anti-iNOS and anti-TNF- and viewed by fluorescence microscopy. (Blue=DAPI, 
Red=TNF-, Green=iNOS). Original magnification was x400 for all panels. (Scale bar: 
20 μm). (B) Higher magnification of cells differentiated with Supernatant
CD8DCLPS
. 
Original magnification was ×630 for all panels. (Scale bar: 12μm) Results are 
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5.2.2   Monocytes differentiated with CD8 T-cell-DC cytokine milieu secrete pro-
inflammatory cytokines 
To further verify the inflammatory nature of these differentiated monocytes, we analyzed 
their ability to secrete extracellular pro-inflammatory cytokine proteins. Monocytes 
cultured for 48 hours with the respective supernatants were washed thoroughly and re-
plated in fresh culture medium and LPS for an additional 24 hours. Differentiated 
monocytes cultured without LPS served as a control. We noticed that monocytes 
differentiated with SupernatantCD8DC or CD8DCLPS resulted in a significant increase in LPS-
stimulated production of IL-1α (Fig. 5.5A), IL-1ß (Fig. 5.5B), IL-6 (Fig. 5.5C) and TNF-
α (Fig. 5.5F) relative to stimulated monocytes that had no prior exposure to these 
supernatants. In addition, LPS-stimulated monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS also produced higher levels of IL-12p40 (Fig. 5.5D) and 
GM-CSF (Fig. 5.5E) compared to LPS-stimulated monocytes differentiated with 
SupernatantDC or DCLPS.  Notably, the levels of these cytokines produced by LPS-
stimulated monocytes differentiated with SupernatantCD8C or CD8DCLPS were above the un-
stimulated controls (Fig. 5.5A-F), suggesting that the cytokines detected were not a result 
of residual transfer from supernatant cultures. The levels of extracellular TNF-α (Fig. 
5.5F) also supported our intracellular flow cytometry (Fig. 5.1A-D) and immunostaining 
results (Fig. 5.4A). Overall, these results suggest that monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS are pro-inflammatory and since they also expressed CD83 
(Fig. 4.6), TNF-α and iNOS, they could resemble Tip-DCs previously described in mice 
(Aldridge et al., 2009; Bosschaerts et al., 2010; Serbina et al., 2003; Tezuka et al., 2007) 
and humans (Lowes et al., 2005). 























































































































DC only     DCLPS     CD8DC     CD8DCLPS No 
cytokines
DC only      DCLPS     CD8DC     CD8DCLPS
No 
cytokines
DC only       DCLPS        CD8DC      CD8DCLPS
No 
cytokines
DC only       DCLPS     CD8DC      CD8DCLPS No 
cytokines
DC only       DCLPS     CD8DC      CD8DCLPS
No 
cytokines
DC only       DCLPS     CD8DC      CD8DCLPS
 




 monocytes were cultured with indicated supernatants or culture 
medium for 48 h. Cells were then harvested, washed 3 times with DMEM and re-plated 
in fresh medium with (black bars) or without (white bars) 100ng/ml of LPS. After 18 h, 
supernatants were harvested and the cytokines (A) IL-1α (B) IL-1ß (C) IL-6 (D) IL-
12p40 (E) GM-CSF and (F) TNF- measured using multiplex bead arrays. Results are 
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5.2.3   Monocytes differentiated with CD8 T-cell-DC cytokine milieu down-regulate 
endocytosis and phagocytosis 
We next investigated the functional properties of these differentiated monocytes by first 
analyzing their ability to endocytose. Monocytes differentiated with SupernatantDC or 
DCLPS displayed a high level of endocytic activity with FITC dextran which were of 
comparable levels to those displayed by mature M-CSF macrophages (Fig. 5.6). In 
contrast, mature IL-4/GM-CSF DCs and monocytes differentiated with SupernatantCD8DC 

















Fig. 5.6 Monocytes differentiated with CD8 T-cell-DC cytokine milieu 
downregulated endocytosis.   
Mature DCs, mature macrophages and monocytes differentiated with supernatants from 
indicated cultures were harvested and analyzed for endocytosis by incubating with FITC-
labeled dextran, washed and analyzed via flow cytometry. Results are representative of 
three independent experiments. 
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We subsequently analyzed the ability of these differentiated monocytes to phagocytose 
Escherichia coli AF488 conjugate bioparticles. Monocytes differentiated with 
SupernatantDC or DCLPS exhibited robust phagocytic activities which were similar to those 
displayed by mature M-CSF macrophages (Fig. 5.7). Strikingly, mature IL-4/GM-CSF 
DCs and monocytes differentiated with SupernatantCD8DC or CD8DCLPS showed reduced 
phagocytic activity as measured by the percentage of cells positive for the fluorescent 
bioparticles (Fig. 5.7). Hence these results suggest that monocytes differentiated with 
SupernatantDC or DCLPS display phagocytic and endocytic properties similar to 
macrophages while monocytes differentiated with SupernatantCD8DC or CD8DCLPS exhibited 











Fig. 5.7 Monocytes differentiated with CD8 T-cell-DC cytokine milieu 
downregulated phagocytosis.   
Mature DCs, mature macrophages and monocytes differentiated with supernatants from 
indicated cultures were harvested and analyzed for phagocytosis by incubating with 
FITC-labeled dextran, washed and analyzed via flow cytometry. Results are 
representative of three independent experiments. 
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5.2.4   Monocytes differentiated with CD8 T-cell-DC cytokine milieu prime naive 
CD4 T-cells for proliferation 
We further analyzed the ability of these differentiated monocytes to induce the 
proliferation of allogeneic naive CD45RA
+
 T-cells which is a defining function of DCs 
(Banchereau and Steinman, 1998). Differentiated monocytes were co-cultured with naive 
CD4 T-cells for 6 days and the proliferative response of the T-cells measured by 
3
H-
thymidine incorporation. We found that monocytes that were differentiated with 
SupernatantDC or DCLPS resembled M-CSF macrophages as these cells exhibited minimal T-
cell priming ability and did not induce a significant proliferative response of CD4 T-cells 
compared to untreated monocytes (Fig. 5.8A). In contrast, monocytes that were 
differentiated with SupernatantCD8DC or CD8DCLPS induced a significant increase in 
proliferating T-cells and this response was also slightly higher than that induced by IL-
4/GM-CSF DCs when the ratio of T-cells to APCs was 10:1 (Fig. 5.8A). 
 
We next investigated if this proliferative trend was similar when differentiated monocytes 
were further activated with LPS. We found that monocytes that were differentiated with 
SupernatantDC or DCLPS still resembled M-CSF macrophages as these cells exhibited 
minimal T-cell priming ability and did not induce a significant proliferative response of 
CD4 T-cells compared to untreated monocytes (Fig. 5.8B). Strikingly, monocytes that 
were differentiated with SupernatantCD8DC or CD8DCLPS were still able to induce a significant 
increase in proliferating T-cells although the response this time was not higher than that 
induced by IL-4/GM-CSF DCs (Fig. 5.8B). Notably, while IL-4/GM-CSF DCs had 
significant differences in their stimulating capacities before and after exposure to LPS, 
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monocytes differentiated with SupernatantCD8DC or CD8DCLPS had minimal differences (Fig. 
5.8A and B). Hence, these results confirm the DC properties of monocytes differentiated 
























































Fig. 5.8  Monocytes differentiated with CD8 T-cell-DC cytokine milieu prime naive 
CD4 T-cells for proliferation.  
 
To test for CD4 T cell proliferation, monocytes differentiated with indicated supernatants 
or conditions were harvested, washed and irradiated before being used as APCs to 
stimulate freshly isolated allogeneic naive CD4+CD45RA+ T cells in the (A) absence or 
(B) presence of 100ng/ml of LPS. The CD4 T-cell proliferative response was measured 
after 6 days by 3H-thymidine incorporation; results are expressed as mean counts per 
minute (cpm) ± SEM. 1x105 T cells and varying numbers of APCs were added per well. 
*p<0.05, **p<0.005 comparing (♦) or (□) versus (▲) or (▬) using one-way ANOVA. 
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5.2.5   Monocytes differentiated with CD8 T-cell-DC cytokine milieu prime CD4 T-
cells for IFN-γ production 
We next studied whether these differentiated monocytes could prime CD4 T-cells 
towards a specific cytokine producing phenotype. To this end, we tested for the presence 
of intracellular IFN-γ, IL-4, IL-17 and IL-10 in these CD4 T-cells after co-culture with 
differentiated monocytes. While there were significant differences in the amount of IL-4 
and IFN-γ expressed (Fig. 5.9A), we did not detect any significant differences in the 
expression of IL-17 and IL-10 in these CD4 T-cells (data not shown). Hence, we focused 
on the expression of IL-4 and IFN-γ in these set of experiments. We found that M-CSF 
macrophages and monocytes that were differentiated with SupernatantDC or DCLPS induced 
a low percentage of IFN-γ expressing CD4 T-cells (Fig. 5.9A). In contrast, monocytes 
differentiated with SupernatantCD8DC or CD8DCLPS generated a similar percentage of IFN-γ 
expressing CD4 T-cells as IL-4/GM-CSF DCs and this was three-fold more than that 
induced by monocytes differentiated with SupernatantDC or DCLPS and M-CSF macrophages 
(Fig. 5.9A). In addition, the percentage of IFN-γ expressing CD4 T-cells by monocytes 
differentiated with SupernatantCD8DC or CD8DCLPS was statistically significant compared to 
those induced by monocytes differentiated with SupernatantDC or DCLPS (Fig. 5.9B). 
Interestingly, M-CSF macrophages and monocytes differentiated with SupernatantDC or 
DCLPS were shown to express a slight increase in percentage of IL-4-producing  CD4 T-
cells compared to those induced by IL-4/GM-CSF DCs and monocytes differentiated 
with SupernatantCD8DC or CD8DCLPS (Fig. 5.9A). Hence, these results suggest that monocytes 
differentiated with SupernatantCD8DC or CD8DCLPS favour the polarization of CD4 T-cells to 
a Th1 phenotype by increasing the percentage of IFN-γ expressing CD4 T-cells 






















































































































Fig. 5.9 Monocytes differentiated with CD8 T-cell-DC cytokine milieu prime CD4 T-
cells for Th1 responses.  
Monocytes differentiated with indicated supernatants or conditions were harvested and 




 T-cells in the presence of 
LPS (100ng/ml). Cells were harvested, fixed, stained intracellularly for IL-4 and IFN-γ 
and analyzed by flow cytometry. Cells were gated on CD3
+
 cells to discriminate T-cells 
from APCs. Numbers represent percentages of positive cells. (A) Results are 
representative of four independent experiments.  (B) Results are pooled from 3 
independent donors. *p<0.05, **p<0.005 using one-way ANOVA test followed by 
Tukey’s post test 
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5.2.6   CD4 Th1 responses is dependent on the expression of TNF-α and iNOS of 
monocyte-derived cells 
Although we were able to detect the presence of IL-12p40 in supernatants of 
differentiated monocytes stimulated with LPS (Fig. 5.5D), we were unable to detect 
significant levels of IL-12p70. Hence, we investigated if other factors produced by 
monocytes differentiated with SupernatantCD8DC or CD8DCLPS could be responsible for the 
increased induction of IFN-γ producing CD4 T-cells. Since monocytes differentiated with 
SupernatantCD8DC or CD8DCLPS showed significant expression of TNF-α and iNOS, we thus 
determined if these 2 factors were responsible for the increased polarization of Th1 cells. 
To this end, we co-cultured naive CD4 T-cells with monocytes that have been 
differentiated with SupernatantCD8DC or CD8DCLPS in the presence of blocking antibodies. To 
block the presence of TNF-α, naive CD4 T-cells were first blocked with 10μg/ml of anti-
TNF-α receptor antibodies for 1 h prior to co-culture. 10μg/ml of anti-TNF-α blocking 
antibodies was also simultaneously added to the co-cultures. To block the effects of NO, 
monocytes that were differentiated with SupernatantCD8DC or CD8DCLPS were treated with 
10mM of L-NAME for 1 h prior to co-culture. Differentiated monocytes and CD4 T-cells 
that were blocked with the relevant isotype-blocking antibodies served as a control. We 
found that the polarization of IFN-γ producing CD4 T-cells by monocytes differentiated 
with SupernatantCD8DC or CD8DCLPS was partially dependent on their expression of TNF-α 
and iNOS as blocking these factors resulted in a reduction in IFN-γ producing CD4 T-
cells (Fig. 5.10). Hence, these results suggest that the increased expression of TNF-α and 
iNOS seen in monocytes differentiated with SupernatantCD8DC or CD8DCLPS is partially 
responsible for the increased polarization of Th1 cells.  




































Fig. 5.10 CD4 Th1 responses is dependent on the expression of TNF-α and iNOS by 
monocytes differentiated with CD8 T-cell-DC cytokine milieu. 
Percentage of IFN-γ positive CD4 T-cells from 3 donors detected using flow cytometry. 
To determine if TNF-α or NO produced by monocytes differentiated with 
Supernatant
CD8DCLPS
 had an effect on the polarization of CD4 T-cells, differentiated 
monocytes were cultured with CD4 T-cells that were blocked with anti-TNFR (bTNFR) 
antibodies (10μg/ml) 1h prior to co-culture as indicated. To further block the effect of 
TNF-α on CD4 T-cells, anti-TNF-α blocking (bTNF-α) antibodies (10μg/ml) were also 
added simultaneously to the indicated co-culture.  Alternatively, differentiated monocytes 
were treated with 10mM of L-NAME to block the effects of NO for 1h at 37ºC, washed 
and used as APCs to stimulate naive CD4 T-cells. Differentiated monocytes and CD4 T-
cells that were blocked with relevant isotype blocking antibodies served as a control. 
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5.3   Discussion 
 
In the previous chapter, we showed that soluble factors from human CD8 T-cell-DC co-
cultures could differentiate monocytes into cells with phenotypic and morphological 
characteristics of mature DCs such as the appearance of long spindle dendrites, high 
expression of MHC class I, HLA-DR, co-stimulatory molecules and upregulation of 
CD83. In this chapter, we show that these monocyte-derived cells also display functional 
properties that were similar to DCs, rather than macrophages, as they could induce an 
allogeneic MLR response and exhibited reduced phagocytic and endocytic activities. 
Interestingly, these cells also expressed high levels of TNF-α and iNOS which resemble a 
subset of inflammatory DCs known as Tip-DCs. We also showed that these Tip-DCs 
were able to prime naive CD4 T-cells for IFN-γ and this was partially dependent on their 
production of TNF-α and NO. The differentiation of monocytes into Th1-inducing Tip-
DCs by human CD8 T-cells thus highlights a novel role similar to other bystander 
mediated cross-talk seen in infectious models (Remoli et al., 2010; Salazar-Gonzalez et 
al., 2007) which allows the transmission of CD8 T-cell mediated Th1-inducing signals 
without the need for physical interaction with infiltrating monocytes.  
 
We found that these Tip-DCs (monocytes differentiated with CD8 T-cell-DC cytokine 
milieus) were able to induce naive T-cell proliferation, an important hallmark of DCs, 
similarly to classically generated IL-4/GM-CSF DCs. On the other hand, monocytes that 
were differentiated with DC-derived cytokine milieus behaved like macrophages and 
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were unable to induce significant T-cell proliferation. Interestingly, while, classically 
generated IL-4/GM-CSF DCs had significant differences in their stimulating capacities 
before and after exposure to LPS, we found that further stimulation of Tip-DCs did not 
increase their capacity to stimulate T-cell proliferation, suggesting that the latter may 
already be semi-mature. Indeed, other studies have shown that certain stimuli such as 
CD137 ligand signaling (Kwajah M M and Schwarz, 2010) can not only induce the 
differentiation of monocytes into DCs, but were also partially able to induce their 
maturation. Their semi-functional mature status induced by exposure to soluble factors 
from CD8 T-cell-DC cytokine milieus during the differentiation process may also be 
explained by the fact that Tip-DCs also expressed high levels of co-stimulatory molecules 
even before LPS exposure. Moreover, Tip-DCs had reduced endocytic activity which is 
an established hallmark of maturation of DCs (Austyn, 1996; Garrett et al., 2000; Sallusto 
et al., 1995; Steinman, 1991).  Downregulation of endocytosis ensures the longevity of 
peptide–MHC class II complexes at the cell surface (Cella et al., 1997) and by 
synchronizing the cessation of endocytosis with the activation of peptide loading onto 
MHC class II molecules, DCs limit their presentation activity to those antigens 
encountered prior to or concomitant with an inflammatory stimulus. In addition, we also 
found that Tip-DCs had reduced phagocytic activities compared to classical 
macrophages. This important functional characteristic further enforces the capacity of 
Tip-DCs to stimulate T-cell proliferation and that their role may not lie in the ability to 
phagocytose pathogens like macrophages. 
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TNF-α is a pivotal mediator of inflammation that activates leukocytes, enhances 
adherence of neutrophils and monocytes to endothelium, promotes migration of 
inflammatory cells into the intercellular matrix and triggers local production of other pro-
inflammatory cytokines (Tracey and Cerami, 1994). On the other hand, the production of 
NO upon iNOS expression is an important mediator for immune defense by directly 
inhibiting pathogen replication (Lowenstein and Padalko, 2004). Both TNF-α and iNOS 
have been shown to be expressed mainly by macrophages, however, there is increasing 
evidence that these two mediators can also be expressed by DCs such as Langerhans cells 
(Larrick et al., 1989; Qureshi et al., 1996) and inflammatory DCs (Lowes et al., 2005; 
Serbina et al., 2003). Therefore, the high expression of TNF-α and iNOS seen in Tip-DCs 
generated from monocytes exposed to CD8 T-cell-DC cytokine milieus suggest that DCs 
may also utilize the production of TNF-α and NO for immunomodulation by interacting 
with other immune cells. Indeed, a previous study has shown that Tip-DCs occur 
naturally in mouse mucosa-associated lymphoid tissues (MALT) and the expression of 
iNOS by these Tip-DCs is crucial for IgA class-switch recombination by plasma cells 
(Tezuka et al., 2007). In addition, Tip-DCs have also been shown to be important for 
supporting the proliferation and effector function of influenza specific CD8 T-cells in the 
lung (Aldridge et al., 2009).  
 
Finally, we observed that Tip-DCs obtained in our in vitro cultures were also able to 
prime naive CD4 T-cells for increased expression of IFN-γ.  This was a surprising 
finding as we were unable to detect any significant IL-12p70 in supernatants of Tip-DCs 
and CD4 T-cell co-cultures (data not shown).  However, we showed that blocking the 
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expression of TNF-α and iNOS partially reduced the ability of Tip-DCs to polarize Th1 
cells. Hence, the ability of TNF-α and iNOS to partially mediate Th1 polarization may 
thus help to explain why residual Th1 responses can still occur in the absence of IL-
12p70 in other disease models (Brombacher et al., 1999; Verhagen et al., 2000). 
Moreover, others have also shown that NO can contribute to the selective differentiation 
of Th1 cells (Koncz et al., 2007; Lee et al., 2011; Niedbala et al., 1999) and TNF-α has 
been shown to drive the in situ proliferation of T-cells by upregulating the expression of 
IL-2 (Agostini et al., 1995) as well as favour Th1 polarization through IL-12 independent 
mechanisms (Brown et al., 2003). Interestingly, a recent studies have also shown that NO 
acts to inhibit Th17 responses while favouring Th1 responses (Lee et al., 2011), and this 
may also explain why we were unable to detect any IL-17 expression (data not shown) in 
CD4 T-cells that have been polarized by Tip-DCs. Hence, the ability of CD8 T-cells to 
mediate Th1 responses by differentiating monocytes into Th1 inducing Tip-DCs 
highlights a previously undescribed mechanism and may also explain the importance of 
CD8 T-cells in microbial infections (Gurunathan et al., 2000; Peterson et al., 2002; Sud et 
al., 2006; Uzonna et al., 2004) since TNF-α and NO production by Tip-DCs are key 
effectors in pathogen clearance (Serbina et al., 2003) 
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6.1   Introduction 
 
In the previous chapter, we found that monocytes differentiated with CD8 T-cell-DC 
cytokine milieus exhibited phenotypic and functional characteristics of Tip-DCs. 
However, it remains unclear which cytokines played a key role in the differentiation of 
these cells. Previous studies have found that certain cytokines had the propensity to skew 
the differentiation of monocytes into DCs or macrophages. For example, IL-6 (Chomarat 
et al., 2000) has been shown to favour the differentiation of monocytes into macrophages 
while cytokines IL-2 (Sanarico et al., 2006), IL-15 (Mohamadzadeh et al., 2001), TNF-α 
(Chomarat et al., 2003; Iwamoto et al., 2007) and IFN-α (Mohty et al., 2003) were 
demonstrated to differentiate monocytes into DCs with their own characteristic 
properties. IFN-γ, an important cytokine for the polarization of Th1 responses, 
demonstrated conflicting results in monocyte differentiation studies. Although an early 
report by Delneste et al. (2002) showed that IFN-γ favoured the differentiation of 
monocytes towards macrophages, a recent report by Eljaafari et al. (2009) argued that 
IFN-γ differentiates monocytes into tolerogenic DCs that prime naive T-cells to express 
Foxp3 instead.  
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In addition, the differentiation of Tip-DCs in mouse models has also been documented to 
rely heavily on MyD88 signaling (Bosschaerts et al., 2010; Jia et al., 2008). In particular, 





into Tip-DCs in the liver of T. brucei infected mice consists of a three-step process 
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) which is IFN-γ and MyD88 signalling independent; and (iii) a 
maturation step of inflammatory DCs to functional (CD80/CD86/MHC-II
high
) TNF-α and 
NO producing Tip-DCs which is IFN-γ and MyD88 signalling dependent. Since IFN-γ 
showed conflicting monocyte differentiation results and its role in the differentiation of 
human Tip-DCs in vitro remains unknown, it would be interesting to determine if IFN-γ 
is indeed an important factor for the differentiation of Tip-DCs in our model.  
 
In this chapter, we determine the factors involved in the differentiation of monocytes into 
Tip-DCs by using blocking antibodies against the cytokine receptors on monocytes. We 
then investigated how the blocking of these cytokine receptors could affect their 
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6.2   Results 
 
6.2.1   TNF-α, in CD8-DC cytokine milieu, did not play a significant role in the 
differentiation of Tip-DCs 
We investigated the factors involved in the differentiation of Tip-DCs. We noted that 
SupernatantCD8DCLPS contained increased amounts of IFN-γ and TNF-α compared to 
SupernatantDC or DCLPS (Table 3.1). Hence, we first determined if TNF-α was implicated in 
Tip-DC differentiation by treating monocytes with a TNF-α receptor blocking antibody 
prior to culture with SupernatantCD8DCLPS. These cells were harvested after 48 h and 
subsequently analyzed by flow cytometry. We found that blocking the TNF-α receptor in 
increasing doses did not result in a dose dependent decrease in the percentage and MFI 
expression of CD40, CD83, Class I and HLA-DR (Fig. 6.1). In addition, we also did not 
detect any dose dependent decrease in the expression of TNF-α and iNOS when 
increasing doses of TNF-α receptor blocking antibodies were added to monocytes (Fig. 
6.2). Hence, these results suggest that the presence of TNF-α in the CD8-DC cytokine 
milieu does not play a significant role in the expression of these markers in the 




















































Fig. 6.1 Differentiation of monocytes into Tip-DCs is not dependent on TNF-α. 
Monocytes were cultured with an isotype blocking antibody (10μg/ml) or indicated 
concentrations of anti-TNF receptor blocking antibodies (bTNF-αR) for 1h before adding 
Supernatant
CD8DCLPS
.  Cells were stained for (A) CD40, CD83 Class I and HLA-DR 
Numbers on right represent percentages of positive cells. Bold numbers represent mean 







































Fig. 6.2 Differentiation of monocytes into Tip-DCs is not dependent on TNF-α. 
Monocytes were cultured with an isotype blocking antibody (10μg/ml) or indicated 
concentrations of anti-TNF receptor blocking antibodies (bTNF-αR) for 1h before adding 
Supernatant
CD8DCLPS
.  Cells were stained for intracellular TNF-α and iNOS by flow 
cytometry. Numbers represent percentages of positive cells. Results are representative of 
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6.2.2   IFN-γ, in CD8 T-cell-DC cytokine milieu, is important for the upregulation of 
CD40, HLA-DR, CD83 and expression of TNF-α by Tip-DCs 
We next determined if IFN-γ may be implicated in Tip-DC differentiation. Monocytes 
were treated with increasing doses of IFN-γ receptor blocking antibodies before culture 
with SupernatantCD8DCLPS. These cells were harvested after 48 h and subsequently 
analyzed by flow cytometry. We found that blocking the IFN-γ receptor in increasing 
doses resulted in a dose dependent decrease in both the percentage and MFI expression of 
CD40, CD83 and HLA-DR (Fig. 6.3). We also noticed that although there were no 
significant changes in the percentage expression of MHC class I on these cells, the MFI 
expression of MHC class I decreased in a dose dependent manner with increasing doses 
of blocking antibodies (Fig. 6.3).  We further investigated if IFN-γ was important for the 
expression of TNF-α and iNOS in Tip-DCs. We found that blocking the IFN-γ receptor in 
increasing doses resulted in a dose dependent decrease in the percentage expression of 
TNF-α, although there was no significant trend for the expression of iNOS when these 
blocking antibodies were added (Fig. 6.4). Overall, these results indicate that IFN-γ is an 
important factor for the differentiation of monocytes into Tip-DCs, especially for the 

















































































































Fig. 6.3  Differentiation of monocytes into Tip-DCs is partially dependent on IFN-γ. 
Monocytes were cultured with an isotype blocking antibody (10μg/ml) or indicated 
concentrations of anti-IFN-γ receptor blocking antibodies (bIFN-γR) for 1h before adding 
Supernatant
CD8DCLPS
.  Cells were stained for CD40, CD83, Class I and HLA-DR. 
Numbers on right represent percentages of positive cells. Bold numbers represent mean 
fluorescence intensity (MFI). (A) Results are representative of three independent 
experiments. (B) MFI results of molecules on Tip-DCs of 3 independent donors with 
indicated amounts of bIFN-γR. 

































































































































Fig. 6.4  Differentiation of monocytes into Tip-DCs is partially dependent on IFN-γ.  
Monocytes were cultured with an isotype blocking antibody (10μg/ml) or indicated 
concentrations of anti-IFN-γ receptor blocking antibodies (bIFN-γR) for 1h before adding 
Supernatant
CD8DCLPS
.  Cells were stained for intracellular TNF-α and iNOS by flow 
cytometry. Numbers represent percentages of positive cells. (A) Results are 
representative of one out of three independent experiments. (B) Percentage of TNF-α and 
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6.2.3   Monocytes differentiated with recombinant human IFN-γ displayed 
morphology distinct from Tip-DCs 
We next determined whether IFN-γ alone was sufficient to differentiate monocytes into 
Tip-DCs. To this end, we added 500 U/ml of recombinant human IFN-γ to monocytes for 
48 h and analyzed their morphology by H&E staining. We found that monocytes 
differentiated with IFN-γ alone formed less extensive dendrites (Fig. 6.5A) compared to 
Tip-DCs which were differentiated from monocytes with SupernatantCD8DCLPS (Fig. 
6.5B). In addition, monocytes differentiated with IFN-γ exhibited vacuoles which were 
similar to activated M-CSF macrophages (Fig. 4.1J) and these structures were not seen in 
Tip-DCs (Fig. 6.5B). Hence, these results suggest that IFN-γ alone was not sufficient to 
differentiate monocytes with similar morphologies as Tip-DCs. 
 
IFN-γ differentiated monocytes





Fig. 6.5  Morphological comparison of IFN-γ differentiated monocytes versus Tip-
DCs (Monocytes differentiated with SupernatantCD8DCLPS).  
Monocytes were differentiated with (A) 500U/ml of rhIFN-γ or (B) Supernatant
CD8DCLPS
 
for 48h. All cells were subsequently stained with H&E and captured using a Leica 
DM2000 microscope (Leica Microsystems Pte Ltd., Singapore). Original magnification 
was ×630 (scale bar: 15μm). Results are representative of four independent experiments. 
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6.2.4   IFN-γ alone is insufficient to differentiate monocytes into cells with similar 
expression of TNF-α and iNOS as Tip-DCs  
We further investigated if IFN-γ was the sole contributing factor for the expression of 
TNF-α and iNOS in Tip-DCs. To study this, we added increasing amounts of rhIFN-γ to 
monocytes and cultured them for 48 h before harvesting these cells for intracellular 
cytokine analysis by flow cytometry. We found that these differentiated monocytes 
expressed a dose dependent increase in both TNF-α and iNOS (Fig. 6.6A and B) when 
increasing amounts of rhIFN-γ was added to the cultures. However, the expression levels 
of TNF-α and iNOS by monocytes differentiated with rhIFN-γ alone was still 
significantly lesser than those expressed by Tip-DCs, even at saturating levels (5000 
U/ml) of IFN-γ (Fig. 6.6A and B). These results further indicate that while the expression 
of TNF-α and iNOS is dependent on the presence of IFN-γ, it is not the sole contributing 
factor in the CD8-DCcytokine milieu for the high expression levels of TNF-α and iNOS 












































Fig. 6.6  IFN-γ alone is insufficient to differentiate monocytes into cells that express 
similar amounts of TNF-α and iNOS as Tip-DCs.  
Monocytes were cultured with Supernatant
CD8DCLPS
 or indicated amounts of rhIFN-γ for 
48 h. Cells were harvested, fixed and stained intracellularly for TNF-α and iNOS 
Numbers represent percentages of positive cells. Results are representative of three 
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6.2.5   IFN-γ alone is insufficient to differentiate monocytes into cells with similar 
priming ability as Tip-DCs 
We also analyzed if IFN-γ was important during the differentiation process to allow 
differentiated monocytes to acquire T-cell priming abilities. To this end, we treated 
monocytes with 10 μg/ml of IFN-γ receptor or relevant isotype blocking antibodies 
before culture with SupernatantCD8DCLPS for 48 h. In addition, we also wanted to 
determine if IFN-γ alone was enough to differentiate monocytes to prime naive T-cells 
for proliferation. Hence, monocytes were differentiated with increasing concentrations of 
rhIFN-γ for 48 h. These differentiated monocytes were subsequently studied for their 
priming ability by using them as APCs to stimulate naive CD4 T-cells for 6 days. The 
proliferation of naive CD4 T-cells was then quantified by 
3
H-thymidine incorporation. 
We found that compared to untreated monocytes, monocytes differentiated with rhIFN-γ 
induced the proliferation of naive CD4 T-cells in a dose dependent manner (Fig. 6.7). 
However, the level of naive CD4 T-cell proliferation was still significantly lower than 
those induced by Tip-DCs even at the highest dose of rhIFN-γ (1000 U/ml) (Fig 6.7). In 
addition, blocking the IFN-γ receptor on monocytes before exposing them to 
SupernatantCD8DCLPS significantly reduced but did not abolish the proliferation of naive 
CD4 T-cells (Fig. 6.7). Overall, these results indicate that although the presence of IFN-γ 
during the differentiation of monocytes may be implicated for their subsequent ability to 
prime naive T-cells, it is not the only factor involved in differentiating monocytes into 
cells with similar priming ability as Tip-DCs. 
 





















Fig. 6.7 IFN-γ alone is insufficient to differentiate monocytes into cells with similar 
priming abilities as Tip-DCs.  
 
Monocytes were incubated with isotype blocking (bisotype) or anti-IFN-γR blocking 
antibodies (bIFN-γR) (both 10μg/ml) before differentiation with SupernatantCD8DCLPS 
(CD8DCLPSsup). Their ability to induce proliferation of naive CD4 T-cells was 
compared to monocytes that have been differentiated in increasing concentrations of 
rhIFN-γ. Proliferation of naïve CD4 T-cells were quantified via 3H-thymidine 
incorporation. **p<0.005 comparing CD8DCLPSsup+bisotype versus rest of the groups. 
*p<0.05 comparing CD8DCLPSsup+bisotype versus rest of groups except 





Chapter 6: Differentiation mechanism of TNF/iNOS-producing dendritic cells 
 185 
6.2.6   IFN-γ alone is insufficient to generate viable monocyte-derived cells 
While analyzing the phenotype of IFN-γ differentiated monocytes by flow cytometry, we 
noticed that the viability of these cells were significantly lower, as seen through the 
forward and side scatter plots, after stimulation with LPS. We found that with the 
exception of untreated monocytes, monocytes that were differentiated with co-culture 
supernatants maintained a relatively high viability even after stimulation with LPS (Fig. 
6.8A). On the other hand, monocytes that were differentiated with rhIFN-γ had a lesser 
percentage of viable cells after stimulation with LPS (Fig. 6.8B) as compared to cells that 
have been differentiated with co-culture supernatants (Fig. 6.8A). 
 
To further investigate this, we determined the viability of these differentiated monocytes 
by comparing their viability before and after 6 h of LPS stimulation using the 
LIVE/DEAD
®
 fixable violet dead cell stain. Cells that are viable will stain negative for 
this dye and results were analyzed by flow cytometry. We found that monocytes that 
were differentiated with co-culture supernatants had no significant changes in viability 
before and after stimulation with LPS (Fig. 6.9). In contrast, monocytes that were 
untreated or differentiated with rhIFN-γ had a drastic reduction in viability after 
stimulation with LPS (Fig. 6.9). In addition, the decrease in viability occurred regardless 
of the amount of rhIFN-γ used. Hence, these results suggest that IFN-γ alone is 
insufficient to generate monocyte-derived cells that remain viable after stimulation with 
LPS. This also suggests that the supernatants from co-cultures contain an important 
survival factor that allows cells to remain viable after LPS stimulation.  






































Fig. 6.8  Differentiation of monocytes with IFN-γ alone reduces their viability 
compared to monocytes differentiated with cultured supernatants.  
Monocytes were differentiated with the (A) indicated supernatants or (B) increasing 
doses of rhIFN-γ for 48 h and stimulated with LPS for another 6 h. Cells were analyzed 
by flow cytometry and live cells were gated using forward and side scatter plots. 
Numbers represent percentages of live cells. Results are representative of three 
independent experiments.  
 
 



































Fig. 6.9 Differentiation of monocytes with IFN-γ reduces their viability compared to 
monocytes differentiated with cultured supernatants.  
Viability of differentiated monocytes from 3 donors (mean ± SD) with (black bars) or 
without (white bars) 6h LPS stimulation assessed by cells negative for the LIVE/DEAD
®
 
fixable violet dead cell stain through flow cytometry. **p<0.005 using a two-tailed 
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6.3   Discussion 
 
We found previously that supernatants of CD8 T-cell-DC cytokine milieus contained 
increased amounts of TNF-α and IFN-γ compared to DC-only derived cytokine milieus. 
This led us to speculate that these two factors could possibly be the key mediators in the 
differentiation of monocytes into Tip-DCs. By using blocking antibodies against these 
cytokines, we found that in contrast to TNF-α which did not play a significant role in the 
differentiation of monocytes into Tip-DCs, blocking IFN-γ in CD8 T-cell-DC cytokine 
milieus resulted in a dose dependent decrease in the expression of CD40, HLA-DR, 
CD83 and TNF-α on Tip-DCs, as well as their ability to induce allogeneic T-cell 
proliferation in a MLR. However, we also found that IFN-γ alone was insufficient to 
generate Tip-DCs as monocytes differentiated with saturating levels of recombinant IFN-
γ were still insufficient to generate viable DCs that can prime and express as high levels 
of TNF-α and iNOS as Tip-DCs. This suggests that while IFN-γ may be a key factor in 
the CD8 T-cell-DC cytokine milieus for differentiation of monocytes into Tip-DCs, it is 
ultimately not the only factor involved in their differentiation.  
 
We observed that blocking TNF-α in our culture supernatants did not result in a 
significant decrease in the phenotype of Tip-DCs. This was surprising, as previous 
studies by Chomarat et al. (2003) and Iwamoto et al. (2007) have both shown that TNF-α 
drives the differentiation of monocytes into DCs. However, these discrepancies could be 
attributed to the differences in experimental setups. While studies from Chomarat’s and 
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Iwamoto’s groups studied the role of TNF-α  on monocyte differentiation by adding 
recombinant TNF-α and GM-CSF to monocytes, our studies employed blocking 
antibodies against TNF-α receptor on monocytes before culturing them with CD8 T-cell-
DC derived cytokine milieus. Since the CD8 T-cell-DC cytokine milieus have been 
shown to contain other cytokines, it is possible that these cytokines may compensate for 
the lack of TNF-α during the process of monocyte differentiation.  
 
In contrast to the unchanged effect seen when blocking TNF-α, blocking IFN-γ in our 
culture supernatants resulted in a decrease in the expression levels of CD40, HLA-DR 
and CD83 on Tip-DCs, as well as their ability to express TNF-α and prime naive CD4 T-
cells for proliferation. This is in line with a very recent study that showed the dependence 
of IFN-γ on Tip-DC differentiation performed in mice (Bosschaerts et al., 2010). In this 
study, they showed that IFN-γ-/- mice that had been infected with T.brucei had 







 inflammatory DCs in the liver. In addition, the expression levels 
of co-stimulatory molecules CD80/CD86 and MHC class II on these inflammatory DCs 
were also reduced in IFN-γ-/- mice compared to their WT counterparts. These findings 
suggest that not only is IFN-γ important for the differentiation of Tip-DCs in mice, but it 
is also a significant factor for human monocytes to acquire the phenotypic and functional 
characteristics of Tip-DCs. Interestingly, the inability of monocytes to express more 
TNF-α and iNOS after differentiation with a certain level of IFN-γ suggests that a 
saturating effect occurs, thereby explaining why monocytes cultured with 
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SupernatantCD8DC or SupernatantCD8DCLPS could both differentiate into Tip-DCs despite 
the latter having higher amounts of IFN-γ and other cytokines. 
 
While our current findings accord with Bosschaerts et al. ‘s study (2010), we found that 
previous groups have demonstrated that IFN-γ skews monocytes towards macrophages 
(Delneste et al., 2003) or tolerogenic DCs (Eljaafari et al., 2009) instead. Nevertheless, 
their results also revealed that IFN-γ increases the expression of CD80, CD86 and CD40 
as well as down-regulation of phagocytosis which are consistent with characteristics of 
Tip-DCs observed in our model. These discrepancies could be attributed to differences in 
experimental models as both studies employed the use of recombinant IFN-γ, GM-CSF 
and IL-4 to differentiate monocytes in contrast to our usage of a cytokine milieu 
generated from cultured CD8 T-cells and DCs.  Moreover, IFN-γ is not the only factor 
involved in Tip-DC differentiation, as monocytes differentiated with saturating levels of 
IFN-γ were still insufficient to generate viable DCs that can prime and express as high 
levels of TNF-α and iNOS as Tip-DCs. Notably, the decreased viability of monocytes 
differentiated with IFN-γ was not surprising, as previous studies have shown that IFN-γ 
induces the apoptosis of myeloid cells upon stimulation with LPS especially in the 
absence of other deactivating cytokines such as IL-4, IL-10 and TGF-ß (Bingisser et al., 
1996; Chawla-Sarkar et al., 2003). Hence, we feel that other factors in the CD8-DC 
supernatants may act in concert with IFN-γ to induce the differentiation of Tip-DCs. In 
particular, IL-12p40 homodimer has been shown to increase the expression of TNF-α and 
iNOS in myeloid cells (Jana et al., 2003; Pahan et al., 2001) while GM-CSF may be an 
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important factor for the maintenance of viability in monocyte derived cells (Kinoshita et 
al., 1995; Witmer-Pack et al., 1987; Woltman et al., 2003).  
 
IFN-γ, released by natural killer (NK) cells and activated T cells, is crucial for innate 
immune responses (Boehm et al., 1997). Despite the ability of both NK cells and 
activated T cells to secrete IFN-γ, CD4 Th1 cells were shown to skew monocytes into 
tolerogenic DCs (Mariotti et al., 2008) while the principal factor for NK induced DC 
differentiation was CD40L (Zhang et al., 2007). In contrast, we show that IFN-γ in our 
CD8 T-cell mediated cytokine milieu was an important factor for monocytes to 
differentiate into cells with Tip-DC characteristics. The role of CD8 T-cells observed in 
our findings can also be extrapolated to human psoriasis studies, where reduced 
infiltration of activated memory CD8 T-cells using alefacept showed decreased DC 
content, inflammation and tissue expression of IFN-γ and iNOS (Chamian et al., 2005). 
Collectively, our results highlight an important role for CD8 T-cells in mediating the 
differentiation of monocytes mainly through the production of IFN-γ which in turns 
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7.1   Introduction 
 
In the past few chapters, we found that human CD8 T-cells could prime DCs for IL-
12p70 production in vitro and could further support Th1 responses by creating a cytokine 
milieu that allows the differentiation of monocytes into Th1-inducing Tip-DCs. We also 
found that IFN-γ was an important factor for the differentiation of Tip-DCs. However, it 
remains unknown if CD8 T-cells and IFN-γ are important for the differentiation of such 
Tip-DCs in vivo. To address this, we used a mouse model of contact hypersensitivity 
(CHS) to study the role of CD8 T-cells in the induction of Tip-DC differentiation. CD8 
T-cells have been extensively shown to be the principal mediators of CHS responses 
(Akiba et al., 2002; Bouloc et al., 1998; Bour et al., 1995; Gocinski and Tigelaar, 1990; 
Xu et al., 1996). Studies have shown that their role in CHS involves the induction of 
keratinocyte apoptosis and the production of IFN-γ and IL-17 which contributes to 
further exacerbation of the inflammatory response (He et al., 2006; He et al., 2009). In 
addition, the presence of granulocytes such as neutrophils and monocytes has also been 
documented to play a significant role in the manifestation of clinical symptoms during 
the elicitation phase (Tuckermann et al., 2007). To date, Tip-DCs have been documented 
to play a pathogenic role in skin diseases such as psoriasis (Lowes et al., 2005; Wang et 
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al., 2006a). However, it remains unknown if Tip-DCs contribute to CHS responses and 
whether CD8 T-cells are the major contributors to their differentiation.  
 
To further address the role of CD8 T-cells and Tip-DCs with CHS Th1 responses, we 
compared the CHS response using a contact allergen 2,4-dinitrochlorobenzene (DNCB) 
that induces the Th1-type allergic contact dermatitis, with another allergen, trimellitic 
anhydride (TMA), which preferentially provokes Th2-inducing diseases such as 
respiratory and skin hypersensitivity (Bernstein et al., 1982). Previous work has 
documented the triggering of selective immune responses in response to these two 
allergens (Ban et al., 2006; Dearman and Kimber, 1991). Dearman and colleagues 
(Dearman et al., 1995) have observed that draining lymph node cells obtained from mice 
that had repeated topical exposure to DNCB produced high levels of Th1 cytokine IFN-γ 
and low levels of Th2 cytokines IL-4 and IL-10, while the opposite was true for TMA. 
These distinct cytokine profiles thus reflect the allergies elicited upon exposure to each 
chemical and allow us to study the role of Tip-DCs in these two different settings.  
 
In this chapter, we investigated the role of CD8 T-cells and Tip-DCs in vivo by first 
identifying the presence of Tip-DCs in the elicitation phase of the CHS response in mice 
that have been sensitized and challenged with either the Th1 inducing allergen, DNCB, or 
the Th2 inducing allergen, TMA. We next analyzed whether CD8 T-cells were involved 
in the differentiation of Tip-DCs during CHS by selective depletion of CD8 T-cells using 
monoclonal antibodies in vivo  as well as performing CHS experiments in mice that have 
defective MHC-class I presentation through deficiency of beta-2-microglobulin (β2M-/-). 
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Finally, we elucidated the role of IFN-γ for the differentiation of Tip-DCs using IFN-γ-/- 
mice as well as confirmed the origin of Tip-DCs to be derived from classical monocytes 
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7.2   Results 
 
7.2.1   DNCB induced significant inflammation in ears of mice compared to TMA 
To investigate the differential ability of DNCB versus TMA to induce inflammatory 
responses, mice were subjected to CHS by first sensitizing them to chemical allergens, 
DNCB (1% w/v) or TMA (10% w/v), or the vehicle (1:4 olive oil: acetone) by topical 
application on shaved dorsal skin. Five days later, they were challenged with the same 
chemical on both the dorsal and ventral sides of the ears and observed for the 
inflammatory response after 18 hours. Severe hyperemia and reddening (erythema) was 
observed in ears of DNCB-treated mice (Fig. 7.1A). In contrast to DNCB-treated mice, 
TMA-treated mice developed only slight erythema while vehicle-treated mice did not 
show any significant signs of inflammation. Measurement of ear thickness using an 
engineer’s micrometer revealed that DNCB-treated mice had a significant increase 
(**p<0.005) in ear swelling compared to vehicle-treated mice (Fig. 7.1B). In contrast, the 
increase in ear thickness of TMA-treated mice was not significantly different from 
vehicle-treated mice. Furthermore, the increase in ear thickness of DNCB-treated mice 
was also significantly larger compared to TMA-treated mice (**p<0.005). Finally, H&E 
staining of ear sections from treated mice indicated that DNCB-treated mice developed 
strong inflammatory reactions at the challenged sites which were characterized by 
marked spongiosis (edema) and extensive cell infiltration in the swollen dermis (Fig. 
7.1C). In contrast, such reactions were substantially attenuated in the ears of TMA-
treated mice. 
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Fig 7.1 DNCB elicitation, but not TMA, resulted in significant CHS responses.  
 
WT mice were sensitized and challenged as described with DNCB, TMA or vehicle. (A) 
Photographs of ears of mice that have been treated with indicated chemical or vehicle. 
White arrows indicate the presence of dilated blood vessels and erythema (B) Ear 
thickness was measured after challenge at indicated time points using an engineer’s 
micrometer (n=6 mice). **p<0.005 using one-way ANOVA  (C) Ear skin tissues were 
harvested after challenge and stained with H&E. Results are representative of three 
experiments conducted 
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To ensure that the attenuated CHS response in TMA-treated, compared to DNCB-treated, 
mice was not due to the absence of immune priming or unresponsiveness to the chemical, 
the draining lymph nodes were examined. Auricular draining lymph nodes were first 
identified by an intradermal injection of a staining dye, Evan’s blue, into the ears. Five 
minutes later, the cervical section was exposed and the draining lymph node was 
identified as the lymph node stained with Evan’s blue, namely at the superficial cervical 
lymph node (Fig 7.2A). To study the CHS response, these auricular draining lymph nodes 
were excised 24, 48 and 72 hours after challenge with the chemical and cell counting was 
performed. DNCB-treated and TMA-treated mice showed no significant differences in 
cell numbers in the lymph nodes at all time points (Fig. 7.2B), suggesting that the 
attenuated inflammatory response seen in the ears of TMA-treated mice was not due to 
the absence of immune priming. 
 
























































Fig 7.2 DNCB and TMA elicitation showed no difference in the activation of lymph 
node cells.  
 
(A) To identify the auricular draining lymph node, Evan’s blue was injected 
intradermally into each ear of the mice, euthanized after 5 min and the thoracic cavity 
exposed. The auricular draining lymph node is identified as the lymph node that have 
stained blue as shown in the photographs. (B) Draining auricular lymph nodes were 
harvested at indicated time points after challenge and cell counting was performed. 
Values are shown as means ± SEM of six mice per group. *p< 0.05, **p<0.001 analyzed 
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7.2.2 DNCB induced less Th2-type cytokines compared to TMA in sensitized mice  
To further understand the increased inflammatory response seen in DNCB-treated 
compared with TMA-treated mice, cytokines in the ears and auricular lymph nodes were 
analyzed. Treated mice were subjected to CHS and ear tissue was harvested 24, 48 and 
72 hours after challenge. The ear tissue was then homogenized and supernatants collected 
for cytokine analysis by ELISA. We found that DNCB-treated mice showed a significant 
increase (**p<0.005) in the presence of GM-CSF 48 and 72 hours after challenge 
compared to TMA-treated mice (Fig. 7.3A). However, we were unable to detect any 
significant changes in the levels of IFN-γ between DNCB-treated and TMA-treated mice 
(Fig. 7.3B). This suggests that the increased inflammatory response seen in DNCB-
treated, but not TMA-treated mice, was not solely due to IFN-γ. We next looked for the 
presence of Th2 cytokines which may potentially antagonize the functions of IFN-γ. We 
found a significant increase (*p<0.05) in the levels of IL-5 in ears that have been excised 
72 hours after challenge (Fig. 7.3C). Notably, we found a significant increase (*p<0.05) 
in the levels of IL-10 in ears 24 and 72 hours after challenge (Fig. 7.3D). In addition, the 
increase in IL-13 levels in TMA-treated mice as compared to DNCB-treated mice was 
statistically significant at all time points (**p<0.005) (Fig. 7.3E). These results 
demonstrate that the elicitation of CHS using TMA was associated with increased Th2 
cytokines such as IL-10 and IL-13 which may have potential attenuation in the 
inflammatory response 


































































































































































































Fig 7.3  TMA-treated mice showed an increase presence of Th2 cytokines in the 
challenge site.  
 
WT mice were treated with DNCB, TMA or vehicle as previously described. Ears were 
excised from mice at indicated time points after challenge, homogenized and supernatants 
collected. Cytokines (A) GM-CSF (B) IFN-γ (C) IL-5 (D) IL-10 and (E) IL-13 were 
analyzed via ELISA. Values are shown as means ± SEM of five mice per group. *p< 
0.05, **p<0.001 analyzed using one-way ANOVA. 
Chapter 7: Differentiation of Tip-DCs in an in vivo mouse model of CHS 
 201 
We further confirmed the Th2 cytokine profile of TMA-treated mice by analyzing the 
cells from the auricular lymph nodes. Lymph nodes were excised 72 hours after challenge 
and were re-stimulated with anti-CD3 and anti-CD28 in vitro. After an overnight culture, 
supernatants were harvested and cytokines were analyzed using ELISA. Consistent with 
the trend of IFN-γ detected in ear tissues, DNCB-treated and TMA-treated mice showed 
no significant differences in the production of IFN-γ (Fig. 7.4A). However, we 
discovered a significant increase (**p<0.005) in the quantities of IL-17 in the lymph 
nodes of DNCB-treated mice compared to TMA-treated mice (Fig. 7.4B). In particular, 
we detected substantial levels of IL-4, IL-5, IL-10 and IL-13 (**p<0.005) (Fig. 7.4C-F) 
in lymph nodes of TMA-treated mice which in contrast, were minimally or not detected 
in DNCB-treated mice. Hence, these results suggest that DNCB induces a Th1/Th17 
response while TMA induces a Th1/Th2 response. In addition, the differential 
inflammatory responses could be due to the upregulation of Th2-inducing cytokines in 






































































































































Fig 7.4 TMA-treated mice showed an increase presence of Th2 cytokines in 
auricular draining lymph nodes.  
 
WT mice were treated with DNCB, TMA or vehicle as previously described. Draining 
lymph nodes were collected 72 h after challenge and cells were re-stimulated with 1 
μg/ml of anti-CD3/anti-CD28 overnight in 48 well plates at a concentration of 2 x 106 
cells/ml. Supernatants were harvested and cytokines (A) IFN-γ (B) IL-17 (C) IL-4 (D) 
IL-5 (E) IL-10 and (F) IL-13 were analyzed via ELISA. Values are shown as means ± 
SEM of six mice per group. *p< 0.05, **p<0.001 analyzed using one-way ANOVA. 
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After determining the cytokine profile of skin tissues that have been exposed to DNCB or 
TMA, we next investigated the population of cells that have infiltrated into the skin tissue 
after CHS. Mice were topically sensitized, sacrificed and ears excised 24 hours after 
challenge. The populations of immune cells were analyzed by flow cytometry according 
to the materials and methods described in chapter 2.3.3. Briefly, the epidermis was 
separated from the dermis by incubating the ear tissue in dispase solution. Subsequently, 
the dermis was digested with Collagenase Type IV and filtered through a piece of 61μm 
gauze before staining with relevant antibodies for flow cytometry analysis.   
 
Live cells were first gated using the forward and side scatter profile before excluding 
doublets using the side scatter linear and area profile. Next, viable cells were selected by 
gating on cells that stained negative for the aqua dead cell stain. This gating strategy was 
used for all subsequent flow cytometry analysis and is described in Fig. 7.5. As the 
majority of cells present in the dermal skin suspension are non-immune cells such as 
fibroblasts and endothelial cells, we stained the skin suspension with CD45, a marker for 
hematopoietic cells, to determine the percentage of immune cells in the skin. Flow 
cytometry analysis revealed that TMA-treated mice showed a small significant increase 
(*p<0.05) in the amount of CD45
+
 cells in the dermis (Fig. 7.6A-B). In contrast to TMA-
treated mice, DNCB-treated mice showed a greater significant increase (**p<0.005) in 
the percentage of CD45
+
 immune cells in the dermis (Fig. 7.6A-B). Staining for 
infiltrating T-cells into the dermis using the anti-TCRαß antibody revealed a significant 
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increase (*p<0.05) in T-cell numbers only in DNCB-treated mice (Fig. 7.6C). However, 
we were unable to differentiate the population of T-cells into CD4 or CD8 subsets as 
staining for these markers was very weak by flow cytometry (data not shown). DNCB-
treated mice also displayed a significant increase (**p<0.005) in neutrophil numbers, 






, compared to vehicle and TMA-treated mice 






 cells, were increased 
significantly (**p<0.005) in both TMA-treated and DNCB-treated mice although DNCB-
treated mice registered a much higher monocyte cell number compared to mice treated 
with TMA (Fig. 7.6C). Hence, these results demonstrate that DNCB elicitation on mice 
ears is accompanied by a greater infiltration of CD45
+
 immune cells with a significant 




















































Fig 7.5 Gating strategy employed for analysis of dermal cells by flow cytometry.  
 
WT mice were treated with DNCB, TMA or vehicle as previously described. Ears were 
excised from mice and digested into single cell suspensions before flow cytometry 
analysis. Live cells were gated using the forward and side scatter profile and were 
selected for singlets by gating on cells using the side scatter linear versus side scatter area 
plot. Finally, viable cells were selected by gating on cells that stain negative for the aqua 
dead cell stain. 
 





















































































Fig 7.6   DNCB elicitation resulted in a larger significant increase in immune cell 
infiltration into the challenge site.  
 
WT mice were sensitized and challenged as described. Ear skin tissues were harvested 24 
h after challenge and digested according to the materials and methods. (A) Cells were 
stained with anti-CD45 antibody and analyzed using flow cytometry. Numbers represent 
percentages of positive cells (B) Statistical analysis of samples. (C) Cells were stained 
with anti-TCRαß to measure T-cells, anti-Ly6G to measure neutrophils and anti-Ly6C 
excluding Ly6G+ cells to measure monocytes. Graph represents the number of cells in 
challenge site. Values are shown as means ± SEM of six mice per group. *p< 0.05, 
**p<0.005 analyzed using one-way ANOVA. 
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7.2.4   DNCB elicitation resulted in the increased presence of Tip-DCs in the skin 
dermis 







) cells that express TNF-α and iNOS by flow cytometry. 










 cells in the dermis of DNCB-treated mice as compared to mice treated 




 cells in 
DNCB-treated mice was also statistically significant when compared to TMA-treated 




cells, we found a slight significant 
increase (*p<0.05) in iNOS-expressing cells in TMA-treated compared to vehicle-treated 
mice (Fig. 7.7C-D). Notably, we found an approximate 4-fold increase in iNOS-
expressing cells in DNCB-treated compared to vehicle-treated mice (Fig. 7.7B) and this 
increase was statistically significant (**p<0.005) compared to both vehicle and TMA-
treated mice (Fig. 7.7D).  We also determined the expression of TNF-α among the MHC 
II expressing cells and only found a significant increase (**p<0.005) in TNF-α-
expressing cells among DNCB-treated mice compared to vehicle-treated mice (Fig. 7.7E-
F). In addition, this increase in DNCB-treated mice was also statistically significant 
(*p<0.05) when compared to TMA-treated mice (Fig. 7.7F). Notably, the TNF-α and 




population all expressed CD11b (Fig. 
7.7C, E), suggesting that they were of myeloid origin. Hence, these results demonstrate 
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and that the increased expression of both TNF-α and iNOS among these cells was also 


































































































































































Fig 7.7 DNCB elicitation resulted in significant infiltration of TNF/iNOS-producing 
DCs.  
 
WT mice were sensitized and challenged as described. Ear skin tissues were harvested 24 
h after challenge and digested according to the materials and methods. (A) Cells were 
stained with anti-CD45 and anti-MHCII. Numbers represent percentages of positive cells 




 cells in treated samples (C) Cells were fixed 
and permeabilized before staining with anti-iNOS. Numbers represent percentages of 
iNOS
+




 cells (D) Average percentage of iNOS expressing 
cells among CD45+MHCII+ cells. (E) Cells were stained for intracellular TNF-α. 
Numbers represent percentages of TNF-α expressing cells among CD45+MHCII+ cells. 
(F) Average percentage of TNF-α expressing cells among CD45+MHCII+ cells. Values 
are shown as means ± SEM of three mice per group. *p< 0.05, **p<0.005 analyzed using 
one-way ANOVA. Results are representative of three experiments. 
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 cells were more representative of Tip-
DCs than macrophages and if they expressed higher levels of TNF-α and iNOS compared 
to the CD45
+





present in DNCB-treated mice displayed a higher MFI expression of CD11c, a marker 









cells expressed lower levels of CD68, a marker commonly 









cells also had a higher 
MFI expression of TNF-α and iNOS compared to CD45+MHCII- cells (Fig. 7.8A). 
Moreover, the differences in the MFI expressions of CD11c, CD68, iNOS and TNF-α 
between these two populations of cells were also statistically significant (Fig. 7.8B). 




 cells were representative of Tip-DCs and 
that the expression of MHC II on CD45
+
 cells is also associated with a lower expression 





























































Fig.7.8  Further characterization of Tip-DCs.  
 
WT mice were sensitized and challenged with DNCB as described. Ear skin tissues were 









 (R2 gate) and analyzed for CD11c, 
CD68, iNOS and TNF-α expression. Numbers represent mean fluorescence index (MFI). 
(B) Statistical analysis of MFI expression of indicated markers. Values are shown as 








 monocytes have been shown to infiltrate into the periphery during 




cells (Tip-DCs) seen in DNCB-treated mice could be due to an increase in differentiated 
Ly6C
+ 
monocytes. We found that vehicle-treated mice had no Ly6C
+
 expressing cells in 
the dermis (Fig. 7.9A).  When mice were treated with TMA, we found a 20% increase in 
total Ly6C
+
 cells with half of them expressing MHCII (Fig. 7.9A). In comparison, mice 









 cells, resulting in a increase of 57% of total Ly6C
+
 cells (Fig. 








 cells revealed that both 
populations expressed TNF-α and iNOS, although the latter was shown to have a higher 
percentage of TNF-α/iNOS expressing cells (Fig. 7.9B).  Notably, the increase in Ly6C+ 
cell populations in DNCB-treated mice were also significantly higher than TMA-treated 





 cells seen in DNCB-treated mice could be due to the increased 
presence of differentiated Ly6C
+




























































































































































 cells.  
 
WT mice were sensitized and challenged with TMA, DNCB or vehicle as described. Ear 
skin tissues were harvested after challenge, digested and analyzed using flow cytometry. 









 cells. Numbers represent percentages of cells in each quadrant. (B) Cells 
were further gated on each indicated quadrant and analyzed for intracellular TNF-α and 









 cells out of CD45
+
 cells. Values are shown as means ± 
SEM of six mice per group. *p<0.05 **p<0.005 analyzed using one-way ANOVA. 
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7.2.5  Deficiency in CD8 T-cells, but not CD4 T-cells, resulted in reduction of Tip-
DC accumulation and a decrease in CHS responses. 
In the earlier chapters, we showed that CD8 T-cells played a role in the differentiation of 
human monocytes into Tip-DCs in vitro. Thus, we investigated if the Tip-DCs seen 
during CHS elicitation with DNCB could also be mediated by CD8 T-cells in vivo. We 
first used mice that were deficient in ß2-microglobulin (ß2m
-/-
), an important component 
of the MHC class I molecule structure.  These ß2m
-/- 
mice have defective MHC class I 
presentation and hence do not have any CD8 T-cells (Koller et al., 1990). We confirmed 
the phenotype of these mice by analyzing the blood and lymph nodes and confirmed that 
CD8 T-cells were indeed absent in these ß2m
-/- 
mice (Fig. 7.10A-B). While CD8 T-cells 
were consistently lacking in ß2m
-/- 
mice, the percentage of CD4 T-cells in the lymph 
nodes were sometimes elevated (Fig. 7.10B) and, although this was not consistently seen 
in all experiments, has been reported previously by others (Giese and Davidson, 1995; 
Vikingsson et al., 1996). Hence, we also used depleting antibodies to remove CD8 T-
cells and CD4 T-cells for comparative purposes. CD8 T-cells or CD4 T-cells were 
depleted by injecting 250 μg of anti-CD8α (clone: 53-6.7) or anti-CD4 (clone: GK1.5) 
respectively two days before the last challenge. Analysis of the blood (Fig. 7.10A) and 
































































Fig. 7.10  Blood and lymph node analysis of β2m-/- mice and mice that have been 
treated with anti-CD8 or anti-CD4 depleting antibodies.  
 
WT or β2m-/- mice were sensitized and challenged with DNCB as described. 3 days after 
sensitization, 250 μg of anti-CD8 or anti-CD4 antibodies was injected i.p. into WT mice. 
24 hours after challenge, CD8 T-cells and CD4 T-cells were analyzed via flow cytometry 
in (A) blood harvested through cardiac puncture and in (B) draining auricular lymph 
nodes to ensure the absence of indicated cells. Numbers represent percentages of positive 
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To determine if the ablation of CD8 T-cells or CD4 T-cells may have a profound effect 
on the CHS response, histology was performed on ear sections through H&E staining. 
We found that ß2m
-/- 
mice and CD8dep mice had a reduction in edema and fluid deposits 
compared to WT mice when subjected to CHS with DNCB, although this was not seen in 
CD4dep mice (Fig. 7.11A). In addition, this decrease in edema was associated with a 
significant decrease in ear thickness for both the ß2m
-/- 
mice (*p<0.05) and CD8dep mice 
(**p<0.005) (Fig. 7.11B). However, there was no significant change in ear thickness in 
CD4dep mice (Fig. 7.11B). Therefore, we conclude that CD8 T-cells, and not CD4 T-










































































Fig 7.11   CD8 T-cells, but not CD4 T-cells, are important for CHS responses.  
 
WT or β2m-/- mice or WT mice that have been depleted of CD8 T-cells or CD4 T-cells 
were sensitized and challenged as described with DNCB. (A) Ear skin tissues were 
harvested after challenge and stained with H&E. (B) Ear thickness was measured 18 
hours after challenge using a micrometer. Values are shown as means ± SEM of eight 
mice per group. *p<0.05 **p<0.005 analyzed using one-way ANOVA. Results are 
representative of three experiments conducted.  
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When CHS was performed using DNCB on ß2m
-/- 





 cells compared to WT mice in the dermis (Fig. 7.12A-B). 
In comparison, mice treated with CD8 depleting (CD8dep) antibodies also showed a 




 cells although this reduction was not 





 cells for iNOS expression, we found that ß2m
-/- 
mice and 
CD8dep mice both exhibited a drastic reduction in iNOS expression (Fig. 7.12C) and this 
reduction was statistically significant (**p<0.005) (Fig. 7.12D). In contrast, we did not 
detect any significant differences in iNOS expression in CD4dep mice compared to mice 





 cells was slightly reduced in ß2m
-/- 
mice and CD8dep 
mice (Fig. 7.12E), although this reduction was only statistically significant (*p<0.05) in 
CD8dep mice (Fig. 7.12F). In addition, we found no significant differences in TNF-α 
expression in CD4dep mice (Fig. 7.12E-F). Hence, these results suggest that CD8 T-cells, 
but not CD4 T-cells, are able to modulate the presence of Tip-DCs during CHS using 



















































































































































































Fig 7.12   TNF/iNOS-producing DCs were reduced in β2m-/- and CD8 depleted mice.  
 
WT or β2m-/- mice or WT mice that have been depleted of CD8 T-cells or CD4 T-cells 
were sensitized and challenged as described with DNCB. Ear skin tissues were harvested 
24 h after challenge and digested according to the materials and methods. (A) Cells were 
stained with anti-CD45 and anti-MHCII. Numbers represent percentages of positive cells 




 cells in treated samples (C) Cells were fixed 
and permeabilized before staining with anti-iNOS. Numbers represent percentages of 
iNOS
+









 cells. (E) Cells were stained for intracellular TNF-α. 
Numbers represent percentages of TNF-α expressing cells among CD45+MHCII+ cells. 
(F) Average percentage of TNF-α expressing cells among CD45+MHCII+ cells. Values 
are shown as means ± SEM of three mice per group. *p< 0.05, **p<0.005 analyzed using 
one-way ANOVA. Results are representative of three experiments. 
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We next investigated if the reduction in Tip-DCs seen in ß2m
-/- 
mice and CD8dep mice 
was due to a decrease in the presence and differentiation of Ly6C
+
 monocytes. We found 




 cells among the CD45
+
 immune cells in 
ß2m
-/- 
mice and CD8dep mice (Fig. 7.13A), although this was not statistically significant 







mice and CD8dep mice although this decrease was not 
detected in CD4dep mice (Fig. 7.13A-B). Thus, these results demonstrate that the 
decrease in Tip-DCs in ß2m
-/- 
mice and CD8dep mice could also be due to a decrease in 
Ly6C
+












































































































Fig.7.13 β2m-/- and CD8 depleted mice had reduced presence of Ly6C+MHCII+ 
cells.  
 
WT or β2m-/- mice or WT mice that have been depleted of CD8 T-cells or CD4 T-cells 
were sensitized and challenged as described with DNCB. Ear skin tissues were harvested 



















 cells out of CD45
+
 cells. Values are shown as means ± 
SEM of six mice per group. *p<0.05 **p<0.005 analyzed using one-way ANOVA. 
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7.2.6  Tip-DCs are reduced in IFN-γ-/- and CCR2-/- transgenic mice during CHS 
responses. 
Previous reports have shown that Ly6C
+
 monocytes require CCR2 to infiltrate into 
inflammatory sites (Serbina et al., 2003). In addition, we showed previously in vitro that 
the differentiation of Tip-DCs was dependent on IFN-γ. Thus, we determined if Tip-DCs 
in our CHS model is dependent on the presence of IFN-γ and CCR2 signalling. When 





 cells compared to WT mice (Fig. 7.14A). In addition, CCR2
-/-
 mice had a 














 cells in IFN-γ-/-  and CCR2-/- mice compared to WT mice was also 





cell population for iNOS and TNF-α expression. We found a significant decrease 
(**p<0.005) in the percentage of iNOS-expressing cells in both IFN-γ-/- and CCR2-/- mice 
compared to WT mice (Fig. 7.14C-D). In contrast, CCR2
-/-
 mice showed a significant 
increase (**p<0.005) in percentage of TNF-α-expressing cells among the CD45+MHCII+ 





 cells in IFN-γ-/-  and CCR2-/- mice are much lesser than WT mice, we 





TNF-α+ cells among total cells and this decrease was statistically 
significant (Fig. 7.14G). Hence these results suggest that both IFN-γ and CCR2 signalling 
were important for modulating the presence of Tip-DCs and expression of TNF-α and 
iNOS during CHS. 













































































































































































































Fig 7.14 TNF/iNOS-producing DCs were reduced in IFN-γ-/- and CCR2-/- mice.  
 
WT, IFN-γ-/- and CCR2-/- mice were sensitized and challenged as described with DNCB. 
Ear skin tissues were harvested 24 h after challenge and digested according to the 
materials and methods. (A) Cells were stained with anti-CD45 and anti-MHCII. Numbers 





among total cells in treated samples (C) Cells were fixed and permeabilized before 
staining with anti-iNOS. Numbers represent percentages of iNOS
+










 cells. (E) Cells were stained for intracellular TNF-α. Numbers represent 
percentages of TNF-α expressing cells among CD45+MHCII+ cells. (F) Average 





TNF-α+ cells among total cells. Values are shown as mean ± 
SEM of three mice per group. *p< 0.05, **p<0.005 analyzed using one-way ANOVA. 
Results are representative of three experiments. 
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We also investigated if the reduction in Tip-DCs in IFN-γ-/- and CCR2-/- mice was due to 
a decrease in the presence and differentiation of Ly6C
+
 monocytes. We found that IFN-γ-
/-
 mice had a comparable percentage of total Ly6C
+
 monocytes (61%) compared to WT 
(64%) (Fig. 7.15A). However, IFN-γ-/- mice had a significant increase (**p<0.005) in 






) compared to WT mice after 
CHS elicitation (Fig. 7.15A-B).  At the same time, this was accompanied by a significant 







compared to WT mice (Fig. 7.15A-B).  We also found that CCR2
-/-
 mice had a severe 
deficiency in total Ly6C
+
 cells (6%) in the dermis compared to WT mice (64%) after 
CHS elicitation that was also statistically significant (**p<0.005) (Fig. 7.15A-B). Hence, 
these results suggest that the reduction of Tip-DCs seen in IFN-γ-/- mice could also be due 
to a defect in Ly6C
+
 cell differentiation while the minimal percentage of Tip-DCs in 
CCR2
-/-

































































































Fig.7.15   IFN-γ-/- and CCR2-/- mice had reduced presence of Ly6C+MHCII+ cells.  
 
WT, IFN-γ-/- and CCR2-/- mice were sensitized and challenged as described with DNCB. 
Ear skin tissues were harvested 24 h after challenge and digested according to the 




 cells to exclude neutrophils 




 cells. Numbers represent percentages of cells in each 








 cells out of 
CD45
+
 cells. Values are shown as means ± SEM of six mice per group. *p<0.05 
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Finally, we determined if the absence of IFN-γ or CCR2 signalling affects the CHS 
response elicited by DNCB. Histological analysis of challenged sites showed that CHS in 
WT mice was associated with vascular enlargement, dermal edema and infiltration of 
mononuclear cells (Fig. 7.16A). However, these observations were present at a much 
lesser extent in IFN-γ-/- and CCR2-/- mice (Fig. 7.16A). In addition, measurement of 





 (**p<0.005) mice compared to their WT counterparts (Fig. 
7.16B). These results suggest that IFN-γ and CCR2 are not only important for the 
presence of Tip-DCs during CHS responses, but are also crucial for the pathological 

































































Fig 7.16 IFN-γ-/- and CCR2-/- mice had reduced CHS responses.  
 
WT, IFN-γ-/- and CCR2-/- mice were sensitized and challenged as described with DNCB. 
(A) Ear skin tissues were harvested after challenge and stained with H&E. (B) Ear 
thickness was measured 18 hours after challenge using an engineer’s micrometer. Values 
are shown as means ± SEM of eight mice per group. *p<0.05 **p<0.005 analyzed using 
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7.2.7 Tip-DCs are located proximately to endothelial structures and T-cells during 
DNCB elicitation 
We further examined the presence of Tip-DCs in the dermis of DNCB-treated mice by 
performing immunostaining on frozen ear tissue cryosections. We noticed that vehicle-
treated mice had a small number of MHCII
+
 cells and were distributed both in the 
epidermis and dermis where they represent Langerhans cells and dermal DCs 
respectively (Fig.7.17A) In addition, staining for CD31, a marker which detects 
endothelial structures such as lymphatic and blood vessel endothelium, revealed that 
these structures are relatively constricted at the steady state. In addition, we were unable 
to detect any iNOS in the dermis of ear sections in vehicle-treated mice (Fig. 7.17A). 
When ear sections from DNCB-treated mice were stained with MHCII, we noticed a 
increase in MHCII
+
 staining in the dermis and this was accompanied by dilation of 
lymphatic and blood vessels as observed by the opened circular structures when stained 
with CD31 (Fig. 7.17B). Staining DNCB-treated ear sections with iNOS revealed a 
brightly stained epidermis which is consistent with literature findings of iNOS-expressing 
keratinocytes during inflammation (Bécherel et al., 1997; Robertson et al., 1996; Sirsjö et 
al., 1996). Closer examination of iNOS production in the dermis revealed iNOS-
expressing cells near endothelial structures (Fig 7.17C) and these iNOS-expressing cells 
were also co-localized with MHCII
+
 cells (Fig. 7.17D). We also analyzed ear sections for 
CD3
+
 cells. Vehicle-treated ears showed minimal CD3 staining in the dermis but 
displayed substantial staining in the epidermis (Fig. 7.18A) where they exhibit dendritic-
like structures and have been shown to be γδ T-cells (or dendritic epidermal T-cells) 
essential for homeostasis and wound healing (Havran and Jameson, 2010; Hayday, 2009; 
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Jameson and Havran, 2007). In contrast, staining for CD3 in DNCB-treated skin samples 
revealed an increased amount of CD3
+
 cells in the dermis (Fig. 7.18B) and they were 
found to cluster with iNOS-expressing MHCII+ cells (Fig. 7.18C-E). These 
immunostaining results suggest that the proximity of Tip-DCs near endothelial structures 
or T-cells during elicitation of CHS may have profound effects during inflammation 
which remains to be explored.  
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Fig 7.17   Tip-DCs are proximately located to endothelial vessels.  
 
WT mice were sensitized and challenged as described with (A) vehicle or (B) DNCB. 
Immunostaining was performed on 7μm of ear cryosections and DAPI (blue), MHCII 
(green), iNOS (red) and CD31 (white) was detected. Scale bar represents 100μm. (C-D) 




 cells near CD31
+
 endothelial cells. Scale bar 
represents 200μm. Results are representative of three experiments. 
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Fig 7.18    Tip-DCs are proximately located to T-cells.  
 
WT mice were sensitized and challenged as described with (A) vehicle or (B) DNCB. 
Ears were harvested 72 h after challenge. Immunostaining was performed on 7μm of ear 
cryosections and DAPI (blue), MHCII (green), iNOS (red) and CD3 (white) was 
detected. Scale bar represents 100μm. (C-E) Magnified analysis of MHCII+iNOS+ cells 
with CD3
+
 T-cells. Scale bar represents 200μm. Results are representative of three 
experiments. 
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7.3   Discussion 
 
In the previous chapters, we showed that human CD8 T-cells can support Th1 responses 
by differentiating monocytes into Tip-DCs in vitro. In this chapter, we demonstrate that 
Tip-DCs can also be detected in vivo in a model of contact hypersensitivity in the dermis 
of mice treated with a chemical hapten. We showed that in contrast to TMA, a chemical 
that favours immune polarization towards Th2 responses, the presence of Tip-DCs was 
significantly increased in mice that have been treated with DNCB, a chemical that 
polarizes Th1 responses. We also found that while TMA-treated mice showed minimal 
ear swelling when challenged with the chemical, DNCB-treated mice showed 
pathological changes in the ears associated with CHS such as vascular enlargement, 
dermal edema and increased infiltration of mononuclear cells. In addition, we 
demonstrated that CD8 T-cells, but not CD4 T-cells, were the major modulators of Tip-
DCs during DNCB-elicitated CHS responses through the use of blocking antibodies in 
vivo. Finally, we also showed that the differentiation and recruitment of Tip-DCs was 
largely dependent on IFN-γ and CCR2 signalling.  
 
Chemical allergens that cause allergic contact dermatitis or occupational asthma, namely 
DNCB or TMA, have been shown to induce divergent immune responses characteristic 
of Th1 and Th2-type cell activation respectively (Bernstein et al., 1982; Botham et al., 
1989; Dearman and Kimber, 1991). In line with these findings, we also observed that 
sensitization of mice to DNCB or TMA resulted in the production of different cytokine 
patterns. In particular, we found that auricular draining lymph nodes excised from mice 
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after challenge with TMA showed the presence of Th2 cytokines, IL-4, IL-5, IL-10 and 
IL-13, which were not detected in DNCB-treated samples. Notably, while there were 
significant differences in Th2 cytokines produced in TMA versus DNCB-treated mice, 
we did not detect any significant difference in IFN-γ production between these two 
samples. While this observation was in contrast to earlier studies which demonstrated 
lower IFN-γ production in TMA samples (Dearman et al., 1996; Moussavi et al., 1998), 
we found that a recent finding had supported our observation by demonstrating that the 
deviating immune responses induced in mice by different classes of chemical allergens 
are independent of IFN-γ-producing cells, but are associated with differential frequencies 
of IL-4-expressing cells (Dearman et al., 2005). In addition, we also found a significant 
increase in IL-17-producing cells in lymph nodes of DNCB-treated compared to TMA-
treated mice. This finding has not been reported in literature thus far and may also help to 
explain the divergent pathological changes seen in DNCB versus TMA-elicited 
responses, since IL-17 has been associated with the infiltration of granulocytes and 
regulation of inflammatory chemokines (Aggarwal and Gurney, 2002; He et al., 2009; 
Kish et al., 2009; Kolls and Lindén, 2004). This differing cytokine patterns seen in lymph 
nodes of DNCB versus TMA-treated mice was also noticed in the challenged site, as we 
are the first to show that while there were no significant differences in IFN-γ, we found a 
significant increase in IL-10 and IL-13 in TMA-treated compared to DNCB-treated ear 
tissues. Moreover, we also found a significant increase in GM-CSF in DNCB-treated 
compared to TMA-treated ear tissues. Since GM-CSF has been associated with the 
development of inflammatory DCs (Auffray et al., 2009; Miller et al., 2002; Xu et al., 
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2007), the increase in GM-CSF seen in DNCB-treated samples may also be associated 
with the increased presence of Tip-DCs which were not detected in TMA-treated mice. 
 
We noticed that mice that have been sensitized with DNCB developed typical symptoms 
associated with CHS such as vascular enlargement, dermal edema and erythema. In 
contrast, these observations were not detected in mice that have been sensitized and 
challenged with TMA. While these observations may suggest that TMA may not elicitate 
any significant dermatological pathogenesis, studies have shown that chronic topical 
exposure to TMA results in atopic dermatitis characterized by significant edema and Th2 
cytokine profile, accompanied by infiltration of T-cells, MHCII
+
 cells, eosinophils and 
mast cells, as well as a strong increase of serum IgE levels (Schneider et al., 2009). Since 
we have adopted an acute protocol of CHS with only one sensitization and one challenge 
procedure compared to the chronic protocol with two sensitization and three challenge 
procedures, this may help to explain the attenuated response seen in our model with TMA 
as opposed to that seen by Schneider and colleagues (2009). This attenuated response in 
comparison to DNCB-treated mice may also be accounted by the increased presence of 
IL-10 detected in TMA but not DNCB-treated mice, since IL-10 has been shown to 
down-regulate immune responses in contact dermatitis (Grimbaldeston et al., 2007; 
Pestka et al., 2004).  
 
We also found an increase in immune cell infiltration into DNCB-elicitated ear tissues 







 cells in DNCB as compared to TMA-
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elicitated ear tissues. Notably, these cells also expressed higher levels of CD11c and 
lower levels of CD68 than MHCII
-
 cells, suggesting that these cells closely resemble Tip-
DCs as described in other models (Aldridge et al., 2009; Bosschaerts et al., 2010; Serbina 
et al., 2003). In particular, we found that CD8 T-cells were important for the presence of 
such Tip-DCs during CHS responses to DNCB, as depletion of CD8 T-cells, but not CD4 
T-cells, resulted in a significant decrease in these cells. Although the expression of TNF-
α by Tip-DCs was not totally abrogated, the loss of CD8 T-cells resulted in the inability 
of these cells to express iNOS, thereby demonstrating the importance of CD8 T-cells in 
the activation of Tip-DCs. Moreover, we found that the reduced presence of MHCII
+
 Tip-





cells) after elicitation of CHS. This phenomenon was also 
observed in IFN-γ-/- mice whereby the absence of IFN-γ also resulted in a decrease in 
differentiated monocytes. To further confirm that Tip-DCs derive mainly from 
monocytes, we found that the absence of CCR2 signalling, important for the recruitment 
of Ly6C
+
 monocytes (Jia et al., 2008; Serbina et al., 2003; Tsou et al., 2007), caused a 
drastic reduction in the presence of Tip-DCs. These findings suggest that the infiltration 
of Tip-DCs is dependent on the recruitment of classical Ly6C
+
 monocytes via CCR2 and 
that their differentiation and activation is dependent on the presence of CD8 T-cells and 
IFN-γ. Since CD8 T-cells have been shown to be the predominant effectors in CHS, 
compared to CD4 T-cells which infiltrate at a much later time point and produce Th2 
cytokines instead (Akiba et al., 2002; Desvignes et al., 1996; Xu et al., 1996), it is 
tempting to speculate that CD8 T-cells may rely on IFN-γ to differentiate infiltrating 




 monocytes into MHCII
+
 cells resembling Tip-DCs as well as for them to acquire 
iNOS and a increase in TNF-α expression.  
 
While studies in IFN-γ-/- mice have shown that the differentiation and activation of Tip-
DCs during CHS is dependent on IFN-γ, it was surprising that TMA-treated mice had a 
significant reduction in the presence of Tip-DCs compared to DNCB-treated mice even 
though both treatments showed similar levels of IFN-γ in the draining lymph nodes and 
challenged sites. These results suggest that the differentiation of Tip-DCs can be down 
modulated by other cytokines. Notably, IL-10 has been shown to reduce the presence and 
pathogenicity of Tip-DCs (Bosschaerts (Bosschaerts et al., 2010; Guilliams et al., 2009) 
and since increased IL-10 concentrations were detected in TMA-treated compared to 
DNCB-treated samples, this could possibly account for the reduced presence of Tip-DCs 
seen in TMA-treated samples. It is also interesting to note that Tip-DCs were detected in 
substantial numbers only in DNCB-treated mice, which was associated with a Th1 
phenotype, as opposed to TMA-treated mice which was associated with a Th2 cytokine 
profile. This suggests that the presence of such Tip-DCs may represent a major class of 
Th1 regulated effector cell population which may serve to further support Th1 responses. 
Similarly, its minimal presence in a Th2 dominant environment, such as in TMA-treated 
mice, may imply that these Tip-DCs do not serve to exacerbate Th2 responses.  In 
support of this observation, CCR2
-/- 
mice have been shown to have enhanced Th2 but 
reduced Th1 differentiation (Rivera et al., 2011; Traynor et al., 2002) and that Tip-DCs 
are important for the clearance of pathogens that require Th1 regulated responses 
(Aldridge et al., 2009; De Trez et al., 2009; Serbina et al., 2003). While the expression of 
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TNF-α and iNOS by Tip-DCs may be important for the clearance of invasive pathogens, 
TNF-α is also a mediator of septic shock (Tracey and Cerami, 1994) and NO exerts 
significant tissue damage through oxidative stress (Aldridge et al., 2009; Ishiyama et al., 
2009). Therefore, in the presence of sterile inflammation such as in CHS responses, the 
differentiation of Tip-DCs by CD8 T-cells may serve to exacerbate the pathology of CHS 
which is supported by our findings demonstrating significant reduction in CHS responses 
when Tip-DCs were absent in CCR2
-/-
 mice. Collectively, our results hence provide 
further insight to the immunomodulatory functions of CD8 T-cells by demonstrating the 
importance of these cells in the differentiation of Tip-DCs as part of a Th1 regulated 
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CHAPTER 8: Final Discussion  
________________________________________________________________________ 
 
8.1 Summary of Main Findings 
 
In this thesis, we first demonstrated the ability of human CD8 T-cells to support Th1 
responses by priming DCs for IL-12p70 and inducing the development of monocytes into 
Tip-DCs (Chong et al., 2011). We show that activated human CD8 T-cells could induce 
DCs to produce IL-12p70 in vitro in the presence of LPS through IFN-γ and that this 
mechanism was independent of CD40L signaling. This CD8 T-cell-DC interaction also 
resulted in the production of a cytokine milieu containing GM-CSF, IL-1, IL-2, IL-6, 
IFN-γ, and TNF-α that promoted the differentiation of monocytes into Tip-DCs. These 
Tip-DCs expressed high levels of TNF-α and iNOS, MHC class II and upregulated co-
stimulatory molecules CD40, CD80 and CD86. They also had increased expression of 
toll-like receptors TLR2, TLR3, TLR4 and chemokine receptors CCR1 and CX3CR1. 
Importantly, Tip-DCs expressed the classical DC maturation marker CD83, exhibited T-
cell priming ability and were capable of further driving Th1 responses, through their 
expression of TNF-α and iNOS, by priming naive CD4 T-cells for IFN-γ production. 
Differentiation of monocytes into Tip-DCs was partially dependent on IFN-γ as blocking 
the IFN-γ receptor on monocytes resulted in a significant decrease in CD40, CD83 
expression and TNF-α production. Finally, we showed that the ability of CD8 T-cells to 
differentiate monocytes into Tip-DCs can also be demonstrated in an in vivo mouse 
model of allergic contact hypersensitivity (CHS). This differentiation and activation of 
Tip-DCs during CHS responses was compromised in ß2m
-/-
, IFN-γ-/- and CCR2-/- mice 
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and mice that were depleted of CD8, but not CD4, T-cells. In particular, the presence of 
Tip-DCs was significantly increased in mice that have been treated with a Th1-inducing 
topical sensitizer, DNCB, but not in mice that have been treated with a Th2-inducing 
sensitizer, TMA. Collectively, our results identify a role for CD8 T-cells in orchestrating 
Th1-mediating signals, not only through the rapid initiation of DC IL-12p70, but also 
through the differentiation of monocytes into Tip-DCs. A schematic illustration of this 


























Fig.8.1   Model for the role of CD8 T cells in orchestrating a Th1 response.  
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8.2 Limitations of study 
 
One of the main limitations of this study is the physiological relevance of the model that 
was proposed of how human CD8 T-cells could interact with DCs to produce IL-12p70 
and support Th1 responses through the differentiation of Tip-DCs. As this model was 
demonstrated in vitro, it remains unknown where and how this could occur in vivo. In 
addition, since we have only adopted supernatants from co-cultures of CD8 T-cells and 
DCs to differentiate monocytes, it is unclear if other soluble factors may play a role in an 
in vivo setting. To try and understand how this may take place, we have investigated CD8 
T-cells and Tip-DCs in an in vivo murine model of contact hypersensitivity and 
demonstrated that CD8 T-cells are indeed important for the differentiation of Tip-DCs. In 
addition, several studies in mice have shown that CD8 T-cells are essential for the 
promotion of Th1 responses in vivo which may occur through promoting IL-12p70 from 
DCs (Gurunathan et al., 2000; MacAry et al., 1998; Peterson et al., 2002; Thomas et al., 
2002; Uzonna et al., 2004). However, while these in vivo studies in mice have supported 
our model of human CD8 T-cell’s role in Th1 responses in vitro, the translational 
implications from mice to humans still remains unknown. 
 
Human psoriasis studies, which allow investigations through skin biopsies obtained from 
normal skin and psoriatic lesions, have provided several indications that CD8 T-cells may 
play an important role in the pathology of this disease. CD8 T-cells have been shown to 
be the key player in the maintenance of chronic human psoriatic lesions, due to the 
association of MHC class I with psoriasis (Henseler and Christophers, 1985), the 
Chapter 8: Final Discussion 
 239 
persistence of Vß3 and Vß13.1-bearing CD8 T-cells in lesions (Chang et al., 1994) as 
well as the rapid and selective clearing of CD8 T-cells with successful UVB therapy 
(Krueger et al., 1995) in association with the clinical resolution of the lesion. CD8 T-cells 
have also been shown to interact with DCs in psoriatic lesions where monocytes were 
also found to accumulate (Ghoreschi et al., 2007). Moreover, increased expression of IL-
12p70 by DC subsets has been detected in these lesions (Rosmarin and Strober, 2005; 
Yawalkar et al., 2009). Notably, a clinical study conducted by Chamian and colleagues 
(2004) has shown that administration of alefacept, an antibody that reduces the 
infiltration of activated memory CD8 T-cells into the skin, reduced DC content, 
inflammation and tissue expression of iNOS and IFN-γ in psoriasis patients. While this 
study did not mention the ability of CD8 T-cells to differentiate monocytes into Tip-DCs, 
the presence of Tip-DCs have also been recently described in human psoriasis studies 
(Lowes et al., 2005; Zaba et al., 2008). Taken together, these studies strongly suggest that 
human CD8 T-cells could mediate Th1 responses through DC IL-12p70 and 
differentiation of Tip-DCs. 
 
8.3 CD8 T-cells and the importance of their Th1-inducing responses 
 
While the ability of CD8 T-cells to eliminate pathogens and transformed cells through 
CTL killing mechanisms is well established, their helper role in maintaining Th1 
responses has only recently been appreciated. Our results demonstrate that activated IFN-
γ producing CD8 T-cells can rapidly prime both allogeneic and peptide-pulsed DCs for 
IL-12p70 production. IL-12p70 is a hallmark inflammatory cytokine essential for 
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inducing potent immune responses (Brunda et al., 1993; Trinchieri, 2003; Weiss et al., 
2007).  Notably, its production is limited to innate immune cells such as DCs, 
macrophages, and neutrophils, thereby providing a critical bridge between innate and 
adaptive immunity (Trinchieri, 2003).  
 
The potential therapeutic uses of IL-12 in correcting Th2 dominant diseases have been 
described. In particular, many murine studies have shown that this cytokine can potently 
inhibit allergic airway inflammation in the lung (Gavett et al., 1995; Hogan et al., 1998; 
Stämpfli et al., 1999). In addition, adoptive transfer of CD8 Tc1 cells into asthmatic mice 
suppressed airway hyperresponsiveness and allergic airway inﬂammation (Ishimitsu et 
al., 2001; Renz, 1994; Takeda et al., 2009; Wells et al., 2007). Unfortunately, 
administration of IL-12 to patients with asthma has been limited due to toxicity and 
adverse side effects (Bryan et al., 2000). Nevertheless, the use of IL-12 linked to 
polyethylene glycol (PEG) moieties serves as another treatment option that has the 
potential of inducing a Th1 cytokine response (Leonard and Sur, 2003). This mode of 
administration is likely to enhance cytokine delivery to the target organ, while decreasing 
its toxicity, thereby serving as a promising IL-12 therapy for asthma.  
 
In cancer, the use of IL-12 in human clinical trials has shown promising results in some 
forms of cancer (Anwer et al., 2010; Atkins et al., 1997; Younes et al., 2004). 
Importantly, studies have shown that transfer of type-1 polarized DCs that are capable of 
producing high amounts of IL-12 have proven effective in treating patients with recurrent 
maglinant glioma (Okada et al., 2011). In particular, Kalinski and colleagues (Nakamura 
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et al., 2007) have shown that heterologous IFN-γ-producing CD8 T-cells can support the 
ability of DCs to produce IL-12p70 in vivo which strongly enhances the IL-12p70-
dependent immunogenic and therapeutic effects of vaccination in the animals bearing 
established tumors. Recently, Kerka and colleagues (Kerkar et al., 2011) also 
demonstrated that engineering tumor-specific CD8 T-cells to secrete IL-12 resulted in 
improved therapeutic efficacy in a B16 mouse model of established melanoma. 
Interestingly, they report that these engineered CD8 T-cells interacted with myeloid 
derived suppressor cells, macrophages, and DCs within tumors via MHC class I and upon 
producing IL-12, triggered a programmatic change in these suppressive APCs which 
allow them to improve the ability of antigen-specific CD8+ T cells to eliminate large 
established tumors. These results suggest that the use of CD8 T-cells or type-1 polarized 
DCs to re-program the suppressive tumor environment into a Th1 inflammatory state is a 
promising therapy for the treatment of solid tumors. 
 
8.4 Challenges of characterizing monocyte-derived cells into DCs or macrophages 
 
The role and function of DCs and macrophages have been clearly distinctive until recent 
years with the discovery of increasing subsets of DCs and macrophages in different 
anatomical sites that appear similar in function and phenotype to each other. This is 
particularly true during inflammation when monocytes can differentiate into DCs or 
macrophages and is compounded by the lack of reliable surface markers that truly 
differentiates DCs from macrophages. For example, while CD11c has been shown to be a 
classical DC marker for mouse studies, alveolar macrophages in the lung have also been 
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found to express CD11c (Gonzalez-Juarrero et al., 2003; Jakubzick et al., 2008); while 
CD11b and F4/80, markers universally thought to identify macrophages have been shown 
to be expressed very poorly on splenic and pulmonary macrophages (Gonzalez-Juarrero 
et al., 2003; Idoyaga et al., 2009; Jakubzick et al., 2008). The functional paradigm of DCs 
and macrophages has also been challenged when recent studies show that LCs are not 
important for T-cell priming (Kissenpfennig et al., 2005) and while some macrophages 
such as Kupffer cells are actively phagocytic, other macrophages like microglial cells are 
not (Geissmann et al., 2010).  Nevertheless, the general consensus is that DCs are the 
most potent antigen-presenting cells (Geissmann et al., 2010) 
 
The characterization of differentiated monocytes into Tip-DCs has also been 
controversial. Some have proposed that these Tip-DCs, first described during infection 
with Listeria monocytogenes (Serbina et al., 2003), resemble activated M1 macrophages 
(Geissmann et al., 2010) as M1 macrophages have also been shown to express high levels 
of co-stimulatory molecules, oxidative metabolites and inflammatory cytokines (Gordon 
and Taylor, 2005). However, although Tip-DCs and M1 macrophages share several 
functions and express common genes, we have shown in our studies that human 
monocytes differentiated with CD8 T-cell-DC supernatants develop functional and 
phenotypic characteristics of Tip-DCs and differed slightly from M1 macrophages.  We 
found that these Tip-DCs had lower phagocytic activity, higher MHC II expression and 
were more efficient in priming naive T-cells compared to M1 macrophages. Moreover, a 
study performed by Delneste and colleagues (2003) has shown that human monocytes 
differentiated with IFN-γ and GM-CSF, two important factors for Tip-DC differentiation, 
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exhibited more DC-like properties compared to monocytes cultured with IFN-γ and M-
CSF. Therefore, it would be interesting to determine if the levels of GM-CSF versus M-
CSF during inflammation may also alter the functional outcome of differentiated 
monocytes into DCs or macrophages respectively in vivo. Moreover, a clearer distinction 
between Tip-DCs and M1 macrophages can only be made when both Tip-DCs and M1 
macrophages can be found and distinguished in the same anatomical inflammatory 
setting in vivo. Therefore, it would be of interest to further characterize the Tip-DCs from 
other macrophage-like cells seen in inflamed skin of CHS mice to establish these 
differences. In addition, it is hoped that microarray and proteomic analysis will yield new 
markers to detect proteins that will better distinguish macrophages from DCs.  
 
8.5 Potential role of Tip-DCs in allergic contact dermatitis 
 
We found that a decrease in Tip-DCs was associated with a reduction in CHS responses 
in our in vivo model of contact hypersensitivity. In addition, our preliminary data 
showing the clustering of Tip-DCs with T-cells in the inflamed skin, as well as with 
endothelial structures, suggest that Tip-DCs may potentially play a role in the induction 
of T-cell responses and vascular changes. Tip-DCs have been shown to interact with T-
cells in many peripheral inflammatory settings. In skin infection with L. major, Tip-DCs 
have been implicated in the induction of CD4 Th1 responses  (León et al., 2007). 
Infection of Cryptococcus neoformans, an environmental fungus that causes pulmonary 
infections following inhalation, also caused a skewing of Th2 from Th1 CD4 T-cell 
responses when Tip-DCs were absent in CCR2
-/-
 mice, thereby resulting in prolonged and 
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more severe pulmonary infection and pathology (Traynor et al., 2002). In addition, Tip-
DCs were also found to be important in supporting virus-specific CD8 T-cells in 
influenza-infected lungs (Aldridge et al., 2009). Lastly, Tip-DCs were also essential for 
supporting both Th1 and Th17 responses in skin lesions of psoriatic patients (Zaba et al., 
2007).  Since Tip-DCs were demonstrated to prime Th1 responses in our human in vitro 
data, it would be of interest to determine if Tip-DCs present in CHS-elicitated skin are 
also capable of mediating such Th1 responses.  
 
In particular, monocyte-derived cells have been shown to be involved in modulation of 
vascular structures as they express high levels of TNF-α, ROS as well as vascular 
endothelial growth factors (VEGFs) (Eubank et al., 2003; Gordon and Taylor, 2005; 
Gröne et al., 1995; Hojo et al., 2000). In particular, TNF-α is a major mediator of 
vascular permeability (Clauss et al., 2001; Ferrero et al., 2001; Hofmann et al., 2002) 
while the production of NO from iNOS-expressing cells can induce vasodilation and 
vascular leakage, resulting in edema at peripheral sites (Hughes et al., 1990; Ialenti et al., 
1992). Moreover, NO can interact with the superoxide anion to produce a reactive 
peroxynitrite radical that causes cell damage and is cytotoxic to endothelial cells leading 
to further vascular damage (Beckman et al., 1990; Parks and Granger, 1983). VEGF 
production not only leads to an increase in angiogenesis and lymphangiogenesis, but also 
an increase in vascular permeability when present in excessive amounts (Murohara et al., 
1998; Sirois and Edelman, 1997; Weis and Cheresh, 2005). Since Tip-DCs also express 
high levels of TNF-α and iNOS and are found to locate proximately to endothelial 
structures, it would be interesting to determine if they also express VEGFs and if they 
Chapter 8: Final Discussion 
 245 
contribute to vascular permeability leading to exacerbation of edema seen in CHS 
responses.  
 
8.6 Monocytes and immunotherapy 
 
The rapid infiltration of classical monocytes during inflammation is important for the 
clearance of pathogens (Geissmann et al., 2010).  However, their excessive and 
prolonged recruitment hinders the resolution of inflammation and is a hallmark of 
numerous diseases. Studies of allergic contact dermatitis have shown that treatment with 
corticosteroids, which resolves symptoms associated with inflammation, is accompanied 
by a reduction in monocytes (Tuckermann et al., 2007). Since we also showed that the 
decreased presence of monocyte-derived Tip-DCs was accompanied with a reduction in 
CHS responses, targeting monocytes could be of therapeutic value to reduce the 




 mice have attenuated levels of inflammation in many disease 
models (Shi and Pamer, 2011). Indeed, a recent study (Leuschner et al., 2011) showed 
that monocytes can be targeted via CCR2 by developing a lipid nanoparticle that encap-
sulated a short interfering RNA (siRNA) that selects for Ccr2 mRNA (siCCR2). By 
labelling the siRNA with a near-infrared fluorochrome, siCCR2 could be tracked in mice 
using fluorescence molecular tomography. siCCR2 was injected intravenously and was 
shown to accumulate in sites of monocyte reservoirs, such as the spleen and bone 
marrow, with the highest uptake of siCCR2 by Ly6C
hi
 monocytes. Importantly, the 
Chapter 8: Final Discussion 
 246 
authors showed that knocking down CCR2 with siRNA yielded therapeutic benefits in a 
couple of disease models. Pre-treatment of mice for 3 days before or 1 hour following 
induction of ischaemia–reperfusion injury with siCCR2 resulted in a decrease in the 
infarct size by 34%. Similarly, treatment of atherosclerotic mice with siCCR2 decreased 
the number of Ly6C
hi
 monocytes in the atherosclerotic plaques and reduced the lesion 
size in the aortic root and siCCR2 treatment of mice with diabetes prior to pancreatic islet 
transplantation significantly extended the normoglycaemic period. Finally, siCCR2 
treatment of mice that had palpable tumors resulted in a reduction in tumor growth and  
tumor-associated macrophage numbers, as well as decreased vascular endothelial growth 
factor levels and number of microvessels in the tumor. 
 
8.7 Future directions 
 
Determining if murine monocytes differentiate towards Tip-DCs in vitro 
Although we have shown that human monocytes are able to differentiate into Tip-DCs in 
vitro with CD8 T-cell-DC cytokine milieus, whether this may occur using murine 
monocytes in vitro remains unknown. Therefore a few key experiments demonstrating 
this phenomenon would be useful to complete the mechanism that has been shown in the 
mouse model of contact hypersensitivity in vivo. 
 
Determining other factors important for the differentiation of Tip-DCs 
We showed that IFN-γ was an important factor for the differentiation of human 
monocytes into Tip-DCs. However, differentiation of monocytes with IFN-γ alone was 
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insufficient to generate viable cells that could prime T-cells as well as Tip-DCs. In 
particular, GM-CSF has been shown to be a promising factor in mouse studies for the 
differentiation and support of inflammatory DCs (Campbell et al., 2011; Shortman and 
Naik, 2007; Xu et al., 2007). It would hence be of interest to determine if GM-CSF is the 
missing factor in our human in vitro studies in the differentiation of viable Tip-DCs. In 
addition, the IL-12p40 homodimer has recently been implicated in the stimulation of 
myeloid cells to produce TNF-α and NO (Jana et al., 2003; Pahan et al., 2001). Therefore 
a greater understanding of the factors that are necessary for the differentiation of Tip-
DCs, this would help with the manipulation of cytokine therapies beneficial for 
improving diseases. 
 
Exploring the dichotomy of CD8 T-cells in DNCB vs TMA elicitation of CHS 
In support of previous findings, we showed that TMA-treated mice had a significant 
increase in Th2 cytokines such as IL-4, IL-5, IL-10 and IL-13 as compared to DNCB-
treated mice. While studies have shown that such Th2 cytokines are mainly produced by 
CD4 T-cells during CHS (Dearman et al., 1996; Gorbachev et al., 2001b; Xu et al., 
1996), CD8 T-cells expressing Th2 cytokines, known as Tc2 cells, have also been 
reported in other disease models (Ito et al., 2005a; Salgame et al., 1991; Ying et al., 
1997). Given that CD8 T-cells infiltrate as early as 3 hours after challenge into the 
elicitation site (Akiba et al., 2002; Kish et al., 2011), it would be of interest to determine 
if CD8 Tc2 cells are present in TMA-treated mice and if they play a role in attenuating 
the inflammatory response.  
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Understanding the physiological and immunological role of Tip-DCs in skin 
inflammation 
We noted that CCR2
-/-
 mice had a dramatic decrease in the infiltration of Tip-DCs during 
CHS elicitation. This was accompanied by a reduction in the amount of edema seen in the 
ears. Neutrophils and mast cells have been shown to be the main mediators of vascular 
permeability (Di Gennaro et al., 2009; Dvorak, 2005; Edens and Parkos, 2003; Oschatz et 
al., 2011). However, it is unknown if Tip-DCs can exacerbate vascular permeability to 
aggravate the inflammatory response. It would therefore be of interest to determine, for 
the first time, if Tip-DCs are responsible for the exacerbation of vascular permeability by 
conducting in vitro assays with Tip-DCs and dermal blood endothelial cells. In addition, 
Tip-DCs were shown to interact with T-cells in the inflamed skin of WT mice. The 
repertoire of T-cells in the dermal skin is heterogeneous, consisting of both αß+ and γδ+ 
T-cells. While the role of αß+ T-cells in CHS is well established, γδ+ T-cells have shown 
both inflammatory and down-regulatory functions (Guan et al., 2002; Sumaria et al., 
2011) and further studies on how Tip-DCs may modulate γδ+ versus αß+ T-cells can be 
conducted to further understand their role in the exacerbation or resolution of 
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